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The transparency of the lens is maintained throughout life, at least in part, by the chaperone 
activity of the small heat shock protein (sHSP) αB-crystallin (αB). However, modified forms 
of αB, including phosphorylated and deamidated isoforms, accumulate in insoluble protein 
fractions from the lens with age. This has led to the suggestion that modification of αB is a 
precursor to age-related nuclear cataract formation. This thesis investigated whether 
phosphorylated αB could contribute to cataract formation by facilitating the formation of the 
nucleocortical barrier, a physical barrier to the diffusion of small molecules into the nucleus 
of the lens that forms at middle age. To determine how phosphorylation may modulate the 
chaperone activity of αB, single (S19D; S45D; S59D), double (S19D and S45D) and triple 
(S19D, S45D and S59D) mutants of αB which mimic phosphosphorylation at three key serine 
residues (Ser19, Ser45 and Ser59) were used in an in vitro aggregation assay and their 
activity compared to wild type (WT) αB. Whilst WTαB failed to inhibit the heat-induced 
aggregation of creatine phosphokinase (CPK), the triple mutant (i.e. αB S19D, S45D and 
S59D) inhibited the aggregation of CPK by 83.9±1.3%. Thus, it is concluded that the addition 
of negative charges to αB, similar to those added by phosphorylation, increases its chaperone 
activity. 
Next, protein was isolated from adult human lenses via sucrose density centrifugation and 
separated using 2-dimensional sodium dodecylsulphate polyacrylamide gel electrophoresis 
(2D SDS PAGE) to identify changes in αB phosphorylation and the deamidation of 
cytoskeletal proteins that occurs with age across different regions of the lens. The amount of 
multiply phosphorylated αB (i.e. phosphorylated at multiple residues) was increased in high-
density protein fractions from the lens (representing membrane-bound protein) compared to 
low density protein fractions. The amount of multiply phosphorylated αB increased towards 
the nucleus in the aged lenses. In some high density protein fractions there was also evidence 
of crosslinked high molecular weight complexes (HMWCs), involving αA-crystallin (αA), 
αB and cytoskeletal proteins including filensin. This provides evidence for the involvement 
of α-crystallin, via binding to intermediate filaments, in the formation of a network that 
supports the fibre cell membrane. 
To determine whether the association of αB with fibre cell membranes could also be 





identify interactions between isoforms of αB and the abundant membrane pore proteins 
aquaporin 0 (AQP0) and connexin 46 (Cx46). Interactions between αB and both AQP0 and 
Cx46 were restricted to the cortex of the lens in a region coinciding with the putative location 
of the nucleocortical barrier, although total αB continued to associate with membranes in the 
nucleus of the lens. This pattern was more prominent for the pSer59 isoform, with minimal 
interactions between pSer19 αB and membrane pore proteins throughout the lens. 
Finally, recombinant human αB was heat-treated under acidic (~pH 3.0), basic (~pH 8.0) and 
unfolding buffer conditions in order to determine whether it was susceptible to non-
enzymatic deamidation, a process known to occur with age in the lens. An additional site of 
deamidation in αB was identified in the sample that was heat-treated under slightly alkaline 
(~pH 8.0) buffer conditions (i.e. deamidation occurred at both N146 and N78) compared to 
the sample heat-treated under acidic buffer conditions (i.e. deamidation occurred only at 
N146). Although the amount of deamidation at each site was unaffected by protein unfolding, 
a slight decrease in buffer pH (from ~pH 8.0 to ~pH 7.4) significantly increased the amount 
of deamidation at N146 and Q151 of αB.  
Based on the results of this work, a new model for age-related cataract formation is proposed, 
whereby phosphorylation of αB induces its association with membrane pore proteins (such as 
AQP0 and Cx46) and deamidated cytoskeletal components (particularly filensin) that coat the 
membrane. It is proposed that if these interactions mediate the formation of the nucleocortical 
barrier at middle age, the inhibition of the transport of glutathione (GSH) and water into the 
lens nucleus would result in an oxidative environment in the nucleus of the lens. This 
provides a pathway for protein cross-linking and aggregation of proteins that form the 
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The lens is a transparent structure located in the eye that is responsible for the transmission 
and focusing of light onto the retina. During life, the lens has negligible protein turnover, and 
thus lenticular proteins are vulnerable to the accumulation of post-translational modifications 
and damage that can compromise the transparency of the lens, leading to cataract. The 
transparency of the lens is therefore maintained, in most cases, throughout life by the 
chaperone activity of α-crystallins (Sun et al., 1997), which act to ensure lenticular proteins 
remain in a soluble state. However, α-crystallin is itself vulnerable to post-translational 
modifications (PTMs), and these are believed to have the ability to alter its chaperone 
activity.  It has been shown that phosphorylated α-crystallin accumulates within lens fibre 
cells with age (Takemoto and Boyle, 1998), but it is unclear if, and in what way, this may 
contribute to cataract formation. It has also been proposed that the formation of the 
nucleocortical barrier, a barrier to diffusion that is known to form in the lens at around middle 
age, directly contributes to cataract formation (Sweeney and Truscott, 1998; Truscott, 2000; 
Truscott, 2005) by leading to the formation of an oxidative environment in the centre of the 
lens. The mechanism behind barrier formation also remains unclear, and any potential link 
between α-crystallin phosphorylation and barrier formation is yet to be elucidated.  This 
chapter discusses these complimentary theories in the context of the ageing lens. 
 
 
1.2 The Lens 
 
The lens is located in the eye, anterior to the vitreous humour and posterior to the aqueous 
humour and the iris. It is held in position by the suspensory ligaments which anchor it to the 
ciliary body (Ross and Pawlina, 2006) (Figure 1.1). The role of the lens is to bend or refract 
incoming light that has already passed through the cornea and the pupil at such an angle that 
the rays focus directly onto the light-sensitive retina, the innermost layer of the wall of the 
eyeball (Ross and Pawlina, 2006). The lens achieves this through the process of 
‘accommodation’, whereby the curvature of the lens is adjusted by the ciliary muscle to allow 
light reflected off objects at various distances from the eye to be bent at the correct angle for 




retina, the sensory organ of the eye, light energy is transferred into action potentials, through 
a process known as ‘transduction’ (Silverthorn, 2007).  
 
Figure 1.1: Internal and external structures of the eye. The lens is attached to the ciliary 
body via the suspensory ligaments (not labelled), which act to suspend it in a position anterior 
to the vitreous humour and posterior to the aqueous humour and iris. Light passes through the 
cornea and pupil and is transmitted through the lens which, through the process of 
accommodation, acts to focus the rays directly onto the retina. Image obtained from National 
Eye Institute (2015a). 
 
Synthesis and growth of the lens commences in utero and continues until death (Phelps 
Brown and Bron, 1996), with the average mature lens reaching 4 mm in width, and 9 mm in 
diameter (Harper and Shock, 2004). The lens, which is asymmetric and biconvex in shape 
(Figure 1.2), is entirely covered by a thick but permeable capsule which protects it from 
bacterial infection whilst allowing the diffusion of materials such as water, ions and proteins 
via the humours. This capsule, which is composed of connective tissue, notably Type IV 
collagen, is secreted by the epithelial cells in utero (Phelps Brown and Bron, 1996).  
Within the capsule, the bulk of the lens consists of a mass of fibre cells covered at the 
anterior surface by a single layer of epithelial cells which extend as far as the equator 




to the equator of the lens as they differentiate into fibre cells, elongate and wrap around the 
lens, meeting at their tips to form sutures (Papaconstantinou, 1967; Grey and Schey, 2009). 
Differentiation of epithelial cells into fibre cells involves the degradation of the organelles 
and nucleus in order to attain the state of transparency required for effective light 
transmission (Han and Schey, 2006; Grey and Schey, 2009) 
This pattern of growth, where the addition of new cells on top of older cells in the centre of 
the lens, results in the formation of two indiscrete zones (Han and Schey, 2006): the nucleus, 
defined as the lenticular material that was present at birth; and the cortex, concentric layers of 
cells that are laid down postnatally (Phelps Brown and Bron, 1996). At around middle-age, a 
barrier forms between these regions, known as the ‘nucleocortical barrier’ (Sweeney and 
Truscott, 1998; Shestopalov and Bassnett, 2000; Cobb and Petrash, 2002b; Truscott, 2005). 
The precise nature of this barrier is unknown, although it is believed to inhibit the diffusion 
of water and other molecules between the two regions (Cobb and Petrash, 2002b; Truscott, 
2005). 
 
Figure 1.2: Structure of the optical lens along the meridial plane. The lens is composed of 
concentrically layered fibre cells, covered at the anterior pole by a single layer of epithelial 
cells, shaded in grey. The outer border of the lens on the equatorial plane is known as the 
equator, indicated by the black broken line, and is the site of differentiation of the epithelial 
cells into fibre cells. The purported location of the nucleocortical barrier is indicated by the 




The lens proteome 
Due to the absence of a nucleus and organelles in lenticular fibre cells, protein synthesis is 
not possible, thus the lens is particularly prone to degradation with age (Han and Schey, 
2006). Most notably, there is a decrease in elasticity that is due, in part, to the loss of α-
crystallin (Heys et al., 2007), the formation of protein crosslinks (Phelps Brown and Bron, 
1996; Truscott, 2005), and the formation of insoluble high molecular weight (HMW) protein 
complexes that also cause increased light scattering (Benedek, 1971; Horwitz, 1993; Carver 
et al., 1996; Phelps Brown and Bron, 1996; Hejtmancik and Kantorow, 2004; Moreau and 
King, 2012). Other changes in the lens that are associated with age include decreased 
membrane permeability due to increased chain length and saturation of membrane 
phospholipids (Merchant et al., 1991), decreased amount and activity of enzymes (Hockwin, 
1965; Hockwin et al., 1965; Sethna et al., 1982; Phelps Brown and Bron, 1996; Cobb and 
Petrash, 2002b), the formation of the nucleocortical barrier (Cobb and Petrash, 2002b; 
Truscott, 2005) and a range of PTMs that occur to proteins  (Lund et al., 1996; Lin et al., 
1997; Lampi et al., 1998; Lin et al., 1998; Ma et al., 1998; Hanson et al., 2000; Lapko et al., 
2001; MacCoss et al., 2002; Truscott, 2005; Han and Schey, 2006; Wang et al., 2013). These 
events are highly significant as they contribute to the conditions of presbyopia and cataract 
(reviewed in Spector, 1995; Phelps Brown and Bron, 1996; Truscott, 2005). Presbyopia, or 
long-sightedness, occurs around middle-age as a result of the lens failing to accommodate 
efficiently, whereas cataracts result from the diffusion and obstruction of light transmission 
by insoluble HMW proteins (Benedek, 1971; Horwitz, 1993; Carver et al., 1996; Phelps 
Brown and Bron, 1996; Hejtmancik and Kantorow, 2004; Truscott, 2005; Moreau and King, 
2012; National Eye Institute, 2015b). 
Despite the lack of protein turnover, lenticular cells retain cytoskeletal and membrane protein 
components. Three cytoskeletal networks exist in the lens i.e. the actin, microtubule and 
intermediate filament networks (Figure 1.3), each of which retain distinct roles and assemble 
independently of each other (Quinlan et al., 1999). The actin and microtubule cytoskeletal 
networks are involved in cellular differentiation and cell transport processes respectively 
(Quinlan et al., 1999). The lenticular intermediate filament network comprises three filament 
proteins specific to the lens; vimentin, phakinin and filensin, the latter two of which are lens 
specific (Quinlan et al., 1999). Phakinin and filensin interact to form a filamentous network 
(FitzGerald and Graham, 1991; Carter et al., 1995; Quinlan et al., 1999) that is believed to be 




al., 2007). Both filensin (Sandilands, Prescott, Hutcheson, et al., 1995) and phakinin 
(Sandilands, Prescott, Carter, et al., 1995) are highly susceptible to cleavage in the lens. It has 
been shown in vitro, that although only a 53 kDa fragment derived from the N-terminal head 
of filensin is required for filament formation (Masaki and Quinlan, 1997), neither filensin nor 
phakinin can form a filament without the presence of the other (Carter et al., 1995; 
Goulielmos et al., 1996).  In the lens, phakinin and filensin co-assemble at the fibre cell 
membrane to form a beaded filament protein (FitzGerald and Graham, 1991; Carter et al., 
1995). This structure interacts with αA and αB, which are believed to produce the 
characteristic beaded appearance of the beaded filament protein (Carter et al., 1995). It has 
been suggested that the association of the α-crystallins with filensin and phakinin is essential 
for intermediate filament formation (Ghosh et al., 2005). Additionally, an R120G point 
mutation of αB has been implicated in the breakdown of the intermediate filament network 
associated with desmin-related myopathy, being incorporated into the protein aggregates 
characteristic of the disease (Vicart et al., 1998).  
 
 
Figure 1.3: Cytoskeletal networks of the cell. Representation of a cell depicting the three 
cytoskeletal networks; the actin (green), intermediate filament (red) and microtubule (blue) 
network. Cytoskeletal networks anchor to the cell membrane (grey) and function in cell 
transport and structural maintenance. The nucleus is indicated by purple sphere. Image 
obtained from the National Institute of General Medical Sciences (2012). 
 
The most abundant membrane pore proteins in the lens are the aquaporins (Bassnett et al., 




present in mature fibre cells (Varadaraj et al., 2007). Both are believed to act as water 
channels in the lens (Varadaraj et al., 2007; Kumari et al., 2011) with AQP0, constituting 
over 50% of membrane proteins (Varadaraj et al., 2007), also taking part in cell-to-cell 
adhesions (Kumari et al., 2011). The second most abundant membrane protein in the lens is 
membrane protein 20 (MP20), which is thought to be involved in fibre cell junction 
formation and organisation (Tenbroek et al., 1992). The final family of membrane proteins in 
the lens are the connexins; Cx43, Cx46 and Cx50. These proteins interact to form hexamer 
hetero- or homotypic hemichannels (connexons), which align with hemichannels on the 
surfaces of neighbouring cells to form gap junctions (Molina and Takemoto, 2012). Each of 
the connexins have distinct distribution patterns within the lens; Cx43 is found exclusively in 
epithelial cells while both Cx50 and Cx46 exist in mature fibre cells, where Cx50 decreases 
in abundance towards the nucleus and Cx46 increases in abundance towards the nucleus 
(Molina and Takemoto, 2012). Like all members of this family, lenticular connexins are 
involved in ion and small solute transport in the lens (Beyer and Berthoud, 2014). However, 
Cx46 has also been shown to transport glutathione (GSH) into the nucleus of the lens (Slavi 
et al., 2014), as well as protect lenticular epithelial cells against hypoxic stress in vitro 
(Banerjee et al., 2010). The remaining 90% of lenticular proteins are comprised of the 
crystallins (Wistow and Piatigorsky, 1988; Groenen et al., 1994; Han and Schey, 2006). 
 
 
1.3  Small Heat Shock Proteins and α-Crystallin 
 
1.3.1 Small Heat Shock Proteins (sHsps) 
The sHSPs are a ubiquitous family of proteins that typically have a monomeric mass less than 
30 kDa (Perng et al., 1999) and reside in the cytosol of cells under physiological conditions 
(Klemenz et al., 1991b), where they form multisubunit oligomers (Peschek et al., 2009). In 
most cells, sHsps, (there are 10 isoforms in humans, denoted HSPB1-10), are induced under 
stress conditions and operate as molecular chaperones by binding exposed hydrophobic 
regions of partially unfolded proteins, thereby acting to prevent aggregation (de Jong et al., 
1998). They differ from other heat shock proteins (Hsps) in that they do not actively aid 
protein refolding (Bloemendal et al., 2004) and as such their activity is adenosine 




are characterised by the presence of a region of conserved amino acid residues known as the 
‘α-crystallin domain’ (ACD), located close to the C-terminus (de Jong et al., 1998). This 
region is flanked by a hydrophobic N-terminal domain, and a hydrophilic C-terminal tail, 
both of which are necessary for maintaining chaperone activity (de Jong et al., 1998). The N-
terminal domain provides accessible binding sites for exposed hydrophobic regions of 
partially unfolded proteins, whilst the flexible C-terminal tail interacts with the solvent to 
maintain solubility (Farnsworth et al., 1998). Both of these domains are variable in sequence 
and length in the different human sHsps, leading to variation between the activity of different 
protein species (Peschek et al., 2009), for example in terms of substrate specificity.  
 
1.3.2 α-Crystallin 
The crystallins are water-soluble proteins (Sun et al., 1997) present in the cytoplasm of 
lenticular fibre cells. The crystallin family constitutes 90% (by weight) of the total protein 
content of the lens (Wistow and Piatigorsky, 1988; Groenen et al., 1994; Han and Schey, 
2006), and encompasses three classes of proteins, the α-, β- and γ-crystallins. These proteins 
are present in the cell at ratios that prevent crystallisation of proteins at high concentrations, 
and ensure optimal conditions for the reduction of cytoplasmic viscosity, the control of cell 
volume through the monitoring of osmotic pressure and the regulation of cytoplasmic 
stability (Tardieu, 1998). In conjunction with this, all three crystallin classes play a structural 
role in the lens (De Jong et al., 1994; Horwitz et al., 1999; Grey and Schey, 2009), 
controlling protein-to-protein interactions in order to provide a light-refractive media that 
optimises light transmission (Carver and Lindner, 1998). 
In the human lens, α-crystallin is present at a concentration of 300-450 mg/mL (Fagerholm et 
al., 1981; Veretout and Tardieu, 1989; Koretz et al., 1998) and consists of two closely related 
subunits, αA (HSPB4) and αB (HSPB5) (Schoenmakers and Bloemendal, 1968; Van Der 
Ouderaa et al., 1973; Van Der Ouderaa et al., 1974; Phelps Brown and Bron, 1996; Sun et 
al., 1997). α-Crystallin is the most abundant of the crystallins, constituting 40% of the total 
protein content of the lens (Peschek et al., 2009). It was originally thought that the sole 
function of α-crystallin was to act as a structural protein, increasing the refractive index of the 
lens above that of the humours (Koretz et al., 1998), a function that it shared with both β- and 
γ-crystallin (Phelps Brown and Bron, 1996). In this way, it was considered to be a ‘required 




solubility and longevity, as opposed to a specific activity (Koretz et al., 1998).  However, 
Ingolia and Craig (1982) observed that a region of α-crystallin showed sequence similarity to 
the regions of Drosophila proteins Hsp23, Hsp22, Hsp26 and Hsp27 (designated the ACD). 
Further studies found that α-crystallin displayed chaperone activity (Horwitz, 1992), that αB 
was also induced in NHN 3T3 cells by heat and chemical stress (Klemenz et al., 1991b), and 
that αB trafficked into the nucleus under stress conditions (Klemenz et al., 1991b). These 
characteristics, which are shared by all sHsps, confirmed α-crystallin as a member of the 
sHsp family.  
The structure of α-crystallins 
The two subunits of α-crystallin, αA and αB, are homologs (Phelps Brown and Bron, 1996; 
Sun et al., 1997) coded for by different genes on different chromosomes (de Jong et al., 
1998).  The subunits are both approximately 20 kDa (Sun et al., 1997),  share 60% sequence 
similarity (Peschek et al., 2009) and, in the lens, exist in the cytoplasm at a ratio of three αA 
subunits to one B subunit (Bloemendal, 1981; De Jong et al., 1994). Each subunit contains a 
highly conserved ACD composed of seven β-strands that form a β sandwich fold 
(Laganowsky et al., 2010) (Figure 1.5A), and this domain alone has chaperone activity 
(Hochberg et al., 2014). The α-crystallin domain is flanked by two globular domains, formed 
by the N- and C- terminal regions (de Jong et al., 1998), with a highly flexible C-terminal tail 









Figure 1.4: Alignment of human αA- and  αB-crystallin. Amino acid sequences for human 
αA (CRYAA_HUMAN, accession number P02489) and αB (CRYAB_HUMAN, accession 
number P02511) were submitted to the ExPASy SIM alignment tool for alignment. N-
terminal domain is indicated with red text, ACD with blue text and the C-terminal domain in 
purple text. β-Sheet regions of ACD are underlined. 
  
Previous studies have shown that sequences within the α-crystallin domain of αB subunits 
interact to form dimers that feature an anti-parallel β-sheet at the interface (Bagneris et al., 
2009; Laganowsky et al., 2010; Braun et al., 2011; Clark et al., 2011; Jehle et al., 2011) 
(Figure 1.5A, B). The C-terminal tails of neighbouring dimers then bind to hydrophobic 
grooves also formed within the α-crystallin domain (Bagneris et al., 2009; Jehle et al., 2010; 
Laganowsky et al., 2010; Baldwin et al., 2011; Braun et al., 2011; Clark et al., 2011; Jehle et 
al., 2011), forming a polydisperse population of hetero-oligomers with an average size of 800 
kDa (Sun et al., 1997). α-Crystallin oligomers have been reported to exist in two 
substructural formations: high affinity monomeric and low affinity dimeric substructures 
(Benesch et al., 2008), the exchange between which is responsible for the moderation of 
activity.  
 Due to difficulty in achieving protein crystallisation, the structure of larger oligomers is 
based largely on conjecture with multiple models being proposed (Tardieu et al., 1986; 
Augusteyn and Koretz, 1987; Wistow, 1993; Carver et al., 1994; Vanhoudt et al., 2000; 
Bagneris et al., 2009; Baldwin et al., 2011; Braun et al., 2011; Jehle et al., 2011). More 
recently, multiple groups have independently proposed a model where hexamers interact to 




as pockets on the surface (Jehle et al., 2011), or within the hollow interior accessible through 
openings in the shell (Haley et al., 1998; Peschek et al., 2009; Braun et al., 2011) (Figure 
1.5C). Figure 1.5C depicts the quaternary structure of αB-crystallin based on electron 
microscopy data obtained by Peschek et al.(2009). 
 It has been reported that αB shows a bias towards a 24meric structure (Braun et al., 2011), 
which allows the formation of differently sized oligomers via either the association of extra 
dimers to the external pockets (Jehle et al., 2011) or the addition and subtraction of subunits 
to the shell itself (Baldwin et al., 2011; Braun et al., 2011). In the latter, the subtraction of 
subunits would lead to the exposure of hydrophobic regions found on the inner walls (Braun 
et al., 2011) and extensions (Bagneris et al., 2009), as well as the production of higher-
activity smaller oligomers (Peschek et al., 2013) and, eventually,  monomers (Aquilina et al., 
2004; Benesch et al., 2008). This may allow for the regulation of activity to be mediated by 
the dissociation of subunits. The importance of the fluidity of the structure has been recently 
highlighted by Mainz et al. (2015) who showed that upon exposure following subunit 
dissociation, the N-terminal domain is able to undergo conformational changes in order to 
mimic the properties of different disordered substrate proteins, allowing a wide range of 
protein interactions essential in order to prevent the  amorphous aggregation of substrate 
proteins. Alternatively, hydrophobic β-sheet structured regions within the static α-crystallin 
domain are also able to bind substrates with similar properties, enabling a separate pathway 
for the prevention of amyloid aggregation (Mainz et al., 2015).  It has been proposed that the 
3:1 ratio of αA to αB subunits in the lens is important in maintaining oligomeric thermal 
stability (Horwitz et al., 1999), while the dimeric substructure is key in regulating chaperone 





Figure 1.5: Model of recombinant human αB-crystallin structure. Model of the (A) ACD 
(pdb entry 2KLR; Jehle et al.(2010)), (B) dimer fold (pdb entry 3J07; Jehle et al. (2011)) of 
αB depicted as a ribbon representation (α-helices - red, β-sheets – blue, coils - grey), and the 
(C) 24-mer depicted as (i) surface representation, (ii) density cross-section and with (iii) 
dimeric α-crystallin domain of Hsp16.5 from M. jannaschii overlay (adapted from Peschek et 
al., 2009).  
 
αA is found almost exclusively in the lens (Peschek et al., 2009) with trace amounts being 
detected in the thymus, the spleen and the retina (Kantorow and Piatigorsky, 1998). The 
HSPB4 gene is located on chromosome 21 (de Jong et al., 1998),  the protein has a molecular 
mass of ~20 kDa and forms polydisperse homo-oligomers ranging in size from 440 to 720 
kDa (i.e. containing 22-36 monomers) (Aquilina et al., 2005) . αB is found in relatively high 
amounts in non-lenticular tissue compared to αA, being detected in the brain, heart, muscle 
tissue (Peschek et al., 2009),  nervous system, retina, iris, thyroid, colon, squamous epithelia, 
placenta, spermatocytes and tissues subjected to high oxidative stress such as in the kidneys 




et al., 1998), and multi-angle light scattering data demonstrate that the protein forms homo-
oligomers within the range of 400-800 kDa (i.e. containing 20-40 monomers), with an 
average molecular mass of 540 kDa (Aquilina et al., 2004). The expression of αB in cells has 
been found to be induced by oncogene expression (Klemenz et al., 1991), osmotic stress 
(Dasgupta et al., 1992), heat shock (Klemenz et al., 1991b), dexamethasone, cadmium, 
sodium arsenite (Klemenz et al., 1993) and muscle stretch (Atomi et al., 1990; Kantorow and 
Piatigorsky, 1998).  
 
 
1.4   α-Crystallin in Health and Disease 
 
As αB is expressed ubiquitously throughout bodily tissues, the functions it serves are highly 
















Table 1.1: Roles of αB-crystallin in non-lenticular tissue. 
Function Mechanism Reference 
Anti-apoptosis Inhibits caspase-3 
 
Induces GSH expression in 
response to tumour necrosis 
factor α (TNFα) 
 
Protects against damage cause by 
inflammation following infection 
 
Inhibits caspase-3 activation 
Morrison et al., 2003 
 




Whiston et al., 2008 
 
 
Ousman et al., 2007  
Protection against oxidative damage Increases expression of GSH Mehlen et al., 1996 
Maintenance of cytoskeletal integrity Prevents interactions between 
intermediate filaments 
 
Binds to intermediate filaments 
following stress to protect during 
network remodelling 
 
Prevents aggregation of actin 
filaments following pH stress 
Perng et al., 1999  
Launay et al., 2006  
 




Bennardini et al., 1992  
Suppression of neurodegeneration Prevents aggregation of glial 
fibrillary acidic protein (GFAP) 
 
Prevents aggregation of SOD1 
and α-synuclein 
Hagemann et al., 2010 
 
 
Wang et al., 2008  
Formation of inclusion bodies in 







Head et al., 1993  
Iwaki et al., 1989  
 
Shinohara et al., 1993  
 
Liu et al., 2015  
Acts as an oncoprotein 
 
Promotes neoplastic changes and 
invasiveness of basal-like breast 
carcinomas 
 
Marker for poor prognosis in 
head and neck cancers 
 





induced apoptosis in various 
cancer cell lines 




Chin et al., 2005  
 
 
Yilmaz et al., 2015  
 
 
Kamradt et al., 2005  
Anti-inflammation Suppresses inflammatory role of 
nuclear factor kappa-light-chain-
enhancer of activated B cells 
(NF-κB) 
 
Reduce inflammatory cytokine 
levels following stroke 











Although the deposition or overexpression of αB in diseased tissues is generally interpreted 
as a sign of pathogenicity, its beneficial role in healthy tissues may suggest that the increased 
levels of αB are simply a by-product of the stress response in diseased cells, rather than the 
cause of disease. This is yet to be fully elucidated and as such needs to be taken into 
consideration when evaluating the pathogenic potential of αB. 
Mutations in α-crystallin have also been associated with cataract and various myopathies. 
These mutations are outlined in Table 1.2. 
 
 Table 1.2 Pathologically significant mutations of αA- and αB-crystallin in humans. 
 
Central to all of these functions is the ability of αB to act as a molecular chaperone through 




Disease  Species Mutation Reference 
Autosomal dominant congenital cataract αB D140N Liu, Zhang, et al., 2006  
450delA Berry et al., 2001  
P20S Liu, Ke,  et al., 2006  
R120G Vicart et al.1998  
αA 
 
R116C Litt et al., 1998  
Vanita et al., 2006  
R49C Mackay et al., 2003  
R116H Richter et al., 2008  
R54P Su, Guyo, et al., 2012  
Autosomal recessive congenital cataract αA W9X Pras et al., 2000  
Desmin-related myopathy  αB R120G Vicart et al., 1998 
Dilated cardiomyopathy αB R157H Inagaki et al., 2006  
G157S Pilotto et al., 2006  
Myofibrillar myopathy αB Q151X Selcen and Engel, 2003  
464delCT Selcen and Engel, 2003 




1.5 Chaperone Activity of α-Crystallin 
 
In conjunction with crystalline-like short-range protein order (Delaye and Tardieu, 1983; 
Bloemendal et al., 2004), the degeneration of vasculature and innervation in utero (Phelps 
Brown and Bron, 1996) and the degradation of cellular organelles and the nucleus (Han and 
Schey, 2006), α-crystallin plays a vital role in the maintenance of lens transparency with age 
through its action as a molecular chaperone (Horwitz, 1992; Sun et al., 1997). Due to the loss 
of the nucleus and other cellular organelles during the process of fibre cell differentiation, it 
is often  assumed that lenticular fibre cells do not experience protein turnover, meaning that 
the proteins present in the lens have existed since birth and cannot be replaced (Bloemendal, 
1977; Lynnerup et al., 2008; Truscott, 2010). However, more recently it has been suggested 
that there are low but variable rates of carbon turnover ranging from 1-3% of soluble protein 
annually throughout the human lifetime (Stewart et al., 2013). Due to this minimal turnover, 
it is essential that lenticular proteins are long-lived to maintain the integrity of the lens 
(Bloemendal et al., 2004). Longevity of a protein is determined by its thermodynamic 
stability, that is, its ability to retain its tertiary or quaternary structure with time, and the 
presence of an efficient chaperone system in the cell that is able to prevent protein 
aggregation (Bloemendal et al., 2004). It is with the latter that α-crystallin plays an important 
role. 
The unfolding of cytoplasmic proteins in response to stresses such as heat or ultraviolet 
radiation (Truscott, 2005) triggers the heat shock response, which acts to inhibit protein 
synthesis and induce molecular chaperone production (Bloemendal et al., 2004). Molecular 
chaperones exist as monomers or oligomers both intra- and extracellularly, where they act to 
preserve the conformation of proteins in solution (Soti and Csermely, 2000). This is achieved 
by either preventing aggregation, solubilising aggregates that have already formed, assisting 
in the folding or refolding of misfolded or unfolded proteins, sequestering damaged proteins 
in insoluble complexes or labelling damaged proteins for degradation (Soti and Csermely, 
2000).   
Proteins with compromised tertiary structure are partially unfolded and contain hydrophobic 
regions that remain exposed to the solvent (Carver and Lindner, 1998).  These exposed 
hydrophobic regions can interact with each other eventually causing the protein to precipitate 
from solution (Carver and Lindner, 1998). In the lens, this leads to the formation of insoluble 




by scattering the incoming light (Phelps Brown and Bron, 1996). α-Crystallin prevents these 
aggregates from forming by binding to the exposed hydrophobic regions of proteins that are 
partially unfolded and on the path to irreversible aggregation (Carver and Lindner, 1998). 
The complexes formed by α-crystallin and its substrates such β- and γ-crystallins remain 
soluble until the chaperone is saturated and co-precipitates with the substrate (Lampi et al., 
2002; Evans et al., 2008; Acosta-Sampson and King, 2010). It has been reported that 
mutations to αA (Koteiche and Mchaourab, 2006) and αB (Bova et al., 1999) can induce 
aggregation by increasing substrate affinity leading to increased binding accelerated co-
precipitation. Each α-crystallin assembly can bind multiple substrate molecules, with the 
exact number being dependent on the substrate and the subunit makeup of α-crystallin 
(Smulders et al., 1998). It has been proposed that in non-lenticular tissues, the bound 
substrate may dissociate from the HMWC so it can be presented to the Hsp70 co-chaperone 
system and be refolded (Horwitz, 1992; Carver and Lindner, 1998).  
Intermediately folded states of proteins are inherently unstable (Carver and Lindner, 1998), 
often differing from those that are on the protein folding pathway, that is, proteins that are in 
the process of folding into their native state. α-Crystallin is selective, in that it binds 
exclusively to partially folded or intermediate states of proteins that have left the folding 
pathway and have entered an off-folding pathway, thereby allowing  proteins that are on the 
folding pathway to achieve their native state (Carver et al., 1993). The chaperone activity of 
α-crystallin is also non-specific; it binds to hydrophobic regions on diverse proteins, 
including non-lenticular proteins such as insulin (Smulders et al., 1998), and not to specific 
amino acid sequences or motifs.  
The major substrates of α-crystallin in the lens fibre cell are γ- and β-crystallin (Horwitz, 
1992; Horwitz et al., 1999; Hanson et al., 2000; Horwitz, 2000; Acosta-Sampson and King, 
2010; Michiel et al., 2010), although interactions with ‘house-keeping’ enzymes such as 
enolase (Valasco et al., 1997), cytoskeletal elements (Quinlan, 2002) and membrane 
associated proteins also occur (Cobb and Petrash, 2002b; Horwitz, 2003). In vitro, α-
crystallin completely suppresses aggregation of β- and γ-crystallin (Horwitz, 1992; Boyle and 
Takemoto, 1994; Wang and Spector, 1994; Evans et al., 2008; Acosta-Sampson and King, 
2010; Andley et al., 2014) at molar ratios of 12:1 and 10:1 respectively (Horwitz, 1992). Like 
all sHsps, both the N- and C-terminal regions are vital in maintaining the chaperone activity 




et al., 1993; Carver and Lindner, 1998) and the N-terminal domain promoting 
oligomerisation (Merck et al., 1992) and providing hydrophobic binding sites (Smulders et 
al., 1998). Furthermore, it appears that the quaternary structure of the protein (with a 
hydrophilic exterior and a hydrophobic interior) is vital to its chaperone activity, as it has 
been observed that the structure is conserved (Farnsworth et al., 1998) and resistant to 
changes in the amino acid sequence (Smulders et al., 1998). However, further studies have 
shown that the chaperone activity of α-crystallin can be altered by buffer conditions or the 
introduction of different surface charges. For example, the addition of calcium or magnesium 
to buffers, or a decrease in pH has a detrimental effect on activity (Bindels et al., 1985), 
while the addition of a negative charge to the protein surface, such as through citraconylation, 
increases activity (Bindels et al., 1985). Significantly, as protein turnover in lenticular fibre 
cells is negligible, various PTMs have also been found to affect the chaperone activity of α-
crystallin, possibly correlating with an observed decrease in α-crystallin chaperone activity 





1.6 Posttranslational Modification of α-Crystallin  
 
Owing to the longevity of lenticular α-crystallins, they are vulnerable to the accumulation of 
PTMs with age (Masters et al., 1977; Bloemendal et al., 2004; Wilmarth et al., 2006; Sharma 
and Santhoshkumar, 2009; Truscott and Friedrich, 2016). PTMs have been detected in human 
lenses using isoelectric focusing and SDS-PAGE (Kramps et al., 1978). Furthermore, it is 
known that modifications occur from a very young age, with modifications being detectable 
in foetal lenses (Phelps Brown and Bron, 1996). Perhaps surprisingly, it was noticed in a later 
study that protein isolated from young lenses (i.e. 17 year old donor) show a similar levels of 
modification to aged lenses (i.e. 54 to 55 year old donors) , implying the modifications occur 
relatively early in life (Lampi et al., 1998). Grey and Schey (2009) reported that the amount 
of intact α-crystallin (i.e. not proteolytically cleaved) decreases with age, with little remaining 




truncation with age compared to αA, suggesting a higher level of stability (Grey and Schey, 
2009). 
The number of PTMs that can occur to α-crystallin is extensive and include carbamylation , 
acetylation , disulphide bond formation, oxidation,  truncation, deamidation , glycation and 
phosphorylation (Lund et al., 1996; Lin et al., 1997; Lampi et al., 1998; Lin et al., 1998; Ma 
et al., 1998; Hanson et al., 2000; Lapko et al., 2001; MacCoss et al., 2002; Han and Schey, 
2006; Wang et al., 2013). Phosphorylation of serine residues is the most common 
modification αB (Kato et al., 1998), and is believed to alter the chaperone activity of the 
protein (Ito et al., 2001; Koteiche and Mchaourab, 2003; Aquilina et al., 2004; Ecroyd et al., 
2007; Benesch et al., 2008). Likewise, deamidation is also common and believed to affect 
chaperone activity (Gupta and Srivastava, 2004; Fujii et al., 2011). For these reasons, this 
thesis focuses on the phosphorylation and deamidation of lenticular αB.  
 
1.6.1 Phosphorylation of α-Crystallin 
Phosphorylation rates of 33-50% have been reported for human lens αB (Carver and Lindner, 
1998; Farnsworth et al., 1998), with phosphorylated products being present from birth 
(Phelps Brown and Bron, 1996). The phosphorylation process occurs naturally in a state of 
dynamic equilibrium under physiological conditions in dividing cells (Ito et al., 1997), for 
example in epithelial cells for αB and in differentiating cells for αA (Phelps Brown and Bron, 
1996). Phosphorylation can also be induced stress conditions such as ischemia (Ahmad et al., 
2008) and heat stress (Ito et al., 1997).  
In vivo, the majority of α-crystallin is phosphorylated via the cyclic adenosine 
monophosphate (cAMP)-dependent pathway in a reversible serine-specific manner 
(Kantorow and Piatigorsky, 1998). It has been a long-held belief that the dominant sites of 
phosphorylation in αB are Ser19, Ser45 and Ser59, and in αA Ser122. Western blots of 
mitotic U373 human glioma cells revealed that the three phosphorylation sites of B are 
regulated separately during mitosis (Kato et al., 1998). The elevated levels of pSer19 
(phosphorylated Ser19) and pSer45 (phosphorylated Ser45) and the lower levels of pSer59 
(phosphorylated Ser59) detected suggested that each site is phosphorylated by a different 
kinase (Kato et al., 1998). Purification and activity assays of the different kinases revealed 
that Ser45 and Ser59 are phosphorylated via p44/42 mitogen-activated protein (MAP) kinase 




kinase responsible for the phosphorylation of Ser19 has still not identified due to instability 
of the enzyme, although it was found to be of a similar molecular weight to p44/42 MAP 
kinase, approximately 60 kDa (Kato et al., 1998). The A Ser122 residue is also believed to 
be phosphorylated by MAPKAP kinase-2 as it lies within a recognition site for the enzyme 
((Arg/Lys)-X-Pro-Ser) (Kantorow and Piatigorsky, 1998). Despite the dominance of these 
sites in the literature, a multitude of other sites of phosphorylation for both subunits have 
been recently reported in the lens (Miesbauer et al., 1994; Kamei et al., 2000; MacCoss et al., 
2002; Searle et al., 2005; Wilmarth et al., 2006; Huang et al., 2011; Wang et al., 2013; Wang 
et al., 2014). These are summarised in Appendix 1, and locations are indicated in Figure 1.7.  
Although much less prominent in the literature, non-enzymatic phosphorylation has also been 
observed in lenticular α-crystallin (Kantorow and Piatigorsky, 1998). Little is known about 
the mechanism of non-enzymatic phosphorylation in the lens, but it has been shown in vitro 
that both α-crystallin subunits are able to undergo non-enzymatic phosphorylation in the 
presence of either Mn+ (Schieven and Martin, 1988) or Mg+ (Kantorow and Piatigorsky, 
1994) and ATP. There is also evidence of a mechanism of non-enzymatic dephosphorylation 
in the lens that involves the spontaneous β-elimination of phosphate groups from 
phosphoserine and phosphothreonine residues and the subsequent glutathionylation of the 
resultant dehydroalanine (DHA) intermediate, resulting in covalent crosslinking (Bessems et 
al., 1987; Linetsky et al., 2004; Srivastava et al., 2004; Linetsky and LeGrand, 2005; Wang 
et al., 2014). It is as yet unclear what proportion of the phosphorylation observed in the lens 
is residual from early enzymatic phosphorylation events, and how much results from 
subsequent non-enzymatic events. However, it is likely that α-crystallin enzymatically 
phosphorylated in the metabolically active cells of the outer cortex are gradually 
dephosphorylated non-enzymatically as they form part of the metabolically inactive nucleus. 
Phosphorylation and α-crystallin chaperone activity 
The effect that phosphorylation has on the chaperone activity of α-crystallin, if any, has met 
with contention in the literature. Earlier studies by Ito et al. (2001) reported a decrease in 
chaperone activity when thermal aggregation assays were performed utilising α-crystallin 
S→D phosphomimics that mimic the negative charge introduced by a phosphate group. They 
attributed this to an observed decrease in oligomeric size. These findings were supported by 
Kamei et al. (2001) who reported a 30% decrease in the ability of phosphorylated bovine α-




Augusteyn et al.(2002), however, reported no effect on chaperone activity.  More recently, 
studies utilising mutations that mimic phosphorylation  have found that the addition of one or 
more negative charges onto αB acts to increase target protein affinity (Koteiche and 
Mchaourab, 2003; Ecroyd et al., 2007), increase oligomeric polydispersity (Ecroyd et al., 
2007) and decrease average oligomeric size (Ito et al., 2001; Ecroyd et al., 2007). It has been 
proposed that such modifications to the N-terminal domain of α-crystallin induces flexibility 
and structural changes that lead to increased exposure of substrate binding sites (Peschek et 
al., 2013). Phosphorylation in this region may also interrupt intersubunit interactions, 
resulting in dissociation of larger oligomers to form smaller oligomers with higher activity 
(Ecroyd et al., 2007; Peschek et al., 2013).  
It has been suggested that this hyperactivity can induce aggregation with the target, rather 
than prevent it, as the αB reaches saturation and co-deposits with the target proteins (Ecroyd 
et al., 2007). This is supported by a study by Aquilina et al. (2004) that reported both a 
change in oligomeric substructure, i.e. a preference towards high affinity monomeric 
substructure and away from low affinity dimeric substructure, coupled with an earlier onset 
of aggregation with the target protein α-lactalbumin. Taken together, it appears that the 
hyperactivity observed recently upon phosphorylation of αB may be a result of the increased 
exposure of substrate binding sites brought about by the dissociation of dimeric subunits. As 
the precise nature of the relationship between phosphorylation and chaperone activity of αB 
is uncertain, an aim of the work described in this thesis was to attempt to elucidate whether 
mimicking phosphorylation of αB, via S→D point mutations, increases or decreases the 
ability of αB to suppress the heat-induced aggregation of a model substrate.   
 
1.6.2 Deamidation of α-Crystallin 
Another major age-related modification of lenticular α-crystallin is deamidation, involving 
the chemically mediated conversion of asparagine and glutamine residues to aspartate and 
glutamate residues respectively (Wilmarth et al., 2006). The reaction occurs non-
enzymatically, taking one of two pathways depending on the environmental pH. At a neutral 
or alkaline pH, the reaction follows two steps (Figure 1.6A); the peptide bond nitrogen of the 
asparagine (or glutamine) residue attacks the carbonyl carbon of the sidechain and forms a 
succinimide (for asparagine) or glutiminide (for glutamine) ring intermediate, which is then 




glutamate). Alternatively, at pH<5.0, the amide group on the asparagine (or glutamine) 
sidechain undergoes direct hydrolysis to produce aspartate (or glutamate) as a sole product 



















Figure 1.6: Mechanism of deamidation of an asparagine residue. (A) At a neutral or 
alkaline pH, the peptide bond nitrogen attacks the carbonyl carbon of the asparagine or 
aspartate sidechain (both shown in red, connected by broken arrow) to form a succinimide 
ring intermediate, which is then hydrolysed at either the α or β carbonyl group (bonds shown 
in red), resulting in aspartate or iso-aspartate residues. (B) At an acidic pH (i.e. pH<5.0), the 
amide group of the asparagine sidechain can undergo direct hydrolysis to form an aspartate 
residue. Note that glutamine forms a 6-member ring (i.e. glutaminide) intermediate via a 






Deamidation is restricted to amino acid residues that contain an amide side chain i.e. 
asparagine and glutamine, and are influenced by the surface exposure of the residue (Lapko 
et al., 2002) as well as the conformational flexibility of the surrounding residues (Kosky et 
al., 1999; Hooi et al., 2012; Truscott and Friedrich, 2016). Multiple deamidation sites have 
been identified in both lenticular αA and αB (Lund et al., 1996; Hanson et al., 2000; 
Srivastava and Srivastava, 2003; Searle et al., 2005; Wilmarth et al., 2006; Asomugha et al., 
2010; Hains and Truscott, 2010), summarised in Appendix 1 with positions indicated in 
Figure 1.7. 
Deamidated α-crystallin is in high abundance in water-insoluble lens fractions, leading to the 
suggestion that the deamidation of α-crystallin contributes to cataract formation (Srivastava 
and Srivastava, 2003; Wilmarth et al., 2006). It has also been reported that, in conjunction 
with other modifications, namely oxidation and C- and N-terminal truncation, deamidation 
inhibits chaperone activity (Gupta and Srivastava, 2004; Chaves et al., 2008) and induces 
insolubility of the protein (Lund et al., 1996; Hanson et al., 2000). Structural changes are 
thought to be responsible for this loss of solubility, for example decreases in β-sheet content 
(Gupta and Srivastava, 2004), exposure of hydrophobic regions (Hanson et al., 2000; Gupta 
and Srivastava, 2004) and the formation of intramolecular disulphide bonds in αA (Lund et 
al., 1996; Hanson et al., 2000). Furthermore, deamidation is known to induce both 
racemisation (conversion of L- to D-) and isomerisation (conversion of α- to β-) to form L-β-
X, D-α-X and D-β-X isotypes that can in turn alter secondary structure (Fujii et al., 2010; 
Fujii et al., 2016; Truscott and Friedrich, 2016) and cause a loss of function (Fujii et al., 
2007; Fujii et al., 2010). High rates of racemisation and isomerisation have been observed at 
the residues N58, N76, N84 and N151 in lenticular αA, and N62 and N96 in αB (Fujii et al., 
2012). Notably, N96 is highly racemised in aged human lenses, where it is thought to 
interrupt higher order oligomeric assembly (Sakaue et al., 2015; Takata and Fujii, 2015). 






Figure 1.7: Location of reported phosphorylation and deamidation sites of human 
lenticular αA (A) and αB (B). Depicts full length protein with N-terminal (N-orange), α-
crystallin (α-blue) and C-terminal (C-purple) regions indicated. Red bars represent 
phosphorylation sites and green bars represent deamidation sites; residue identities are 
labelled with arrows. Phosphorylation sites investigated in this thesis are highlighted in red. 
 
Similar to the α-crystallins, β- and γ-crystallins are heavily deamidated in the insoluble 
fraction of aged and cataractous human lenses (Lapko et al., 2002; Wilmarth et al., 2006; 
Hains and Truscott, 2010). Multiple studies have utilized deamidation mimics to investigate 
the effect deamidation has on the structure and function of these proteins. Deamidation of 
residues at the dimeric interface has been shown to not affect secondary structure or interfere 
with dimer formation (Lampi et al., 2006; Takata et al., 2007; Takata et al., 2008). However, 
the presence of deamidated residues at the oligomeric interface is suggested to alter tertiary 
structure by interrupting hydrogen bond formation, thereby inhibiting interactions between 
hetero- and homodimers (Takata et al., 2009). Deamidation has also been shown to 
destabilise β- and γ-crystallins, inducing aggregation in urea and heat treatment (Kim et al., 
2002; Lampi et al., 2002; Flaugh et al., 2006; Lampi et al., 2006; Takata et al., 2007; Takata 
et al., 2008; Michiel et al., 2010). 
 
1.6.3 Protein crosslinking 
Covalent crosslinking has been identified between crystallins, and between crystallins and 
other proteins (Srivastava et al., 2004; Su, McArthur, Truscott, et al., 2011) in human lenses.  




et al. (2004). Wang et al. (2014) later identified such non-disulphide crosslinks between β- 
and γ-crystallin proteins in lens extracts, and were able to induce formation under 
physiological conditions in vitro. Crosslink formation via this mechanism is believed to occur 
when phosphoric acid is cleaved from phosphorylated serine or threonine residues by β-
elimination, and the resulting DHA or dehydrobutyrine (DHB) intermediates are targeted for 
nucleophilic attack by GSH (Wang et al., 2014). It has been suggested that this mechanism is 
a predominant pathway of crosslink formation in lens proteins, thereby contributing to 
protein aggregation and cataract (Wang et al., 2014). 
 
 
1.7 Role of Phosphorylated α-Crystallin in Non-lenticular tissues 
 
In non-lenticular tissues, phosphorylated αB-crystallin has been implicated in various cellular 
responses ranging from cytoprotection in response to stress, the regulation of apoptosis  and 















Table 1.3: Purported roles of phosphorylated αB-crystallin isotypes in non-lenticular 
tissue. 




Localisation to Z-bands of 





Induces Bcl2 expression in 
myoblasts in presence of TNF-α 
 
Inhibits caspase-3 activation in 
myocytes following hyperosmotic 
or hypoxic stress 
 
 
Nuclear speckle formation 
following heat shock 
 
 
Induced by PAR-2 in astrocytes in 




Prevents exosomal secretion of αB 


























Hoover et al., 2000 
Golenhofen et al., 1999 
Golenhofen et al., 1998 
Eaton et al., 2001 
 
 
Adhikari et al., 2011 
 
 





Den Engelsman et al., 2013 
Den Engelsman et al., 2005 
 
 





Kore and Abraham, 2014 




Reduces anti-apoptotic activity of 
αB in differentiation induced cell 
death of myoblasts 
 
Binds to and  inhibits anti-apoptotic 
activity of Bcl2 in vinblastine 











Launay et al., 2010 
Modulation of actin 
dynamics 
Co-localises with and stabilises 
cytoskeletal components at focal 
adhesions in myoblasts treated with 
vinblastine and cytochalasin D 
 
Co-localises with proteins of the 
actin nucleation complex involved 
with membrane protrusion and cell 
migration in migratory lenticular 
epithelial cells 
 
Negatively modulates actin 


















Wang and Spector, 1996 
Protein quality 
control 
Participates in the ubiquitin-
proteasome system to degrade 
excess protein in disused rat soleus 
muscle 
 
Accumulates in and potentially 
facilitates formation of aggresomes 
















1.8 Cataracts  
 
The term cataract refers to any light-scattering opacity in the lens which significantly 
obstructs vision. It is the leading cause of blindness worldwide, contributing to 48% of all 
cases (World Health Organisation, 2010). The different classes of cataract can be divided into 
those that are non-progressive, including congenital nuclear, sutural and coronary cataracts, 
and those that are progressive, or age-related, with age-related cataract being defined as 
cataracts that occur past the age of 50 years old, without an obvious cause (Phelps Brown and 
Bron, 1996). Age-related cataract are thought to result from a combination of genetic, age-
related and environmental factors (Hammond et al., 2000). Age-related cataracts encompass 
three different types: cortical, sub-capsular and nuclear (Phelps Brown and Bron, 1996). 
Cortical and sub-capsular cataracts are caused by disorder in the cytoplasm or fibre cell 
membranes (Phelps Brown and Bron, 1996).  
Nuclear cataracts differ in that they result from the formation of insoluble protein aggregates 
that directly obstruct light transmission (Phelps Brown and Bron, 1996).  As these aggregates 
remain insoluble, even in 8 M urea and 6 M guanidine hydrochloride (Truscott and 
Augusteyn, 1977), it has traditionally been difficult to obtain molecular information 
regarding the protein composition of the aggregate (Takemoto and Boyle, 1998). Truscott et 
al. (1998), using tryptic digestion and high performance liquid chromatography (HPLC) to 
purify peptides from the insoluble fraction of human cataractous lens tissue, found αB 
subunits to be in overabundance when compared with αA and other lenticular proteins, 
suggesting that αB is more directly involved in age-related cataract formation than αA (Chen 
et al., 1997; Truscott et al., 1998).  
This claim has been supported by work from a number of studies in recent years. The 
identification of peptides derived from αB as well as αA, βB2-, γs- and βA3-crystallin in high 
abundance in the insoluble protein fractions from aged human lenses suggests that truncation 
of these proteins may be involved in protein insolubilisation (Hanson et al., 2000; 
Santhoshkumar et al., 2008; Su et al., 2010). The addition of peptides αB1-18 and βA3/A159-74 
decreases the chaperone activity of α-crystallin in vitro, while βA3/A159-74 increases the 
oligomeric size and induces aggregation of αB homo-oligomers (Santhoshkumar et al., 
2008). In separate studies, αA66-80 was reported to bind to the C-terminal extension, the 
chaperone site and the subunit interaction site of αB to form complexes with reduced 




2013),while αB1-18 was reported to increase the association of α-crystallin to purified 
membranes in vitro (Su, McArthur, Friedrich, et al., 2011).  Zhou et al. (2015), with the aid 
of isobaric tag for relative and absolute quantitation (iTRAQ) technology, were able to report 
that αB, but not αA, was downregulated in the nucleus of cataractous lenses compared to 
healthy lenses. Datiles III et al. (2016), used dynamic light scattering to monitor free 
lenticular α-crystallin levels in patients over 6-36 months and  reported that low base levels of 
free α-crystallin, as well as faster rates of free α-crystallin loss, positively correlate with 
increased occurrence and faster progression of nuclear cataract. Finally, Makley et al. (2015) 
were able to reverse R120G associated cataract opacity in mouse lenses in situ and in aged-
related opacities in human lenses ex situ by incubating lenses with 5-cholesten-3b, 25-diol. It 
is reported that this compound binds to the hydrophobic groove of αB, thereby stabilising the 
oligomer and preventing aggregation (Makley et al., 2015), suggesting that instability of αB 
is a contributing factor to cataract formation. 
The exact role that phosphorylated αB plays in cataract formation is unclear due to the 
contention surrounding the effect that phosphorylation has on αB chaperone activity. If 
activity is decreased upon phosphorylation, aggregates may form as a consequence of the 
inability of αB to prevent interactions between other proteins (Phelps Brown and Bron, 1996; 
Ito et al., 2001; Bloemendal et al., 2004; Grey and Schey, 2009). Alternatively, if activity is 
increased, the affinity of αB to protein substrates may be increased to the point where it binds 
excessively to substrate and co-deposits prematurely (Aquilina et al., 2004). Additionally, 
previous studies have found that α-crystallin associates with fibre cell membranes 
increasingly with both age (Boyle and Takemoto, 1996) and oxidation-induced 
phosphorylation (Takemoto and Boyle, 1998). The mechanism behind this may be explained 
by the theory proposed by Aquilina et al. (2004). If a change in αB substructure was in fact 
responsible for the induction of hyperactivity due to the increased exposure of hydrophobic 
regions, the protein may also have increased affinity with proteins that interact with fibre cell 
membranes, which in turn could lead to greater localisation of αB with membranes  (Aquilina 
et al., 2004). This phenomenon is of particular interest when considering the formation of the 





1.8.1  Barrier Theory of Cataract Formation 
The barrier theory was first proposed by Sweeney and Truscott (Sweeney and Truscott, 1998) 
following the paradoxical observation that although levels of the reduced form of GSH were 
observed to decrease in the nucleus of older lenses, concentrations in the cortex often remain 
within the normal range. In a healthy lens, GSH is synthesised in the cortex and diffuses into 
the nucleus via gap junctions that are present between fibre cells (Goodenough, 1992). To 
determine the cause of this phenomenon, Sweeney and Truscott incubated lenses of varying 
ages in artificial aqueous humor containing labelled [35S] cysteine, which is incorporated into 
GSH metabolically. Following localisation experiments, the labelled cysteine was found to be 
homogenously distributed in young lenses. However, only very low amounts of label were 
detected in the nucleus of older lenses, indicating the presence of a barrier retarding the 
diffusion of small molecules from the cortex into the nucleus, dubbed the nucleocortical 
barrier (Sweeney and Truscott, 1998). As a minimum concentration of 2 mM GSH is required 
to protect proteins from oxidation by reactive small molecules such as ascorbate (Truscott, 
2005), it is believed that the decrease in the reduced form of GSH allows the oxidation of 
proteins leading to the formation of disulphide bonds and thereby aggregate formation 
(Truscott and Augusteyn, 1977; Truscott, 2005).  
Evidence supporting a role for barrier formation in cataractogenesis includes the observation 
that a sharp decrease in the concentration of reduced GSH always precedes the formation of 
experimentally induced cataracts (Harding, 1991), the abundance of oxidised proteins in the 
nucleus of aged lenses (Truscott, 2005) and the coinciding of the putative location of the 
barrier and the sclerotic zone of cataractous lenses (Sweeney and Truscott, 1998). The 
process of barrier formation itself is less well understood with multiple theories being 
proposed, such as the uncoupling of gap junctions as a result of cellular damage or 
modification of transport proteins (Sweeney and Truscott, 1998). It has also been postulated 
that changes in lens membrane lipid composition and fibre cell compression may alter lens 
membrane dynamics (Deeley et al., 2010). These models however have not been extensively 
studied and little literature regarding them is available.   
One well-documented phenomenon that has been proposed as a potential mechanism of 
barrier formation is the binding of cytosolic proteins to fibre cell membranes with age 
(Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). Membrane association of fibre 
cell membranes was first reported by Cenedella and Fleschner (1992), who observed that 




components as high density bands on sucrose density gradients. Western blotting of these 
bands indicated that 70% of membrane associated protein consisted of αA and its modified 
forms, while 20% consisted of β- and γ-crystallins with the remaining components consisting 
of cytoskeletal proteins (Cenedella and Fleschner, 1992). Later studies involved incubating 
isolated bovine fibre cell membranes with either purified rat (Chandrasekher and Cenedella, 
1997) or recombinant human α-crystallin (Cobb and Petrash, 2002b) to replicate membrane 
binding in vitro. It was reported that α-crystallin was most likely to associate with membranes 
as part of HMW aggregates (Chandrasekher and Cenedella, 1997; Cobb and Petrash, 2002b) 
via hydrophobic interactions (Chandrasekher and Cenedella, 1997), and that once bound, 
chaperone activity was diminished (Cobb and Petrash, 2002b) and the rate of disulphide 
crosslinking was increased (Chandrasekher and Cenedella, 1997).  
 Localisation of α-crystallins with plasma membranes in aged and cataractous human lenses 
was also confirmed using electron microscopy immunolocalisation (Boyle and Takemoto, 
1996). Sucrose density centrifugation has been used to isolate high density membrane-bound 
protein fractions from aged normal (Friedrich and Truscott, 2010) and cataractous 
(Chandrasekher and Cenedella, 1995) human lenses. It has been shown that the proportion of 
bound protein to total protein increases with both age (Friedrich and Truscott, 2010) and in 
cataracts (Chandrasekher and Cenedella, 1995), and is coupled with a decrease in soluble 
protein (Friedrich and Truscott, 2010). These high-density protein fractions are 
predominantly composed of modified crystallins (Chandrasekher and Cenedella, 1995; 
Friedrich and Truscott, 2010), that when separated via  2D SDS-PAGE, focus as a series of 
negatively charged spots, suggesting the presence of deamidated and/or phosphorylated 
species (Friedrich and Truscott, 2010).  
How these associations with the membrane are mediated i.e. through direct binding to the 
phospholipid membrane or interactions with cytoskeletal components and integral membrane 
proteins, is yet to be fully elucidated. It has been proposed, however, that interactions 
between α-crystallins and membrane pore proteins in the lens maybe be a contributing factor 
to nucleocortical barrier formation (Cobb and Petrash, 2002b; Friedrich and Truscott, 2009; 
Friedrich and Truscott, 2010). In short, the accumulation of HMW aggregates at fibre cell 
membranes are thought to potentially occlude pore proteins, such as AQP0 and Cx46, which 
are responsible for the transport of water (Gorin et al., 1984) and glutathione (GSH) (Slavi et 
al., 2014) in the lens respectively. This would account for the fact that both the diffusion of 




Cx46 were to occur, it is believed it may result in an oxidative environment in the nuclear 
region of the older lens, leaving resident proteins vulnerable to oxidative damage (Truscott, 
2005). 
Phosphorylation and membrane association of αB-crystallin 
This thesis expands upon this model, postulating that phosphorylation-induced hyperactivity 
of αB is responsible for α-crystallin association with the pore proteins AQP0 and Cx46, 
resulting in the formation of the nucleocortical barrier. This model is illustrated in Figure 1.8. 
Although it is postulated that α-crystallin associates with fibre cell membrane components as 
a HMW complex that includes αA, this thesis focuses mostly on αB. This is based on recent 
reports that implicate αB, but not αA, in cataract formation (Makley et al., 2015; Datiles III et 
al., 2016), as well as previous reports showing that αB has comparatively higher chaperone 
activity (Sun et al., 1997) and lower thermostability (Sun and Liang, 1998; van Boekel et al., 
1999; Liang et al., 2000), which may predispose it to stress-induced aggregation. 
 
 
Figure 1.8: Representation of obstructed fibre cell pores. In young lenses, membrane pore 
proteins (AQP0 represented by pink ovals and Cx46 represented by purple ovals) facilitate 
the transport of water and GSH into the nucleus of the lens (represented by blue circles where 
intensity of colour represents concentration of metabolites). As αB becomes phosphorylated 
with age (green oval, red spot represents phosphate group), hyperactivity causes its 
association with fibre cell membranes in the barrier region (represented by dotted line), 




Little is known regarding the relationship between protein modification and membrane 
association of lenticular proteins. It is also important to note that as interactions between α-
crystallins and Cx46 or AQP0 have not been detected in vivo, obstruction of pore proteins 
due to membrane association of  cytosolic proteins is still largely speculative.  However, if 
barrier formation is indeed instigated by the binding of proteins such as α-crystallins to 
membrane or cytoskeletal proteins or the fibre cell membranes themselves, characterising the 
modifications associated with age and protein deposition is likely to give a critical insight 
into the molecular mechanisms behind barrier formation, and hence cataractogenesis. This 
thesis attempts to elucidate how protein modification may be involved in barrier formation by 
identifying what modifications are prevalent in membrane associated fractions, determining 
how phosphorylation may affect the chaperone activity of αB, and by identifying interactions 
between unmodified and phosphorylated αB, and the membrane pore proteins Cx46 and 





Post-translational modification and membrane-binding of α-crystallin are two age-related 
phenomena in lenticular fibre cells that have been implicated in cataractogenesis. However, 
the relationship between these two events has not been extensively studied. This thesis 
investigates phosphorylation and deamidation and how they may contribute to protein 
deposition and membrane-binding in aged human lenses.  
 
The specific aims of this thesis were to: 
 
1. Determine the effect of phosphorylation on the chaperone activity of αB 
Present knowledge regarding chaperone activity of phosphorylated αB is conflicting 
and appears to be dependent on the substrate protein and buffer system. In chapter 3, 
the chaperone of isoforms of αB containing mutations that mimic phosphorylation 
were compared to WT αB using a biologically relevant substrate in order to elucidate 
how the addition of a negative charge (like that added by phosphorylation) modulates 





2. Characterise the age-related phosphorylation of αB in aged human lenses 
Lenticular proteins are susceptible to the accumulation of modifications with age, and 
it is highly likely such modifications play a role in protein deposition and cataract 
pathogenesis. In chapter 3, proteomic profiles of human lenses of varying ages were 
compared, and used to establish patterns of αB phosphorylation across regions of the 
lens in order to track the relationship between αB phosphorylation and age-related 
protein insolubilisation and/or membrane association. 
 
3. Elucidate αB localisation at fibre cell membranes 
Association of αB with fibre cell membranes has been observed in aged human lenses 
and may be the origin of nucleocortical barrier formation. In chapter 4, interactions 
between αB and membrane pore proteins were visualised in order to elucidate how αB 
localises with fibre cell membranes and to explain how these interactions may 
obstruct transport GSH in vivo.  
4. Identify and characterise sites of  non-enzymatic αB deamidation in vitro 
Non-enzymatic deamidation can induce structural changes within proteins that can 
result in altered activity of the protein. This is relevant for all lens proteins including 
αB as they exist in an essentially enzymatically inert environment in the lens. In 
chapter 5, deamidated residues of αB were identified following various storage and 



































2.1.1 Antibodies  
Antibodies used and their sources are listed below in Table 2.1. 
 
Table 2.1: Product details for the antibodies used in these experiments. Dilution values 
are working dilution factors for immunblotting and immunofluorescence experiments. 
Antibody Catalogue 
number 


















































(H + L), Alexa 
Fluor® 488 










2.1.2 Reagents and materials 
Recombinantly expressed human αB was gifted by Dr Amie Morris (University of 
Wollongong, Australia) or Dr Megan Kelly (University of Wollongong, Australia). All other 
reagents were obtained from Sigma-Aldrich (USA) or Amresco (USA) unless otherwise 
specified. Tris-base was obtained from PanReac AppliChem (Germany). 
Ethylenediaminetetraacetic acid (EDTA) was obtained from Astral Scientific (Australia). 
Dithiothreitol (DTT) was obtained from Pro-Lab (Canada). Biolyte® 3/10 Carrier Ampholyte 
(100x), ReadyStripTM  IPG Strips (17cm, pH 3-10 NL) and the RCDCTM Protein Assay Kit II 
were obtained from BioRad (USA). Unichrom® methanol and Univar® phosphoric acid and 
acetic acid were obtained from Ajax Finechem (Australia). SuperSignalTM West Pico 
Chemiluminescent Substrate and Slide-A-Lyzer TM MINI Dialysis Devices were obtained 
from ThermoFisher Scientific (USA). Sequencing Grade Modified Trypsin (porcine) was 
obtained from Promega (USA). Duolink® products including the reagents Duolink® In Situ 
PLA® Probe anti-rabbit MINUS, Duolink® In Situ PLA® Probe anti-goat PLUS,  Duolink® 
In Situ Detection Reagents Orange (including ligase and polymerase and dilution buffer 
solutions) were obtained from Sigma-Aldrich (USA). Wheat germ agglutinin-Alexa 488 was 




2.2 Phosphorylation and membrane-binding events in aged human lenses 
 
2.2.1 Chaperone assays 
Recombinant WT αB (referred to as WTαB or 0P) and αB isoforms containing mutations that 
mimic phosphorylation  were expressed and purified by Dr Amie Morris (University of 
Wollongong, Australia) according to the method previously described by Horwtiz et al. 
(1998). Serine to aspartate (i.e. S→D) point mutations were made at all three dominant 
phosphorylatable serines (Ito et al., 1997), i.e. S19 (referred to as S19D or 1P), S45 (referred 
to as S45D), S59 (referred to as S59D), S19 and S45 (referred to as 2P), and S19, S45 and 
S59 (referred to as 3P). Assays were performed in phosphate buffered saline (PBS; pH 7.4) at 
40°C with creatine phosphokinase (CPK) concentrations of 0.125 µM and αB concentrations 
of 0.5 or 0.25 µM, in 384 well plates (Greiner Bio-One, Austria) with a total volume of 20 





Germany) for 10 hours at 43°C with absorbance readings at 360 nm every 60 seconds, with 
each reading preceded by a 10 second double orbital shake at 100 rpm. To assess the effect of 
multiple phosphorylation sites, assays were performed for the 0P, 1P, 2P and 3P 
phosphomutants using CPK concentrations of 0.125 µM and αB concentrations of 0.5 µM or 
0.125 µM. To compare the effect of phosphorylation at each residue, single mutants were 
used and assays were repeated using WTαB, S19D, S45D and S59D phosphomutants. 
Samples using only CPK at 10 µM or only αBs at 10 µM or 5 µM acted as controls for each 
set of assays. The ability to prevent aggregation was calculated as the percentage inhibition 
using the formula: % protection = ((ACPK-AC)/ACPK) x 100 based on the final average 
absorbance reading where AC denotes absorbance of sample containing chaperone and ACPK 
denotes absorbance of CPK control, as previously described (Ecroyd et al., 2007). Assays 
were performed in triplicate and results are expressed as means ± SD. Results were analysed 
using analysis of variance (ANOVA) and Tukey’s statistical tests where P<0.05 was 
considered statistically significant. 
 
2.2.2 Tissue dissection  
Donated human lenses aged 41-77 years of age were sourced from the Lions Eye Bank at the 
Sydney Eye Hospital and stored at -80°C until use. Tissue was handled according to the 
tenets of the Declaration of Helsinki. Trephines (6 mm and 4.5 mm) precooled with liquid 
nitrogen were used to manually dissect lenses into cortical, barrier and nuclear regions 





















Figure 2.1: Regions of the human lens. Schematic depicts cross section of human lens in 
the equatorial plane. Cortical (C), barrier (B) and nuclear (N) regions are demarcated by 
dotted lines and the approximate width of the regions is indicated in mm. 
 
Briefly, decapsulated lenses were placed in precooled polytetrafluoroethylene moulds 
(DuPont, USA) with a diameter of 8 mm, and a 6 mm trephine was used to excise cortical 
tissue. From the cylindrical core that remained, approximately 0.5-1 mm of tissue was 
removed from both ends using a precooled razor blade and was combined with previously 
excised tissue to provide cortical samples. The remaining tissue was placed again into a 
precooled 6 mm mould and a 4.5 mm trephine was used to isolate barrier and nuclear tissue 
samples. Trephines and mould were precooled to -20°C and lenses were kept frozen 
throughout process with regular submersion in liquid nitrogen. 
 
2.2.3 Density sucrose gradient centrifugation 
Sucrose solutions were prepared in sucrose buffer (Appendix 2) and layered into 9 mL 
centrifuge tubes from bottom to top as follows: 1 mL 80% w/v sucrose, 2 mL 70%, 1.5 mL 
60%, 1.5 mL 50%, 1.5 mL 45%, 1.5 mL 25%. Gradient tubes were kept cold on ice while 
tissue was aspirated in 1 mL of 8% sucrose solution using a 21 g syringe. Homogenised 
tissue was then layered on top of the gradient, before being overlayed by a further 1 mL of 












bucket rotor (Ti41; Beckman Coulter, USA) in an Optima-100 XP Ultracentrifuge (Beckman 
Coulter, USA). Images were taken of the gradient tubes with a digital camera before protein 
was extracted from bands (SG1-SG6, labelled with decreasing density) using glass pasture 
pipettes. Sucrose was removed by diluting the sample twofold with sucrose buffer and 
centrifuging at 4°C at 12281 g for 10 minutes in a MIKRO 20 microfuge (Hettich, Germany). 
Protein was then delipidated by resuspension in 100% v/v ethanol and incubating overnight at 
-20°C. 
 
2.2.4 Protein quantitation 
For 1D SDS-PAGE and western blotting, protein was solubilised in 8 M urea and absorbance 
at 280 nm was measured using a NanoDrop 2000 system (ThermoFisher Scientific, USA) 
using 8 M urea as a blank to compensate for absorption caused by urea in the buffer. The A280 
readings were then used to calculate protein concentration assuming a molar extinction 
coefficient of 19000 M-1 cm-1 (Horwitz et al., 1998). Samples were then made up to a final 
concentration of 1 mg.mL-1 using 8 M urea. For 2D electrophoresis, protein was solubilised 
in SSS buffer and protein concentration was calculated using a RC DCTM  Protein Assay Kit 
II, performed in microfuge tubes according to the manufacturer’s instructions. The RC DCTM 
Protein Assay Kit was selected for quantitation of these samples as it is compatible with 
buffers that contain high concentrations of reducing agents and detergents such as SSS buffer.  
Briefly, 125 µL of RC Reagent I was added to 25 µL of sample, vortexed and incubated at 
room temperature for 1 minute. Following this, 125µL of RC Reagent II was added, and 
samples were vortexed and centrifuged at 15 000 g for 5 minutes using a Centrifuge 5415C 
(Eppendorf, Germany). The supernatant was removed via aspiration and discarded following 
centrifugation, before adding 127 µL of Reagent A’ (previously prepared by combining DC 
Reagent S and DC Reagent A at a ratio of 1:5). Samples were then vortexed before being 
incubated at room temperature for 5 minutes. Samples were again vortexed and 1 mL of DC 
Reagent B was added, immediately vortexed, and incubated at room temperature for 15 
minutes. Following incubation, 120 µL of each sample was transferred into a 98 well 
microplate (Greiner Bio-One, Austria) and absorbance was read on a Spectramax Plus 384 
(Molecular Devices, USA) at a wavelength of 750 nm. Samples were then made up to a final 







2.2.5 1-Dimensional (1D) electrophoresis and western blotting of protein bands  
Protein isolated from SG2, SG3 and SG5, and Cortical SG6 bands was quantified and 
prepared in 8 M urea as described in section 2.2.4. Samples were prepared in 2-times loading 
buffer (Appendix 2), unfolded by incubation at 37°C for 30 minutes and subjected to SDS 
PAGE on a 15% v/v gel for one hour at 110V.  The gel was stained using Coomassie stain 
(Appendix 2) for one hour, destained with coomassie destain (Appendix 2) overnight and 
imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). Relative protein load 
was compared using ImageJ 1.49v densitometry software (Wayne Rasband, NIH, USA). 
Duplicate gels (but for the exclusion of the cortical SG6 sample) were prepared and proteins 
were transferred onto a polyvinylidene fluoride (PVDF) (MerckMillipore, USA) membrane 
electrophoretically at 30 V overnight at 4°C for western blotting. Briefly, membranes were 
blocked with 3% w/v bovine serum albumin (BSA) (Sigma, USA) in Tris buffered saline-
tween 20 (TBST) (Appendix 2) prior to incubation with individual anti-phosphoserine αB 
antibodies specific to pSer19, pSer45 and pSer59, or an anti-αB antibody at concentrations 
outlined in Table 2.1. Blots were washed 3 times for 5 minutes in TBST, prior to labelling 
with goat anti-rabbit IgG/horse radish peroxidase (HRP). Blots were washed again 3 times for 
5 minutes in TBST and developed using SuperSignalTM West Pico Chemiluminescent 
Substrate and 3,3’ –Diaminobenzidine Tetrahydrochloride (DAB) substrate, before being 
imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). In-gel analysis of 
scanned images was performed using ImageJ 1.49v densitometry software (Wayne Rasband, 
NIH, USA). It should be noted that densitometric analysis was limited to the comparison of 
the relative proportion of each band compared to the total signal for each lane within the 
same gel as no one sample was run on all gels, therefore preventing comparison between 
gels. Cross-reactivity of anti-phosphoserine antibodies with αA and unphoshporylated αB 
was tested by repeating the blots with recombinant αA and αB alongside αB purified from 
bovine lens lysate. 
 
2.2.6 2-Dimensional (2D) electrophoresis and spot analysis 
Protein extracted from SG2, SG3, SG5 and SG6 bands was quantified and prepared in SSS 
buffer as previously described in section 2.2.4. For each protein extract, 300 µL of sample 
(i.e. 300 µg protein) was loaded onto a ReadyStripTM  IPG trip (17cm, pH 3-10 NL) via 
overnight rehydration, and separated by charge using a Protean® IEF system (Biorad, USA) 





for 1 hour, 2000 V for 1 hour, 4000 V for 1 hour, 40000 V for 10 hours, then a 100 V hold.  
For the second dimension, IEF strips were equilibrated for 20 minutes in equilibration buffer 
(see Appendix 2) before being layered over 12.5% v/v polyacrylamide gels and subjected to 
electrophoresis for 5 hours at 45 mA to separate the proteins by mass. Gels were stained with 
colloidal Coomassie stain (Appendix 2), destained with colloidal destain (Appendix 2) and 
imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). Scanned images were 
analysed using ImageJ 1.49v densitometry software (Wayne Rasband, NIH, USA). It should 
be noted that no protein standards of a known amount were used, therefore densitometric 
analysis is limited to the comparison of the relative proportion of each spot compared to spot 
3 (as it was the most abundant spot on most gels). As such, comparison between gels of the 
absolute amounts of protein present was not performed. To confirm spot identity, individual 
protein spots were excised from gels of SG2 protein and were subjected to in-gel tryptic 
digestion with 1 µg of trypsin at room temperature overnight. Resultant peptides were 
detected using positive ion nano liquid chromatography quadrupole time-of-flight (NanoLC 
QTOF) MS (SynaptTM HDMS; Waters, USA) and Masslynx V4.1 software (Waters, USA), 
and parent proteins were identified by comparison with a peptide match database (UniProt).  
 
2.2.7 Separation of crosslinked complexes  
Western blot analysis was used to identify phosphorylated αB species present in the gels 
present as discrete spots and as components of crosslinked complexes of ~45-90 kDa. 
Briefly, a region of the gel of the SG3 fraction from the cortex incorporating non-complexed 
αB spots (~20 kDa) was excised and labelled with anti-phosphoserine αB antibodies specific 
to the residues pSer19, pSer45 and pSer59 as previously described in section 2.2.5. The blot 
was then developed using SuperSignalTM West Pico Chemiluminescent Substrate. Blots were 
scanned and imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). To 
characterise the protein composition of crosslinked protein complexes, spots (1-10) were 
excised from the gel, and submitted for MS analysis.  
 
2.2.8 Analysis of crosslinked complexes  
The following work was undertaken at the Australian Proteome Analysis Facility (APAF), 
the infrastructure provided by the Australian Government through the National Collaborative 
Research Infrastructure Strategy (NCRIS). Briefly, excised spots were subjected to in-gel 





gel with acetonitrile:formic acid. Purported positively and negatively charged peptide bands 
were excised from the dye front of the barrier and nuclear SG3 gels respectively. Peptides 
were extracted from the gel spots using sonication and incubation with acetonitrile overnight 
at 37°C without further digestion.  All samples were then concentrated and desalted using a 
peptide trap (Michrom peptide Captrap, USA). Peptides were separated using an Eksigent 
Ultra NanoLC system (Eksigent, USA), and analysed using positive ion nanoflow 
electrospray MS in an information dependent acquisition mode (IDA). The ten largest 
multiply charged ions (counts>150) observed in the TOF-MS survey scan (m/z 350-1500, 0.5 
seconds) were further analysed using MS/MS. MS/MS spectra were acquired over 100 
milliseconds (m/z 100-1500) with rolling collision energy. Peptide identities and 
modifications were determined by comparison with a human MASCOT database, and 
deamidated residues were identified based on what potential sites were present on the 
peptides (i.e. it is important to note that if more than a single potential deamidation site was 
present on a single peptide, it was not possible to determine which residue was deamidated) 
Percent deamidation of deamidated filensin sites was calculated by integrating ion 
chromatograms of precursor peptides, and calculating the relative peak area of the 




2.3 Characterisation of αB membrane binding in aged human lenses 
 
2.3.1 Tissue sectioning and treatment 
Lenses were treated and mounted according to Lim et al. (2009). In short, intact lenses were 
incubated for 24 hours in 0.75% w/v paraformaldehyde (PFA, see Appendix 2) in PBS at 
4°C. Lenses were then encased in 6% w/v agarose in PBS prior to being cut in half along the 
equatorial plane with a razor blade, and incubated again in 0.75% w/v PFA in PBS for a 
further 24 hours at 4°C. Lens halves were equilibrated for 1 hour in 10% w/v sucrose in PBS, 
1 hour in 20% w/v sucrose in PBS and overnight in 30% w/v sucrose in PBS at 4°C. Lens 
halves were then sectioned at 15 µm at -20°C using a Leica CM1905 cryostat (Leica 









For direct labelling of αB, sections were washed 3 times with PBS, permeabilised for 30 
minutes with 0.25% v/v Triton X-100 in milliQ and blocked with 3% w/v BSA in TBST for a 
minimum of 1 hour at room temperature. The sections were then labelled with antibodies 
specific to WTαB, pS19αB, pS45αB or pS59αB using concentrations outlined in Table 2.1. 
Labelled sections were then washed 3 times for 5 minutes in TBST before being incubated 
with goat anti-rabbit IgG/Alexa 488 (Table 2.1) in blocking buffer (i.e. 3% w/v BSA in 
TBST). Sections were washed 3 times for 10 minutes in TBST and mounted with CitifluorTM 
CFPVOH and AF100 anti-fadent before being imaged on a Leica TCS SPS II confocal 
microscope (Leica, Germany) and analysed using LAS AF Lite software (Leica, Germany). 
To label fibre cell membranes, separate lens sections were washed 3 times for 5 minutes with 
Hank’s balanced salt solution (HBSS) buffer (Appendix 2) and incubated with WGA/Alexa 
633 diluted (1:200 in HBSS buffer) for 10 minutes at room temperature. Sections were 
washed 2 times for 5 minutes with HBSS buffer before being mounted, imaged and analysed 
as previously described. 
 
2.3.3 Duolink® proximity assays 
Mounted lens sections were permeabilised and blocked as previously described in section 
2.3.2. Sections were then co-labelled with  antibodies specific to either WTαB, pS19αB, 
pS45αB or pS59αB and  antibodies specific to either AQP0 or Cx46 in blocking buffer (i.e. 
3% w/v BSA in TBST), at concentrations outlined in Table 2.1. Sections were incubated with 
anti-rabbit and anti-goat PLA® probes for 1 hour at 37°C, and washed twice for 5 minutes 
with wash buffer A (Appendix 2). Sections were then incubated with ligase according to the 
manufacturer’s instructions for 30 minutes at 37°C and washed twice for 2 minutes in wash 
buffer A. Sections were then incubated with polymerase according to company instructions 
for 100 minutes at 37°C in the dark, before being washed twice for 10 minutes in wash buffer 
B (Appendix 2) and for 1 minute in 0.01x wash buffer B (Appendix 2) in the dark. Sections 
were allowed to air dry in the dark and mounted with CitifluorTM CFPVOH and AF100 anti-





and analysed using LAS AF Lite software (Leica, Germany). Two negative control sections 
were prepared using no primary antibodies or co-labelling of rabbit polyclonal IgG with goat 
anti-AQP0 IgG at concentrations outlined in Table 2.1. A positive control section was 
prepared by co-labelling with polyclonal rabbit anti-BFSP2 antibody and AQP0 at 
concentrations outlined in Table 1.2, as BFSP2 (also known as phakinin and CP49) is known 
to associate with AQP0 in human lenses (Rose et al., 2006). 
 
 
2.4 In vitro deamidation of αB 
 
2.4.1 In vitro deamidation of αB under storage conditions 
A batch of recombinant human αB expressed and purified by Dr Amie Morris (see section 
2.2.1) was stored in 200 mM ammonium acetate (pH 7.0) at -20°C for a minimum of 5 years 
(referred to as batch 1). To investigate deamidation events under low temperatures and pH 
following long term storage, the method published by Liao et al. (2009) was modified and 
adapted. Briefly, protein was transferred into 34 mM acetic acid (~pH 3.0) at a concentration 
of 1 mg.mL-1, and incubated at 4°C for a total of 72 hours. Aliquots were taken at 0, 23, 48 
and 72 hours, and were snap frozen in liquid nitrogen and stored at -20°C until analysis. To 
compare deamidation events under varying pH conditions with the addition of heat following 
long term storage, protein was transferred into either 34 mM acetic acid (~pH 3.0) or 200 
mM ammonium acetate (pH 7.0) at a concentration of 1 mg.mL-1, and incubated at 50°C for 
16 hours. Samples were digested with trypsin at a concentration of 0.5 µg.mL-1 for either 5 
minutes or 2 hours, and resultant peptides were snap frozen in liquid nitrogen and stored at -
20°C until analysis. For each experiment, protein samples that had not been subjected to heat 
treatment were used as controls. Samples were analysed using positive ion NanoLC QTOF 
MS (SynaptTM HDMS; Waters, USA) using a mass range m/z 1800-2000 for the 4°C treated 
samples to allow detection of intact proteins, and m/z 300-1800 for the 50°C treated samples 
to allow detection of peptides. Data was analysed using Masslynx V4.1 software (Waters, 
USA). Mass changes were detected in 4°C treated samples by identifying mass shifts in 
matching peaks between time point samples, and predicted masses were used to identify 





2.4.2 In vitro deamidation of unfolded αB protein 
A second  batch of recombinant human αB was donated by Dr Megan Kelly (University of 
Wollongong, Australia) and stored in 50 mM phosphate buffer (~pH 7.4) at -20°C until use, 
but for a period of less than 12 months (referred to as batch 2). To determine the rate of 
deamidation under unfolding conditions following short term storage, protein samples were 
diluted into either 6 M urea (~pH 8.0) or 1 M ammonium bicarbonate (~pH 8.0)  to a final 
concentration of 2 mg.mL-1, and incubated at either 37°C for 4 hours or 50°C for 18 hours 
respectively. Samples were then transferred back into PBS using Slide-A-Lyzer TM MINI 
dialysis cups in order to allow for the slow refolding of the 6 M urea treated sample (Saha 
and Das, 2007; Benesch et al., 2008). Samples were then snap frozen in liquid nitrogen and 
stored at -20°C until submission for analysis at APAF.  Protein samples in PBS with and 
without heat treatment at 50°C for 18 hours were prepared and submitted as controls. To 
compare isoelectric profiles of treated samples, 6 µg aliquots of the urea treated sample and 
the PBS and PBS heat treated samples were retained prior to submission for MS analysis.  
 
The following work was undertaken at APAF, the infrastructure provided by the Australian 
Government through the National Collaborative Research Infrastructure Strategy (NCRIS). 
Prior to MS analysis, 50 µg aliquots of each sample were made up to 0.5 mg.mL-1 with 
ammonium bicarbonate and digested with 2 µg trypsin overnight. Samples were then 
concentrated and subjected to MS analysis as previously described in section 2.2.7. For 
further MS/MS analysis, MS/MS spectra were acquired over 200 milliseconds (m/z 100-
1500) with rolling collision energy for the ten largest multiply charged ions (counts>150) 
observed in the TOF-MS survey scan (m/z 380-1500, 0.25 seconds). Peptide identities and 
theoretical retention times were determined using a MASCOT database search, and a 
computer simulation method was used to calculate deamidation percentages of peptides 
containing asparagine (N) and glutamine (Q) residues. Briefly, this was performed using a 
peak harvester program to develop a Poisson model for each isotopic distribution (Breen et 
al., 2000), and then calculating the intensity of the peak corresponding to the deamidated 
peptide as a proportion of the total intensity of the peaks corresponding to both the 
deamidated and non-deamidated peptides. Samples were analysed three times, and results 
were presented as mean ± SD. Results were analysed using ANOVA and Tukey’s statistical 














Investigation of αB phosphorylation 
















Although αB is generally believed to play a protective role in the human lens, it has also been 
reported to be the dominant protein in insoluble, membrane-bound protein fractions in aged 
and cataractous human lenses (Cenedella and Fleschner, 1992; Fleschner and Cenedella, 
1992; Chandrasekher and Cenedella, 1995; Friedrich and Truscott, 2010). This has led to 
speculation that membrane association of the protein may be a pivotal step in 
cataractogenesis (Sweeney and Truscott, 1998; Cobb and Petrash, 2002b; Friedrich and 
Truscott, 2009). Membrane associated αB has also been shown to have a range of 
modifications (Friedrich and Truscott, 2010; Wang et al., 2013), including phosphorylation.  
To elucidate how phosphorylated αB may participate in pathogenic processes in the lens, it is 
essential to determine how phosphorylation affects the chaperone activity of the protein. The 
results from previous studies in this area are conflicting. For example, Ahmad et al. (2008) 
reported that a triple αB phosphomimic (i.e. S19D/S45D/S59D αB) had increased chaperone 
activity against insulin, citrate synthase and α-synuclein under either reducing conditions or 
heat stress compared to wild type αB. In contrast, Aquilina et al. (2004) reported that a 
double phosphomimic (i.e. S19D/S45D αB) co-aggregated with α-lactalbumin under 
reducing conditions, while a single phosphomimic (i.e. S19D αB) retained activity similar to 
WTαB. Ecroyd  et al. (2007) later showed that the effect of phosphorylation on αB activity 
was dependent on the substrate and buffer conditions. For example, αB phosphomimics were 
more efficient than WTαB at preventing amyloid formation of RCMκ-casein (but not ccβ-
Trp), the heat-induced aggregation of catalase, βL-crystallin and alcohol dehydrogenase, and 
the DTT-induced aggregation of insulin and α-lactalbumin in phosphate buffer (Ecroyd et al., 
2007). However, incubation of αB phosphomimics with α-lactalbumin in ammonium acetate 
buffer induced aggregation, suggesting that the stability of the chaperone in certain buffers 
containing ammonium ions may be compromised, leading to hyperactivity and co-
precipitation (Ecroyd et al., 2007).  A number of phosphorylation-induced structural and 
kinetic changes in αB oligomers have also been reported, including an increase in subunit 
exchange (Ahmad et al., 2008), increased polydispersity, loss of dimeric substructure 
(Aquilina et al., 2004) and an increase in flexibility and solvent accessibility of the N-
terminal domain (Peschek et al., 2013).   
An indication that protein modification may be involved in pathogenic processes in the lens is 





insoluble, membrane associated lens fractions (Wang et al., 2013). Studies have shown an 
age-related loss of soluble protein in the lens, coupled with an increase of membrane 
associated protein (Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). This pattern 
becomes more pronounced towards the nuclear region of lenses (Truscott et al., 2011). It has 
been shown that these membrane associated fractions are composed predominantly of α-
crystallin (Friedrich and Truscott, 2009; Friedrich and Truscott, 2010; Truscott et al., 2011; 
Wang et al., 2013), with lower levels of β- and γ-crystallins as well as cytoskeletal proteins 
such as filensin, phakinin and spectrin (Wang et al., 2013). It is believed that α-crystallin 
becomes tightly bound to membranes though hydrophobic interactions with either 
phospholipids or integral membrane proteins (Chandrasekher and Cenedella, 1997; Cobb and 
Petrash, 2000; Truscott et al., 2011). Soluble cytoplasmic HMWCs, consisting of α-crystallin 
and its substrate proteins, then form low affinity associations with tightly-bound α-crystallin 
at the membrane (Chandrasekher and Cenedella, 1997; Cobb and Petrash, 2002b; Friedrich 
and Truscott, 2009). These soluble complexes show higher membrane affinity than native α-
crystallin and, once bound, display decreased chaperone activity, although the ability to 
participate in subunit exchange events is retained (Cobb and Petrash, 2002b). As such, these 
complexes can recruit more cytoplasmic proteins, incorporating them into the complex 
(Friedrich and Truscott, 2010).  
However, protein modifications present in membrane associated fractions have not been 
extensively studied. Friedrich and Truscott (2010) identified a pattern of multiple negatively 
charged spots, corresponding to unmodified and modified αB, on 2D gels of high density 
membrane associated fractions. However, this study did not differentiate between 
phosphorylated or deamidated isoforms. More recently, a comprehensive phosphoproteomic 
study was performed on human fibre cell membrane extracts (Wang et al., 2013). Although 
this identified seventeen sites of αB and 22 sites of αA phosphorylation, some of which were 
previously unreported, the study did not differentiate between lens age and region, and did 
not compare levels with a soluble protein control. A full understanding of the mechanism of 
membrane association and the role phosphorylation may play in this process is therefore 







3.2 Experimental Rationale 
 
Creatine phosphokinase is found in the brain, myocardium and skeletal muscle (Baird et al., 
2012), and is overexpressed in diseases such as myocardial infarction (Vincent and Rapaport, 
1965; Van der Veen and Willebrands, 1966; Goto, 1974) and muscular dystrophies (Van der 
Veen and Willebrands, 1966; Goto, 1974; Somer et al., 1976). It is commonly used as a 
substrate for chaperone assays (Dabbs and Wilson, 2014; Wyatt et al., 2015)  due to its 
tendency to reproducibly form amorphous aggregates following thermal stress, and it has 
previously been shown that non-chaperone proteins have no effect on its aggregation (Dabbs 
and Wilson, 2014). Both CPK and αB co-exist in skeletal muscle (section 2.2.1). 
Furthermore, the comparatively low temperature used for these assays (i.e. 40°C) compared 
to temperatures required to destabilise proteins native to the lens, such as β-crystallins 
(Ecroyd et al., 2007; Takata et al., 2008), are closer to physiological temperatures 
experienced by the lens. For these reasons, CPK was selected as a substrate for aggregation 
assays rather than a native substrate to investigate the activity of αB. 
Density sucrose centrifugation has become a well-established method to isolate membrane 
associated and soluble protein fractions from lens homogenates. This method was previously 
published by Lampi et al. (1992) and Cenedella and Fleschner (1992), and later modified by 
Friedrich and Truscott (2009; 2010). This current work employed the modified protocol 
published by Friedrich and Truscott (2009; 2010) to isolate membrane associated protein 
fractions (section 2.2.3). Prior to this, human donor lenses from different ages were manually 
dissected into cortical, barrier and nuclear regions to allow for comparison between different 
lens regions (section 2.2.2). These fractions were then separated by 1D (section 2.2.5) and 2D 
SDS PAGE (section 2.2.6). As 2D SDS PAGE separates proteins in two dimensions i.e. mass 
and pI, modified proteins resolve as a series of discrete spots due to the variance in charge 
bestowed on them by the modification. This method, used previously by Lampi et al. (1998) 
to identify crystallin deamidation and truncation products in human lenses, was therefore 
employed in order to separate modified forms of αB for more detailed analysis. To identify 
phosphorylated species of αB, commercially available anti-phosphoserine antibodies specific 
to pSer19, pSer45 and pSer59 αB were used for western blotting of 1D and 2D gels (section 
2.2.5, section 2.2.6). These three residues were selected for study as they are the dominant 
sites of phosphorylation (Miesbauer et al., 1994; MacCoss et al., 2002), the most extensively 





antibody specific to the C-terminal residues of αB was used as a control to detect both 
phosphorylated and unphosphorylated αB, thereby reflecting the total αB pool. Densitometry 
software was used on 1D blots to measure relative intensity of spots representing 
phosphorylated αB in order to compare αB phosphorylation profiles between lens region and 
density fractions, and with age (section 2.2.5). 
Tandem mass spectrometry (MS/MS) is often used to determine peptide identity and to detect 
modification sites. In-gel tryptic digests of discrete 2D spots were therefore subjected to 
MS/MS to determine protein identities. This method was also applied to spots within the 
mass range ~40-95 kDa to identify proteins and modification sites present in crosslinked 





3.3.1 Mimicking phosphorylation activates chaperone activity of αB.. 
To determine how the addition of a negative charge can affect the chaperone activity of αB, 
aggregation assays were performed to compare the ability of αB with single (S19D; hereafter 
1P), double (S19D/S45D; hereafter 2P) and triple (S19D/S45D/S59D; hereafter 3P) point 
mutations that mimic phosphorylation to inhibit the heat-induced aggregation of CPK. There 
was minimal aggregation when WT or 1P αB were incubated alone under these experimental 
conditions (Figure 3.1C). When present at a molar ratio of 1αB:1CPK, WTαB (no mutations) 
increased the amount of aggregation of CPK by 2.8-fold (P=0.001) compared to when CPK 
incubated alone (Figure 3.1A). In contrast, the amorphous aggregation of CPK was inhibited 
by 72.3±2.9% (P=0.009) in the presence of 3P αB (Figure 3.1A). The amount of CPK 
aggregation was also reduced (45.8±7.7%) by 2P αB, although these results did not reach 
statistical significance (P=0.195) (Figure 3.1A). Incubation with 1P did not significantly 
affect CPK aggregation (P=0.9) (Figure 3.1A). At a molar ratio of 1αB:2CPK, each subsequent 
addition of a mutation that mimics phosphorylation led to a decrease in the amount of CPK 
aggregation (Figure 3.1B). At this lower concentration of αB, incubation with WT (P=0.9) or 
1P αB (P=0.134) did not significantly affect aggregation of CPK. However, 2P αB inhibited 





83.9±1.3% (P=0.001) (Figure 3.1B). WT, 1P, 2P and 3P αB incubated in the absence of 




Figure 3.1: Effect of mutations that mimic phosphorylation on the ability of αB to 
inhibit the heat-induced aggregation of CPK. CPK (0.125 µM) was incubated in PBS (pH 
7.4) at 40°C in the presence of WT, 1P, 2P or 3P αB at a concentration of (A) 0.5 µM or (B) 
0.25 µM. (i) The change in light scatter was measured at 360 nm over time. (ii) The amount 
of aggregation at 600 minutes was calculated as a proportion of the control i.e. no αB. Data 
are shown as means±1SD (N=3). Differences between group means were tested using a one-
way ANOVA and Tukey’s post-hoc test (P≤0.01 is indicated by an asterisk). Note – scale of 









To determine if the observed increase in chaperone activity of 2P and 3P αB was due to 
mutation of a specific residue (e.g. Ser45), the CPK aggregation assays were repeated using 
phosphomutants with single S→D point mutations at Ser19, Ser45 or Ser59 (i.e. S19D, S45D 
and S59D αB). Again, there was minimal aggregation observed when CPK was not present in 
the sample (Figure 3.2C). At a molar ratio of 1CPK:1αB, the addition of WTαB significantly 
increased CPK aggregation by 2-fold (P=0.001) compared to when CPK was incubated alone 
(Figure 3.2A). At a 1αB:1CPK ratio, the aggregation of CPK was not significantly affected by 
incubation with the S19D, S45D or S59D αB phosphomutants (Figure 3.2A). At a molar ratio 
of 1αB:4CPK, CPK aggregation was not significantly affected by incubation with any of the αB 
isoforms (Figure 3.2B). WT, S19D, S45D and S59D incubated in the absence of chaperone 
were used as negative controls (Appendix 3). 
 
  
Figure 3.2: Effect of single-site αB phosphomimics on the heat-induced aggregation of 
CPK. CPK (0.125 µM) was incubated in PBS (pH 7.4) at 40°C in the presence of WT, 1P, 
2P or 3P αB at a concentration of (A) 0.5 µM or (B) 0.125 µM. (i) The change in light scatter 
was measured at 360 nm over time. (ii) The amount of aggregation measured as light scatter 
at 600 minutes was calculated as a proportion of the control i.e. no αB. Data are shown as 
means±1SD (N=3). Differences between group means were tested using a one-way ANOVA 





3.3.2 The amount of multiply phosphorylated αB is increased in the nucleus of aged human 
lenses and coincides with the formation of high-density protein fractions. 
 
Isolation of high density lens protein fractions 
Density sucrose centrifugation was performed separately on two human lenses (aged 41 and 
77 years old, representing a younger and an older lens respectively) to investigate how 
density profiles from different regions of the lens change with age. Prior to centrifugation, 
each lens was dissected into cortical, barrier and nuclear regions with a trephine (section 
2.2.2, Figure 2.1). Protein deposited at density interfaces, was observed as cloudy white 
bands (sucrose gradient 6-1, SG6-1, in order of increasing density). The amount of protein for 
each band was measured as a percentage of the total protein in the tube.  
The predominant band in the cortical sample from the younger lens was SG3 (Figure 3.3A, 
B). As the amount of SG3 decreased in the younger lens towards the nucleus, SG5 increased 
to become the predominant band in the nuclear sample (Figure 3.3A, B). The predominant 
band in the older lens for all regions (i.e. cortical, barrier and nuclear samples) was SG2 
(Figure 3.3A, B).  
In the cortical samples, SG6, SG5 and SG3 decreased from 17%, 28% and 38% of the total 
protein respectively in the younger lens to 14%, 19% and 24% in the older lens (Figure 3.3B, 
C). The amount of SG4 remained constant (at 10% of the total protein) and SG2 increased 
from 7% of the total protein in the younger lens to 32% in the older lens (Figure 3.3B, C).  
In the barrier region, SG6, SG5, SG4 and SG3 decreased from 17%, 31%, 14% and 38% of 
the total protein respectively in the younger lens to 14%, 20%, 7% and 16% in the older lens 
(Figure 3.3B, C). While no SG2 band was evident in the younger lens, SG2 constituted 42% 
of the total protein in the barrier region from the older lens (Figure 3.3B, C).  
In the nuclear samples, SG5, SG4 and SG3 decreased from 44%, 16% and 23% of the total 
protein respectively in the younger lens to 16%, 8% and 6% in the older lens (Figure 3.3B, 
C). The amount of SG6 and SG2 increased from 12% and 4% of total protein respectively in 
the younger lens to 16% and 41% in the older lens (Figure 3.3B, C). Although absent in the 
nuclear region from the younger lens, and from cortical and barrier samples from both lenses, 
SG1 constituted 11% of the total protein content in the nuclear sample from the older lens 






Figure 3.3: Comparison of sucrose density gradient profiles from human lenses as a 
function of age. (A) Human lenses from a 41 year-old and a 77 year-old were manually 
dissected into cortical, barrier and nuclear regions and density fractions (SG6-SG1) were 
separated via density sucrose centrifugation. Images were inverted using densitometry 
software, and the amount of protein for each band was determined by measuring the area 
under the corresponding peak on the densitometry profile. The relative amount of protein in 
each band for the (B) 41 year-old and the (C) 77 year-old lens is expressed as a percentage of 












Comparison of protein composition of sucrose density bands 
To compare proteins present in different density fractions, SG2, SG3, SG5 and SG6 were 
isolated from each region of a 53 year-old human lens and separated using 1D SDS PAGE. 
Fraction SG4 was not analysed as analysis was limited to high and low density fractions. 
Additionally, SG4 was a relatively minor component for each lens. As a known amount of 
standard was not loaded for each gel, densitometry analysis was limited to the comparison of 
relative proportions compared to the total signal from each lane. A different lens of this age 
was used in order to obtain sufficient protein yield for each fraction for analysis. Barrier and 
nuclear SG6 were not analysed due to insufficient protein yields. In the cortical SG6 sample, 
αB migrated a shorter distance than in the higher density fractions, potentially due to overall 
lower rates of modification, notably truncation. Levels of protein (observed as discrete bands) 
increased with decreasing density across all lens regions. Across all regions of the lens and all 
density fractions, αA and αB were the predominant protein species in these samples (Figure 
3.4A, B).  
Additional protein bands at 100 kDa, 55 kDa and 40 kDa were also observed in some 
samples (Figure 3.4A, B). The 100 kDa and 55 kDa bands were exclusively present in high 
density fractions (i.e. SG2 and SG3) from cortical samples, albeit at low levels (1.1-2.0% and 
0.8-1.7% of the total protein respectively) (Figure 3.4A, B). In comparison, the 40 kDa band 
was observed in samples from all lens regions (Figure 3.4A, B). In cortical samples, levels of 
the 40 kDa band decreased from 7.6% of the total protein in the SG5 fraction to 3.9% in the 
SG2 fraction (Figure 3.4A, B). In barrier samples, the 40 kDa band was only observed in the 
SG3 fraction, accounting for 6.1% of the total protein in the sample (Figure 3.4A, B). Levels 
of a protein migrating with αA (‘αA’) decreased with increasing density across all lens 
regions (Figure 3.4A, B). In the cortical samples, ‘αA’ decreased from 16% of the total 
protein in SG6 to 6.7% in SG2 (Figure 3.4A, B). In barrier and nuclear samples, ‘αA’ 
decreased from 7.1% to 9.2% of total protein in the SG5 fraction to 6.1% and 5.9% in the 
SG2 fraction respectively (Figure 3.4A, B). Although the levels of a protein migrating with 
αB (‘αB’), as a proportion of the total protein, varied across density fractions, a trend towards 
a decrease in ‘αB’ levels was observed when comparing cortical and nuclear samples across 
all SG fractions (Figure 3.4A, B). In SG2 fractions, ‘αB’ accounted for 28.5% of the total 
protein in cortical samples but only 11.5% in nuclear samples (Figure 3.4A, B). Levels of 





31.8% in cortical samples to 19.1% and 24.4% in nuclear samples respectively (Figure 3.4A, 




Figure 3.4: Protein components of SG fractions from different regions of a human lens. 
(A) SG2, SG3 and SG5 fractions were isolated from the cortical, barrier and nuclear regions 
of a 53 year-old female human lens via density sucrose centrifugation and separated using 1D 
SDS PAGE. The position of dominant protein bands at 100 kDa, 55 kDa, 40 kDa, as well as 
bands running at the distance of αA and αB are shown on the left. (B) The amount of each 
protein band was measured using densitometry and calculated as a percentage of the total 
protein in each lane to the closest whole number. Note - an empty lane was digitally excised 







Detection of phosphorylated αB in sucrose density bands 
To compare levels of phosphorylated αB across density fractions from each region of this 53 
year-old lens, protein from SG2-SG5 from each region was separated on 1D SDS gels, 
transferred onto PVDF and labelled with antibodies specific to pSer19, pSer45 or pSer59 αB. 
An identical blot was prepared and labelled with an anti-αB antibody for use as a control to 
indicate levels of total αB for each sample. Densitometric data for each αB band was 
standardized against the cortical SG5band for each blot (i.e. density of band was calculated as 
a proportion of the signal for cortical SG5 band for each blot) as it was found to have the 
highest level of total protein. Differences in the amount of protein in each sample were 
accounted for by calculating the relative amount of phosphorylated αB as a proportion of the 
relative amount of αB in the sample (i.e. density of pαB as a proportion of corresponding 
band on blot labelled for total αB). 
With regards to the pSer19 to total αB ratio between samples, the highest levels of pSer19 αB 
were found in cortical samples for SG2 (0.9) and SG3 (0.8) (Figure 3.5). In comparison, SG5 
had pSer19 αB levels equal to the amount of αB in the sample (Figure 3.5). The relative 
levels of pSer19 αB were slightly lower in the barrier samples for SG2 (0.6), SG3 (0.8) and 
SG5 (0.7) (Figure 3.5). The lowest relative levels of pSer19 αB were in nuclear samples for 
SG2 (0.2), SG3 (0.3) and SG5 (0.6) (Figure 3.5).  
With regards to the pSer45 to total αB ratio between samples, the highest levels of pSer45 αB 
were also in the cortex, with the relative levels the same across all fractions and similar to the 
amount of αB in the samples (Figure 3.5). The relative levels of pSer45 αB were lower in the 
barrier samples for SG2 (0.5) and SG3 (0.6). However, relative levels of SG5 were elevated 
in the barrier sample (1.2) compared to SG2 and SG3 (Figure 3.5). The lowest levels of 
pSer45 αB were in nuclear samples for SG2 (0.1), SG3 (0.2) and SG5 (0.5) (Figure 3.5).  
With regards to the pSer59 to total αB ratio between samples, the highest levels of pSer59 αB 
were in the barrier for SG2 (0.9), SG3 (0.9) and SG5 (0.8) (Figure 3.5). The relative levels of 
pSer59 in cortical and nuclear samples were comparable when levels across each of the 
fractions were averaged (Figure 3.5). In the cortical samples, relative levels of pSer59 were 
equal to the amount of αB in SG5 (Figure 3.5). However, relative levels of pSer59 were 
lower for SG2 (0.5) and SG3 (0.8) compared to SG5 (Figure 3.5). In the nuclear samples, the 









Figure 3.5: Identification of phosphorylated isoforms of αB and their relative amounts 
in SG fractions from a human lens following 1D SDS-PAGE. SG2, SG3 and SG5 
fractions were isolated from the cortical, barrier and nuclear regions of a 53 year-old human 
lens, separated using 1D SDS PAGE and transferred onto PVDF membranes. Membranes 
were incubated with anti-αB antibody (total αB) or antiphosphoserine specific antibodies to 
pSer19, pSer45 or pSer59 αB, and developed with DAB. The intensity of each band was 
measured using densitometry, standardised to the cortical SG5 band for each membrane, and 
the relative amount of pαB in each band was calculated as a ratio of the relative amount of αB 





2D SDS PAGE separation of modified αB from SG fractions 
To compare differences in αB phosphorylation patterns between density fractions and 
between age groups, SG2, SG3 and SG5 fractions from each region were isolated from a 
range of human lenses (aged 41-77 years), and separated using 2D SDS PAGE. As 
corresponding controls for each region, another lens was dissected into cortical, barrier and 
nuclear regions, and subjected to 2D SDS PAGE without sucrose density centrifugation i.e. 
separated as a whole homogenate. Spots identified as αB (based on MS analysis and 
migration patterns) were labelled 1-9 in order of increasing negative charge, and 
phosphorylated isotypes were identified by immunoblotting with the pSer19, pSer45 and 
pSer59 αB specific antibodies. The relative intensity for each gel spot was calculated as a 
ratio of its density compared to that of spot 3 which, based on its pI, corresponds to the 
unphosphorylated form of αB.  
Gel spots 1-3 were not reactive with any of the αB phosphospecific antibodies (Figure 3.6), 
suggesting these spots correspond to unphosphorylated forms of αB. The differences in 
migration (i.e. the pI) between these αB isoforms is likely to be due to post-translational 
modification (e.g. deamidation), other than phosphorylation, that act to change the pI of the 
protein. The pSer19 antibody reacted with the fewest spots (spots 4-6) (Figure 3.6). The 
pSer45 antibody reacted with five discrete spots, spots 4-7 and spot 9 (Figure 3.6). The 
pSer59 antibody reacted with six discrete protein spots, spots 4-9 (Figure 3.6). The existence 
of protein isoforms that reacted with the phosphospecific antibodies indicates the presence of 
multiply phosphorylated isoforms of αB in some samples. It should be noted that on the 
membrane probed with the pSer59 antibody (Figure 3.6), the negative banding of spot 4 is 










Figure 3.6: Identification of phosphorylated isoforms of αB in SG3 fraction from a 77 
year-old human lens following 2D SDS-PAGE. SG3 was isolated from the cortical region 
of a 77 year-old human lens and separated using 2D SDS PAGE. Sections of the gels were 
excised and transferred onto PVDF membrane. Membranes were incubated with anti-
phosphoserine specific antibodies to pSer19, pSer45 or pSer59 αB, and developed using 
chemiluminescence on X-ray film. X-ray films were superimposed onto a corresponding 
Coomassie stained gel section to identify spots (labelled 1-9) corresponding to αB isoforms. 













To compare phosphorylation profiles of different density fractions, SG2 and SG3 were 
isolated from a 77 year-old lens. Due to insufficient protein yields from this lens, SG5 was 
isolated from a 41 year-old lens. The fractions were then separated using 2D SDS PAGE. 
Analysis of SG1, SG4, SG6 and cortical SG2 was not performed due to insufficient amounts 
of proteins in these samples. Homogenised tissue from each region (i.e. cortex, barrier and 
nucleus) was prepared and analysed for use as corresponding controls.  
Control gels 
The cortical region gel displayed only two phosphorylated spots, spot 4 and 6, both of which 
had half the amount of protein (i.e. 0.5-fold) compared to spot 3 from the same gel (Figure 
3.7A; Table 3.1). The relative amount of spot 4 remained constant in the barrier control (i.e. 
0.5-fold) (Figure 3.7B; Table 3.1). The relative amount of spot 6 decreased slightly in the 
barrier region compared to the cortical region (i.e. 0.3-fold the amount of protein compared to 
spot 3 from the barrier region) (Figure 3.7B; Table 3.1). The nuclear region had only one 
phosphorylated spot, spot 5 (i.e.  0.9-fold the amount of protein as spot 3 from the same gel) 
(Figure 3.7C; Table 3.1). All control gels, i.e. the cortical, barrier and nuclear whole 
homogenate gels, also displayed spot 2 (i.e. corresponding to an unphosphorylated isoform of 
αB) at high levels (Figure 3.7A-C; Table 3.1) (i.e. 1.5-fold for the cortical region, 0.8-fold for 
the barrier region and 1-fold for the nuclear region.  
SG2 gels 
Gels of the SG2 fractions demonstrated that there is an increase in phosphorylation levels 
between the barrier and the nucleus, observed as an increase in the number of multiply 
phosphorylated spots (i.e. spots 5-9) (Figure 3.7D-E; Table 3.1). The gel of the SG2 fraction 
from the barrier displayed two phosphorylated spots; spot 5 (i.e. 0.3-fold) and spot 6 (i.e. 0.2-
fold the amount of protein compared to spot 3 from the same gel) (Figure 3.7D; Table 3.1). 
The gel of the SG2 fraction from the nucleus displayed an increase in multiply 
phosphorylated species compared to both the nuclear control gel (Figure 3.7C) and the SG2 
gel from the barrier (Figure 3.7D) as evidenced by an increase in the number of negatively-
charged spots (spots 5-9). These had 0.5-fold (spot 5), 0.4-fold (spot 6), 0.4-fold (spot 7), 0.2-
fold (spot 8) and 0.1-fold (spot 9) the amount of protein compared to spot 3 from the same 
gel respectively (Figure 3.7E; Table 3.1). The amounts of spot 2 (i.e. an unphosphorylated 
isoform of αB observed in the gels), decreased in the SG2 gel from the nucleus compared to 





fold the amount of protein compared to from spot 3 from the same gel for the nucleus) 
(Figure 3.7D-E; Table 3.1). This relative decrease in this unphosphorylated αB could be 
explained by either the presence of additional modifications that affect pI or an increase in 
the relative amount of phosphorylated αB in the sample. Spots corresponding to truncated 
forms of αA were present, predominantly on the nuclear gel. However, the spots were not 
sufficiently resolved to allow for densitometric analysis. 
SG3 gels 
All gels of SG3 fractions (i.e. cortical, barrier and nucleus) displayed the maximum number 
of spots observed amongst the gels (i.e. spots 4-9) (Figure 3.7F-H; Table 3.1) indicating 
higher levels of αB phosphorylation compared to SG2 and SG5 fractions as well as whole 
lens homogenates. The relative amounts for spots 4 and 6-8 decreased slightly from the 
cortex towards the nucleus for the SG3 fraction (i.e. decreased from 0.6-fold, 0.6-fold, 0.3-
fold and 0.3-fold in the cortex to 0.5-fold, 0.3-fold, 0.2-fold and 0.2-fold in the nucleus 
respectively) (Figure 3.7F-H; Table 3.1). The relative amounts of spots 5 and 9 remained 
consistent in SG3 from the cortex and nucleus (0.3-fold and 0.2-fold the amount of protein 
compared to spot 3 from the same gel) (Figure 3.7F-H; Table 3.1). Relative amounts of spot 2 
decreased in SG3 between the cortex and the nucleus (i.e. 1.3-fold in the cortex to 0.4-fold in 
the nucleus) (Figure 3.7F-H; Table 3.1). Spot 1 was only present in SG3 from the cortex 
(Figure 3.7F) and the barrier (Figure 3.7G) (0.3-fold and 0.2-fold the amount of protein 
compared to spot 3 from each gel). Spots corresponding to truncated forms of αA were 
present on gels from each region (Figure 3.7F-H, indicated by boxed area). However, the 
spots were not sufficiently resolved to allow for densitometric analysis.SG5 gels 
Gels of SG5 fractions demonstrated a gradual decrease in αB phosphorylation levels towards 
the nucleus, as evidenced by a decrease in the number and relative amounts of spots (Figure 
3.7I-K; Table 3.1). The SG5 gel from the cortex displayed three spots corresponding to 
phosphorylated αB isoforms i.e. spots 4-6, each having 0.5-fold the amount of protein 
compared to spot 3 from the same gel (Figure 3.7I; Table 3.1). Relative amounts for spots 4 
and 6 were similar to relative amounts of the corresponding spots on the cortical control 
(Figure 3.7A; Table 3.1). Spot 5 however was not present on the cortical control gel, 
indicating higher levels of αB phosphorylation in cortical SG5 compared to cortical 
homogenate (Figure 3.7A, I; Table 3.1). The SG5 gel from the barrier displayed a single spot 





protein compared to spot 3 from the same gel) (Figure 3.7J; Table 3.1), indicating levels of 
αB phosphorylation had decreased compared to the levels in the barrier control (Figure 3.7B). 
The SG5 gel from the nucleus also only displayed spot 4, the relative amount of which had 
decreased to 0.3-fold the amount of protein compared to spot 3 from the same gel (Figure 
3.7K; Table 3.1). The relative amounts of spot 2 increased in SG5 between the cortex and the 
nucleus (i.e. from 0.5-fold in the cortex to 0.7-fold in the nucleus) (Figure 3.7I-K; Table 3.1). 
However, these amounts remained below those observed for spot 2 in the corresponding 














Figure 3.7: Comparison of phosphorylated isoforms of αB in SG fractions from 
different regions of human lenses. SG2 (D-E) and SG3(F-H) isolated from each region (i.e. 
cortex, barrier and nucleus) of a 77 year-old human lens, and SG5 (I-K) isolated from each 
region of a 41 year-old human lens were separated using 2D SDS-PAGE. Tissue homogenate 
from each region of a 53 year-old lens was separated using 2D SDS-PAGE without prior 
sucrose density gradient centrifugation for use as a total protein control (A-C). Spot identities 
for αA and αB were confirmed by MS, and spots corresponding to αB were labelled 1-9. The 
regions of the gels corresponding to the acidic (+) and basic (-) region of the IEF strip used in 
the first dimension separation are as indicated. Spots consistent with truncated αA are 






Table 3.1: Relative amounts of αB isoforms in SG fractions from different regions of human lenses. The intensity of αB spots (labelled 1-9; 
see Figure 3.7) detected in SG2, SG3 (77 year-old lens), SG5 (41 year-old lens) fractions and the control sample (53 year-old lens) from each 
region of the lens was measured using densitometry and the relative amount calculated as a proportion of spot 3 (corresponding to unmodified 
αB) from each corresponding gel. Pink shading indicates spots corresponding to unphosphorylated αB isoforms and blue shading indicates spots 
corresponding to phosphorylated αB isoforms. Samples which could not be analysed due to low yield are indicated by “ND”. 
 Cortex Barrier Nucleus 
 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 
Control 0 1.5 1 .5 0 .5 0 0 0 0 .8 1 .5 0 .3 0 0 0 0 1 1 0 .9 0 0 0 0 
SG2 ND ND ND ND ND ND ND ND ND 0 .8 1 0 .3 .2 0 0 0 0 .6 1 0 .5 .4 .4 .2 .1 
SG3 .3 1.3 1 .6 .3 .6 .3 .3 .2 .2 .8 1 .5 .4 .5 .3 .3 .2 0 .4 1 .5 .3 .3 .2 .2 .2 





Comparison of phosphorylated αB in SG2 as a function of age 
To compare phosphorylation profiles of membrane associated αB across three lenses of 
different ages, the same 2D gels of the SG2 fraction from the 77 year-old lens were compared 
to gels of the SG2 fractions isolated from two younger human lenses (aged 41 and 62 years) 
that had been separated using 2D SDS PAGE. Analysis of the 41 year-old barrier and 77 
year-old cortical region was not performed due to insufficient amount of protein in these 
samples. 
The gels of the cortex and nucleus of the 41 year-old lens both displayed four spots 
corresponding to phosphorylated αB isoforms; spots 4-8 (Figure 3.8A-B; Table 3.2). The 
relative amounts of these spots varied between the nucleus and cortex of the 41 year-old lens. 
Relative amounts of spots 6 and 8 were decreased in the nucleus compared to the cortex (0.4-
fold and 0.2-fold in the nucleus compared to 0.7-fold and 0.3-fold in the cortex respectively) 
(Figure 3.8; Table 3.2). Spot 4 was only present in the cortical sample from the 41 year-old 
lens, having 0.5-fold the amount of protein compared to spot 3 from the same gel (Figure 
3.8A; Table 3.2). The relative amounts of spots 5 and 7 were increased in the nucleus 
compared to the cortex for the 41 year-old lens (0.7-fold and 0.4-fold in the nucleus 
compared to 0.5-fold and 0.2-fold in the cortex respectively) (Figure 3.8A-B; Table 3.2). 
Relative amounts of spot 2 (i.e. corresponding to an unphosphorylated αB isoform) were 
slightly decreased in the nucleus compared to the cortex for the 41 year-old lens (0.8-fold in 
the nucleus compared to 0.9-fold in the cortex) (Figure 3.8A-B; Table 3.2).  
62 year-old lens 
The number and relative amounts of spots corresponding to phosphorylated αB isotypes 
decreased towards the nucleus in the 62 year-old lens (Figure 3.8C-E; Table 3.2). The cortical 
gel displayed three spots corresponding to phosphorylated αB isoforms i.e. spots 4-7 (Figure 
3.8C). Spots 4-6 had 0.4-fold and spot 7 had 0.3-fold the amount of protein compared to spot 
3 from the same gel (Figure 3.8C; Table 3.2). The barrier gel from the 62 year-old lens 
displayed two spots corresponding to phosphorylated αB isoforms i.e. spots 5 and 6 (Figure 
3.8D; Table 3.2). Spot 5 had 0.6-fold and spot 5 had 0.4-fold the amount of protein compared 
to spot 3 from the same gel (Figure 3.8D; Table 3.2). The nuclear gel from the 62 year-old 
lens displayed a single spot corresponding to a phosphorylated αB isoform, spot 5 which had 





The relative amount of spot 2 decreased towards the nucleus in the 62 year-old lens (0.5-fold 
in the nucleus compared to 0.8-fold in the cortex) (Figure 3.8C-E; Table 3.2).  
77 year-old lens 
The number and relative amounts of spots corresponding to phosphorylated αB isoforms 
increased towards the nucleus in the 77 year-old lens (Figure 3.8F-G; Table 3.2). The barrier 
gel from the 77 year-old lens displayed two spots corresponding to phosphorylated αB 
isoforms, spots 5 and 6 having 0.3-fold and 0.2-fold the amount of protein compared to spot 3 
from the same gel respectively (Figure 3.8F; Table 3.2). The nuclear gel from the 77 year-old 
lens displayed five spots corresponding to phosphorylated αB isoforms, spots 5-9 having 0.5-
fold, 0.4-fold, 0.4-fold, 0.2-fold and 0.1-fold the amount of protein compared to spot 3 from 
the same gel respectively (Figure 3.8G; Table 3.2). The relative amount of spot 2 decreased 
between the barrier and the nucleus of the 77 year-old lens (0.8-fold in the cortex compared 
to 0.6-fold in the nucleus) (Figure 3.8F-G; Table 3.2). 
Spots corresponding to truncated forms of αA were present on gels for each lens (Figure 3.8). 












Figure 3.8: Comparison of phosphorylated isoforms of αB in SG2 from different regions 
of human lenses with age. SG2 from each region of a 41 year-old (A-B), 62 year-old (C-E) 
and 77 year-old (F-G) human lens was separated using 2D SDS-PAGE. Spots corresponding 
to αB were identified and labelled 1-9. The regions of the gels corresponding to the acidic (+) 
and basic (-) region of the IEF strip used in the first dimension separation are as indicated. 
Spots consistent with truncated αA are indicated by boxed region. Analysis of SG2 from the 
barrier of the 41 year-old lens and SG2 from the cortex of the 77 year-old lens was not 
performed due to insufficient protein yields. Samples for which analysis could not be 
performed due to low yield are indicated by “ND”. Note: panels D and E from Figure 3.7 are 






Table 3.2: Relative amounts of αB isoforms from SG2 as a function of age. The intensity of αB spots (labelled 1-9; see Figure 3.8) detected 
in SG2 from each region of a 41 year-old, 62 year-old and 77 year-old lens was measured using densitometry and the relative amount calculated 
as a proportion of spot 3 (corresponding to unmodified αB) from each corresponding gel. Pink shading indicates spots corresponding to 
unphosphorylated αB isoforms and blue shading indicates spots corresponding to phosphorylated αB isoforms. Spots for which not enough 
protein was isolated for analysis are indicated by “ND”. 
 Cortex Barrier Nucleus 
 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 
41 0 .9 1 .5 .5 .7 .2 .3 0 ND ND ND ND ND ND ND ND ND 0 .8 1 0 .7 .4 .4 .2 0 
62 0 .8 1 .4 .4 .4 .3 0 0 0 .7 1 0 .6 .3 0 0 0 0 .5 1 0 .2 0 0 0 0 





3.3.3 Modified filensin and crystallins form complexes 
Protein from the SG3 fraction from the cortex of the 77 year-old lens was isolated and 
separated by 2D-SDS-PAGE. A cluster of negatively charged proteins were observed in this 
fraction, ranging in size from ~40-95 kDa (red boxed zone and expansion, Figure 3.9A). 
Although most prominent in this gel, similar but fainter spots were also observed in the 
barrier and nuclear gels from the same lens (Figure 3.7), and on cortical SG2 gels from a 41 
and a 62 year-old lens (Figure 3.8). Discrete spots were excised and submitted for MS/MS 
analysis to determine the composition and modification profile of each. A total of ten spots 
were analysed and labelled complex 1-10 according to decreasing mass. The proportion of 
filensin deamidated at each site (as a %) was calculated based on relative peak area for 
complexes where filensin was the predominant protein (Table 3.3, Figure 3.10). A 
comprehensive list of identified peptides and modified residues is available in Appendix 3. 
With the exception of complex 3, based on the number of tryptic peptides, all spots were 
predominately (>60%) composed of peptides derived from filensin (~75 kDa), with lower 
amounts of peptides derived from αA (~20 kDa), αB (~20 kDa), βB1 (~28 kDa), phakinin 
(~46 kDa), serum albumin (~ 69 kDa), retinol dehydrogenase (~55 kDa) and actin, 
cytoplasmic 1 (~42 kDa) (Figure 3.9B). Complex 1 resolved as a discrete spot of ~95 kDa 
with a pI of ~4.5 (Figure 3.9A), and was found to be composed of peptides derived from 
filensin (83%), phakinin (7%) and αA (4%) (Figure 3.9B). From complex 1, four sites of 
filensin deamidation (N383, N478, N145 and N304) and two of oxidation (M649 and M207) 
were identified (Figure 3.9A). The proportion of filensin peptides deamidated at N478, N145 
and N304 was calculated from the peak areas from the ion chromatograms (Figure 3.10) and 
found to be 25.2%, 7% and 42.2% respectively (Table 3.3). For N383, only the deamidated 
peptide was detected in complex 1 (Table 3.3).  
Complex 2 resolved as a discrete spot of ~60 kDa with a pI of ~5 (Figure 3.9A), and was 
shown to be composed of peptides derived from filensin (74%), phakinin (5%), αA (3%), 
βB1 (6%), retinal dehydrogenase (4%) and αB (5%) (Figure 3.9B). From complex 2, a single 
site of filensin oxidation (M207), and five of deamidation (N155, N145, N304, N383, N268) 
were identified, as well as a single αB oxidation (M68) site (Figure 3.9A). The proportion of 
filensin peptides deamidated at residues N155 and N304 was 3.8% and 34.7% respectively 
(Table 3.3). The peptide containing both N145 and N155 had a percent deamidation of 12.4% 





Complex 3 resolved as a discrete spot of ~55 kDa with a pI of ~4 (Figure 3.9A), and had a 
unique protein profile predominantly composed of peptides derived from brain acidic soluble 
protein 1 (BASP1, 54%), with lower amounts of filensin (22%), phakinin (9%), αA (4%), 
serum albumin (6%) and αB (4%) (Figure 3.9B). From complex 3, a single site of filensin 
oxidation (M649) was identified, as well as single site of BASP 1 deamidation (N218) 
(Figure 3.9A). 
Complexes 4-9 resolved as a cluster of spots with similar mass (~45 kDa) and pIs ranging 
from 5.8 -6 (Figure 3.9A). Complex 4 had a pI of ~6.2 (Figure 3.3.9A) and was composed of 
peptides derived from filensin (86%), αA (2%), βB1 (6%) and αB (2%) (Figure 3.9B). From 
complex 4, a single αB deamidation site (N146) was identified, as well as four deamidation 
(N268, N304, N145 and N155) and a single oxidation (M207) site from filensin (Figure 
3.9A). The proportion of filensin peptides deamidated at N155 and N304 was 3.5% and 
29.2% respectively (Table 3.3). The peptide containing both N145 and N155 was deamidated 
2.5% (Table 3.3).  
Complex 5 had a pI of ~6 (Figure 3.9A) and was shown to be composed of peptides derived 
from filensin (85%), αA (3%), βB1 (5%) and αB (3%) (Figure 3.9B). From complex 5, three 
sites of filensin deamidation (N304, N145 and N155) and a single site of oxidation (M207) 
was identified (Figure 3.9A). The proportion of filensin peptides deamidated at N155 and 
N304 was 3.8% and 56% respectively (Table 3.3). The peptide containing both N145 and 
N155 was deamidated 2.8% (Table 3.3).  
Complex 6 had a pI of 5.9 (Figure 3.9A) and was shown to be composed of peptides derived 
from filensin (80%), αA (4%), serum albumin (4%), βB1 (5%) and αB (4%) (Figure 3.9B). 
From complex 6, a single site of αB deamidation (N146) was identified, as well as four sites 
of deamidation (N318, N304, N145 and N155) and a single site of oxidation (M207) from 
filensin (Figure 3.9A). The proportion of filensin peptides deamidated at N155 and N304 was 
3.5% and 59.4% respectively (Table 3.3). The peptide containing both N145 and N155 was 
deamidated 2.7% (Table 3.3). For N318, only the deamidated peptide was detected (Table 
3.3). 
 Complex 7 had a pI of ~5.8 (Figure 3.9A) and was shown to be composed of peptides 
derived from filensin (78%), αA (3%), serum albumin (5%), βB1 (5%) and αB (5%) (Figure 
3.9B). From complex 7, a single site of αB deamidation (N146) was identified, as well as 





from filensin (Figure 3.9A). The proportion of filensin peptides deamidated at N155 and 
N304 was 3.5% and 56.7% respectively (Table 3.3). The peptide containing both N145 and 
N155 was deamidated 2.9% (Table 3.3).  
Complexes 8-9 were shown to have a slightly lower mass than complexes 4-7 (~42 kDa), 
while having pIs similar to complex 6 and complex 7 respectively (~5.8 – 5.9) (Figure 3.9A). 
Complex 8 was shown to be composed of peptides derived from filensin (83%), αA (4%), 
βB2 (5%) and αB (5%) (Figure 3.9B). From complex 8, a single site of αB deamidation 
(M146) was identified, as well as four sites of deamidation (N155, N145, N304 and N318) 
and a single site of oxidation (M207) from filensin (Figure 3.9A). The proportion of filensin 
peptides deamidated at N155 and N304 was 3.7% and 42.3% respectively (Table 3.3). The 
peptide containing both N145 and N155 was deamidated 3.4% (Table 3.3). For N318, only 
the deamidated peptide was detected (Table 3.3).  
Complex 9 was shown to be composed of peptides derived from filensin (71%), phakinin 
(2%), αA (5%), βB1 (9%) and αB (8%) (Figure 3.9B). From complex 9, five sites of filensin 
deamidation (N145, N155, N478, N304 and N268) were identified, as well as two sites of 
deamidation (N78 and N146) and single site of oxidation (M68) from αB (Figure 3.9A). The 
proportion of filensin peptides deamidated at N155 and N304 was 5.3% and 44.2% 
respectively (Table 3.3). The peptide containing both N145 and N155 was deamidated 3.3% 
(Table 3.3). For N478, only the deamidated peptide was detected (Table 3.3). 
Complex 10 resolved as a discrete spot of ~40 kDa with a pI of ~4 (Figure 3.9A), and was 
shown to be composed of peptides derived from filensin (60%), phakinin (14%), αA (6%) 
and actin, cytoplasmic 1 (10%) (Figure 3.9B). From complex 10, two sites of filensin 
deamidation (N478 and N304) and two sites of phosphorylation (S488 and T450) were 
identified (Figure 3.9A). The proportion of filensin peptides deamidated at N155, N304 and 










Figure 3.9: Identification of proteins and modified residues from protein complexes in 
the SG3 fraction from the cortex of the 77 year-old human lens. Discrete spots (labelled 
1-10; inset) were excised from the gel of the SG3 fraction from the cortex of the 77 year-old 
lens (Figure 3.3.7), digested with trypsin and characterised using MS/MS. (B) Proteins that 
constituted ≥2% of the total peptide hits were identified for each spot by comparison with a 
peptide database. (A) Modified residues within each spot were identified for filensin (in 








Table 3.3: Deamidation of filensin in crosslinked complexes (see Figure 3.9). The 
proportion of filensin deamidated in each 2D gel spot following tryptic digestion and analysis 
of peptides. Values are expressed as the amount of deamidated peptide as a proportion of the 
total amount of that peptide (i.e. deamidated + and non-deamidated peptide), calculated using 
the relative peak areas from the ion chromatograms of the mass spectra. Residues located in 
regions of the protein not included within the sequence coverage (i.e. cleaved regions) are 
indicated by a dash. Peptides that were not detected are indicated with (ND). Residues 
located within the same tryptic peptide are indicated with an asterisk. 
Complex N145* N155 N145/N155* N304 N318 N383 N478 
1 7% 0%  42.2% n.d. 100% 25.2% 
2  3.8% 12.4% 34.7% 0% 100% - 
4  3.5% 2.5% 29.2% 0% - - 
5  3.8% 2.8% 56% 0% - - 
6  3.5% 2.7% 59.4% 100% - - 
7  3.5% 2.9% 56.7% ND - - 
8  3.7% 3.4% 42.3% 100% - - 
9  5.3% 3.3% 44.2% ND ND 100% 





Figure 3.10: Ion chromatogram of filensin tryptic peptide 294-308 of mass 1726.9 Da. 
Ion chromatograms were integrated for each precursor peptide containing a deamidation site 
to calculate peak area for the (A) non-deamidated and (B) deamidated peptide. Relative peak 
area for each deamidated peptide was calculated as a proportion of total amount of peptide 








3.4.1 Substitution of Asp at Ser19, Ser45 and S59 of αB increases chaperone activity in a 
cumulative manner. 
The results of this work demonstrate that at a 1αB:1CPK molar ratio, WT αB significantly 
increased aggregation of CPK (Figure 3.1A; Figure 3.2A), however this isoform suppressed 
aggregation when CPK was present in excess (i.e. 1αB:2CPK or 1αB:4CPK). Furthermore, the 
activity of αB and its ability to suppress aggregation was increased by the mutations that 
mimic phosphorylation (Figure 3.1).  Although a trend of increased activity with an 
increasing number of mutations that mimic phsophorylation was observed, the only 
statistically significant results obtained were for the double and triple αB phosphomutants 
(i.e. 2P and 3P) (Figure 3.1). While the presence of 2P at a 1αB:1CPK molar ratio was able to 
inhibit aggregation of CPK by 41.9%, the addition of an extra negative charge (i.e. 3P) led to 
an 83.9% inhibition of CPK aggregation (Figure 3.1B). Additionally, 3P was the only 
phosphomutant to significantly suppress aggregation of CPK at a 1αB:1CPK molar ratio (Figure 
3.1A). It has been postulated that multiple aspartate substitutions may induce hyperactivity of 
αB and that this leads to co-aggregation of the substrate and the chaperone protein under 
certain conditions (Aquilina et al., 2004). However, Ecroyd et al. (2007) demonstrated that 
the use of buffer systems containing ammonium ions (e.g. ammonium acetate) has the ability 
to destabilize 3P αB, leading to co-precipitation with the substrate (although this effect is 
ameliorated by increases in pH). Furthermore, the addition of mutations that mimic 
phosphorylation and destabilization of substrate proteins have both been shown to increase 
αB substrate affinity (Koteiche and Mchaourab, 2003). Studies of an ∆41-58 αB mutant (a 
mutant form of αB where residues 41-58 have been deleted) have shown that its ability to 
prevent the heat-induced aggregation of fully unfolded citrate synthase is reduced compared 
to WTαB, however, its activity is comparable to WTαB in regards to inhibiting the 
aggregation of partially unfolded βL-crystallin and alcohol dehydrogenase (Ghosh et al., 
2006). This may explain why some studies, such as that by Aquilina et al. (2004), have 
reported co-precipitation of αB phosphomimics with substrate proteins, i.e. destabilization of 
the chaperone and/or substrate increased the affinity of the interaction to the point that both 
proteins co-precipitate from solution. 
The results of this study are consistent with previous reports that αB phosphomimics are 





al., 2006; Ecroyd et al., 2007; Ahmad et al., 2008). As αB remains stable in the buffer system 
used for this study (i.e. PBS, pH 7.4)  (Ecroyd et al., 2007), it appears that the presence of 
mutations that mimic phosphorylation increase the chaperone activity of αB without inducing 
hyperactivity (Figure 3.1). These results do confirm however that αB can induce the 
aggregation of substrate proteins when the chaperone activity is reduced, suggesting that 
phosphorylation-induced increases in αB activity may be pivotal for maintaining cellular 
homeostasis in the lens.   
To confirm that an increase in chaperone activity was the cumulative effect of multiple 
mutations that mimic phosphorylation and not the result of a particular single mutation, the 
chaperone activity of αB with single serine-to-aspartate mutations at Ser19, Ser45 and Ser59 
were compared (Figure 3.2). No αB isoform with a single mutation to mimic phosphorylation 
was able to significantly reduce the aggregation of CPK compared to WTαB (Figure 3.2). 
This is consistent with the previous finding that αB isoforms with a single mutation to mimic 
phosphorylation have similar activity to WTαB  (Aquilina et al., 2004). Moreover, these 
results demonstrate that the significant increase in chaperone activity observed for 2P and 3P 
(Figure 3.1) is due to the cumulative effect of multiple serine-to-aspartate substitutions, 
suggesting that multiple phosphorylation events may be required in situ to enhance the 
chaperone activity of αB.  
 
3.4.2 Loss of soluble αA and αB may involve phosphorylation 
It is important to note that it has previously been shown that lens proteins are already heavily 
modified by early adulthood (Lampi et al., 1998), therefore feotal lenses would have 
provided a more suitable control for this study. Unfortunately, feotal lenses were unavailable 
for use, therefore lenses that covered the age when barrier and cataract formation occur (41– 
77 years) were used.  
Previous studies have reported that α-crystallin binds to fibre cell membranes with age, 
forming high density fractions that can be isolated using density sucrose centrifugation 
(Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). The density profiles of this 
work support these findings, i.e. there is a loss of low density soluble protein coupled with an 
increase in high density membrane associated protein with age (Figure 3.3). This was further 
validated by 1D SDS PAGE, where the relative amount of bands corresponding to 





bands were not definitively identified by MS analysis) decreased in the high density samples 
(i.e. SG2 and SG3) from the cortex concomitant with the appearance of bands of ~40 kDa, 
~55 kDa and ~100 kDa compared to the lowest density sample (i.e. SG6) (Figure 3.4). Spots 
with similar masses were resolved following 2D SDS PAGE of the cortical SG3 fraction, and 
were found to contain, among other proteins, αA and αB (Figure 3.9). This suggests that the 
loss of αA and αB in the cortex is a consequence of their incorporation into soluble higher 
molecular weight complexes. Furthermore, the relative amount of αA and αB (i.e. amount of 
monomeric αA and αB compared to the total protein) was decreased in nuclear SG fractions 
compared to cortical SG fractions (Figure 3.4). As this loss was concomitant with an increase 
in protein smearing that was immunoreactive to αB (Figure 3.5), this suggests that loss of αA 
and αB in the nucleus may be due to insolubilisation events. This is consistent with αA and 
αB forming soluble complexes with substrate proteins in the cortex, which later become 
insoluble in the nucleus. Similar to previous reports (Friedrich and Truscott, 2009; Friedrich 
and Truscott, 2010), αA and αB were shown to be the predominant protein species in the high 
density fractions i.e. SG2 and SG3 (Figure 3.4). The loss of αA or αB, whether via 
incorporation into complexes (i.e. in the cortex) or insolubilisation (i.e. in the nucleus) 
(Figure 3.4), could then potentially render the resident proteins susceptible to insolubilisation. 
This is supported by a recent report that showed a negative correlation between free α-
crystallin levels (i.e. α-crystallin not involved in HMWCs) and the prevalence and 
progression of nuclear cataract (Datiles III et al., 2016), suggesting that free α-crystallin loss 
is a phenomenon that precedes cataract in aged but otherwise healthy lenses. 
When pSer19, pSer45 and pSer59 αB levels were compared across density fractions and lens 
regions (Figure 3.5), it was shown that pSer19 and pSer45 were elevated in low density 
fractions (i.e. SG5) compared to high density fractions. As this soluble state may allow higher 
levels of activity and substrate accessibility, it is proposed that this reflects a physiological 
role for these isoforms in vivo. A similar preference (i.e. increased levels in SG5) was shown 
for pSer59 αB in cortical tissue. However, pSer59 αB was elevated in high density fractions 
(i.e. SG2) compared to low density fractions in nuclear tissue, suggesting that 
phosphorylation at this site may be associated with membrane association in the nucleus. As 
single serine-to-aspartate substitutions were found to be insufficient to significantly affect the 
chaperone activity of αB (Figure 3.2), it remains unclear how the charge provided by a single 





therefore likely that pSer59 works in conjunction with other phosphorylatable residues to 
induce hyperactivity that could lead to αB membrane association.  
This is supported by data from the 2D western blots (Figure 3.6) that indicated that, although 
αB was more likely to be phosphorylated at Ser19 when overall phosphorylation levels were 
low (i.e. 1-3 phosphorylated residues), pSer59 (and to a lesser extent pSer45) were present in 
multiply phosphorylated species (i.e. 4-6 phosphorylated residues). This suggests that the 
increased ability of pSer59 to alter the membrane association of αB is a product of its 
tendency to be present in more multiply phosphorylated species. The reason why pSer59 and 
pSer45 are more often associated with highly phosphorylated species of αB while pSer19 is 
associated with lower overall phosphorylation levels is unclear. It is possible that 
phosphorylation at Ser59 or Ser45 induces structural changes that make neighbouring sites 
more susceptible to phosphorylation. For example, Ser59 has been shown to directly contact 
the β3 region of the α-crystallin domain (Jehle et al., 2010) and mutations within the 
neighbouring region of Ser59 (Trp60-Ser66) were shown to alter oligomeric size and subunit 
exchange rates between αA and αB (Sreelakshmi and Sharma, 2005). Likewise, Ser45 is 
located within a substrate recognition and subunit interaction site (i.e. Ser41-Pro58) (Ghosh 
et al., 2005; Ghosh et al., 2006). It is therefore plausible that phosphorylation at Ser59 or 
Ser45 may induce subunit dissociation, resulting in exposure of otherwise occluded residues, 
increasing the likelihood of further phosphorylation events. As the number of 
phosphorylation events increases, increased exposure of binding sites caused by alterations in 
subunit exchange dynamics, may in turn increase chaperone activity of the protein (Ahmad et 
al., 2008). As Ser19 lies within a substrate recognition site (Trp9-Pro20), but not a subunit 
interaction site (Ghosh et al., 2005), it would be expected that this process would not apply to 
phosphorylation at this residue. Furthermore, the comparatively low number of spots 
corresponding to phosphorylated αB that reacted with anti-pSer19 antibody suggests that 
phosphorylation at Ser19 occurs early and inhibits phosphorylation of other residues, 
preventing the formation of multiply phosphorylated isoforms.  
It was observed that the amount of multiply phosphorylated αB increased in higher density 
fractions such that the predominant isoforms in SG2 had 2-4 phosphate groups (i.e. spots 2-4) 
while only the monophosphorylated isoform (i.e. spot 4) was present in SG5 from the barrier 
and nucleus (Figure 3.7; Table 3.1). This further implicates multiply phosphorylated αB 
isoforms with the formation of high density and membrane-bound fractions. Additionally, 





compared to the cortex for SG3 and SG5, multiply phosphorylated isoforms were increased 
in the nucleus for SG2 (Figure 3.7; Table 3.1). A similar pattern was observed for pSer59, 
which was elevated in the nuclear and barrier samples compared to the cortical sample for 
SG2 while pSer19 and pSer45 were decreased (Figure 3.5). These results again suggest a link 
between phosphorylation at Ser59, αB hyperphosphorylation, and in turn membrane binding. 
Furthermore, the fact that the increased amount of multiply phosphorylated isoforms was 
only observed in the nucleus of the 77 year-old lens (Figure 3.5) suggests that the switch to 
pathogenicity is gradual and occurs at later stages of life. 
 
3.4.3 Deamidation and oxidation of filensin may contribute to HMWC formation 
Clusters of spots between ~40-95 kDa were observed within the acidic region of SG3 and 
cortical SG2 2D gels (Figure 3.7; Figure 3.8). As their masses were similar to the ~40-100 
kDa bands observed following 1D separation (Figure 3.4), it was inferred they represent these 
species. The dominant protein species for each complex (with the exception of complex 3) 
was filensin. Intact filensin has a mass of ~75 kDa and is known to undergo extensive 
truncation in the lens (Sandilands, Prescott, Hutcheson, et al., 1995; Su, McArthur, Truscott, 
et al., 2011), producing largely N-terminal fragments. As the mass of each of the complexes 
(with the exception of complex 1) was below 75 kDa, filensin must be present as truncated 
forms. No spot consistent with intact non-crosslinked filensin was present (Figure 3.9). 
Sequence coverage of filensin from each spot suggests that filensin undergoes truncation at 
both N- and C-termini, with filensin from complex 1 remaining the most intact (24-652) 
(Figure 3.11A). Notably, complex 1 exceeds the mass expected mass for intact filensin. 
Sequence coverage for complexes 3 and 10 suggests that filensin from these complexes 
underwent further N-terminal truncation (78-652 and 78-630 respectively), while complexes 
2 and 4-9 underwent further C-terminal truncation (24-411 for complex 2, 24-362 for 
complexes 4-8 and 24-483 for complex 9). Others have reported cleavage of filensin in 
HMWCs (Srivastava et al., 2004; Su, McArthur, Truscott, et al., 2011). The cleavage of 
filensin reported here is not as extensive as that previously reported from similar HMWCs by 
Srivastava et al. (2004). For this study, peptides were detected that covered the residues 24-
652 (Figure 3.11A). Srivastava et al. (2004) detected peptides from residues 79-239 of 
filensin, suggesting more extensive truncation than that observed for this study, particularly at 





Compared to the number of peptides detected derived from filensin, fewer peptides derived 
from αA were detected in each complex, and fewer peptides derived from αB (complexes 2-
9) and phakinin (complexes 1-3 and 9-10) were detected in some complexes (Figure 3. 9). 
These proteins are well documented to interact with filensin in lens fibre cells (Carter et al., 
1995; Djabali et al., 1997), where they assemble to form beaded-chain filaments at fibre cell 
membranes (Goulielmos et al., 1996). Additionally, filensin is also known to act as a 
substrate for αB following stress (Muchowski et al., 1999). The co-migration of αA and αB 
with filensin despite having a much smaller mass (~20 kDa) than what was observed (i.e. 40 
kDa), suggests that these proteins exist together as soluble, covalently crosslinked complexes 
in the lens. Notably, the peptides matching to αA and αB were derived solely from the N- and 
α-crystallin domains of the proteins, covering the residues 12-99 for αA (Figure 3.11A) and 
12-146 for αB (Figure 3.11B). This suggests that αA and αB involved in these complexes 
may also be N- and C-terminally truncated. This is consistent with the presence of spots 
corresponding to truncated αA on 2D gels from the SG2 and SG3 fractions (Figure 3.7, 
Figure 3.8). Sequence coverage of αA and αB also indicates that the proteins are further 
truncated in some complexes. Sequence coverage of αA from complexes 1, 3 and 7 indicated 
further C-terminal truncation (13-78, 13-65 and 13-88 respectively). Sequence coverage of 
αB indicated further C-terminal truncation (12-103) from complex 5 as well as N- and C-
terminal truncation (75-103) from complex 3. This suggests that interaction sites and 
crosslinking regions for intermediate filaments lie within residues 13-65 for αA and 75-103 













Figure 3.11: Sequence coverage of filensin. Sequence coverage of (A) filensin, (B) αA and 
(C) αB precursor peptides following tryptic digestion. Regions detected are indicated by the 
presence of coloured lines corresponding to each 2D spots from which the peptides were 
obtained: spot 1 (dark green), spot 2 (red), spot 3 (purple), spot 4 (light blue), spot 5 (light 
green), spot 6 (dark blue), spot 7 (orange), spot 8 (pink), spot 9 (grey) and spot 10 (brown). 
Modified residues are highlighted in red. Boundaries of the head (1-40), rod (41-320) and tail 
(321-665) domains of filensin, and the N- (1-60 and 1-64 respectively), ACD (61-160 and 65-
156 respectively) and C-terminal (161-173 and 157-175 respectively) domains of αA and αB 







Low levels of actin (complex 10), serum albumin (complex 3 and complexes 6-7), retinal 
dehydrogenase (complex 2) and βB1-crystallin (complex 2 and complexes 4-9) were also 
observed in some complexes (Figure 3.9B). To our knowledge, these proteins have not been 
previously reported to associate with filensin. Complex 3 is unusual in that BASP 1, not 
filensin, was the major component (Figure 3.9). BASP 1 is a membrane protein that has been 
detected in the brain (Mosevitsky, 2005), axonal termini, testis, kidney, spleen, thymus 
(Mosevitsky et al., 1997) and, more recently, in the lens (Bagchi et al., 2008; Truscott et al., 
2011). In the lens, BASP 1 is most abundant in the cortex, where it has been suggested to be 
involved in membrane deformation and the formation ball and socket joints (Wenke et al., 
2016). Although it has a reported mass of ~23 kDa (Mosevitsky et al., 1997), in this study it 
migrated to a distance corresponding to a protein of α55 kDa (Figure 3.9). Although this may 
indicate crosslinking of the protein, BASP 1 has been reported to show retarded migration 
patterns on SDS PAGE gels caused by interactions with non-ionic detergents (Mosevitsky et 
al., 1997). The abnormal migration pattern of BASP 1 in this study is therefore unlikely to be 
caused exclusively by protein crosslinking. The presence of these complexes in a high density 
fraction (i.e. SG3), and the high levels of membrane associated proteins (i.e. filensin, 
phakinin, actin and BASP1), suggests that the spots may be derived from soluble HMWCs 
that had localised at fibre cell membranes (Chandrasekher and Cenedella, 1997; Cobb and 
Petrash, 2002b; Friedrich and Truscott, 2009).  
 High molecular weight complexes have been reported in lens extracts previously, occurring 
from a young age (Srivastava et al., 2004; Su, McArthur, Truscott, et al., 2011) and 
increasing in abundance and complexity with age (Srivastava et al., 2004). Su et al.(2011) 
reported complexes composed exclusively of crosslinked crystallin proteins in the water-
soluble fraction of human lenses. Previously, Srivastava et al. (2004) reported complexes in 
the urea-soluble fractions of human lenses formed by crystallin proteins, predominantly αA, 
along with lower levels of intermediate filament proteins. As intermediate filaments were 
only detected in complexes from lenses over 25 years of age, it was suggested that the 
incorporation of intermediate filaments into such complexes is age-related (Srivastava et al., 
2004). In contrast, this study reports filensin as the predominant protein component of 
crosslinked complexes, with lower levels of αA (Figure 3.9). However, as Srivastava et al. 
(2004) were unable to resolve discrete HMW spots in lenses older than 41 years-old, it is 
possible that the increased incorporation of filensin reported here is a continuation of this 





terminal truncation, oxidation, conversion of serine to DHA and formylation, suggesting that 
modified αA (particularly oxidised and DHA-containing αA) contributes to the formation of 
HMWCs by mediating crosslink formation (Srivastava et al., 2004). In the current study, no 
modifications to αA were identified (Appendix 3). However, filensin was observed to be 
heavily deamidated (Figure 3.9), suggesting that modified filensin (particularly deamidated 
filensin) may be more highly involved in complex formation.  It is important to note that a 
limitation of 2D SDS PAGE analysis is bias regarding which proteins are able to penetrate 
the different dimensions of the gel. Although the effect of this is perhaps ameliorated by the 
fact the complexes appear crosslinked, it is possible that proteins exist as part of these 
complexes in situ that were not able to be detected. 
There have been few reports of how filensin is modified in human lenses. Wilmarth et al. 
(2006) reported extensive deamidation (i.e. 23 sites), as well as a single phosphorylation site 
(S5), two sites of pyroglutamic acid formation (Q71 and Q294) and five sites of 
carbamylation (V51, L144, E230, Q294 and S607). Su et al. (2011) observed truncation of 
filensin, reporting products of 60 kDa, 53 kDa, 43 kDa and 24 kDa, predominantly in urea 
soluble fractions. In the current study, seven previously identified sites of deamidation were 
observed (N145, N155, N304, N318, N383, N478) as well as a previously unreported site, 
N268 (Figure 3.9A). The most abundant site of deamidation was N304, with between 29.2-
66.8% of this residue deamidated in the complexes studied in this work (Table 3.3). Whilst 
the high degree of deamidation at this site suggests that deamidation at this residue is 
involved in complex formation, the degree of deamidation did not directly correlate with the 
size of the complex, i.e. the amount of deamidation did not increase correspondingly with the 
mass of the complex (Figure 3.9, Table 3.3). Residue N304 lies within the rod domain of the 
protein (Hess et al., 1998), a region of intermediate filament proteins are highly conserved 
and predominantly composed of α-helices (Hess et al., 1998). As deamidation typically 
requires a high level of conformational flexibility to occur (Paranandi et al., 1994; Kosky et 
al., 1999; Hooi et al., 2012; Truscott and Friedrich, 2016), the high degree of deamidation in 
this region may suggest that filensin is, at least partially, unfolded in the lens. Other filensin 
residues with a high degree of deamidation were N383 (100%) and N478 (25.2-100%) (Table 
3.3), both of which are positioned within the tail domain of the protein. Although having a 
high proportion of these residues deamidated when present in complexes, including those 
with a higher molecular mass (i.e. complexes 1 and 2), N383 and N478 were often not 





Deamidation at N318 was only detected in filensin from complexes 6 and 8, although in these 
complexes it was always deamidated (100%) (Table 3.3). Spots 6 and 8 co-migrated in the 
first dimension on the 2D gel, but were separated in the second dimension, demonstrating that 
they differ in mass (Figure 3.9A).  This suggests they correspond to truncated forms of the 
same isotype. However, as the sequence coverage was identical for both following tryptic 
digestion, it cannot be determined where the truncation site is located. Additionally, as the 
mass of these complexes does not vary substantially from the other complexes identified in 
which N318 was not deamidated (i.e. complexes 4-5, 7 and 9), it is unclear how this residue 
is involved in complex formation. With regards to residues N145 and N155, these were often 
located on the same peptide, which made it difficult to determine the exact site of 
deamidation. However, as the proportion of deamidation was consistently low for this peptide 
in each complex (Figure 3.3), it is unlikely that deamidation at these two residues plays an 
important role in complex formation.  
Notably, in a previous study, 14 of the deamidation sites identified were found to be at 
glutamine residues (Wilmarth et al., 2006). This is unusual as asparagine residues are known 
to be deamidated much more readily than glutamine residues due to energetic stability of the 
succinimide intermediate compared to the glutaminide intermediate (Wright, 1991; Robinson, 
2002; Robinson and Robinson, 2004a; Hains and Truscott, 2010). This may suggest that 
filensin has a tertiary structure that favours glutamine deamidation. However, in contrast, in 
this work there was a strong preference towards deamidation of asparagine residues (Figure 
3.9A). This is in accordance with previous research that indicated that asparagine residues of 
αB undergo deamidation at 3-fold the rate of glutamine residues in aged human lenses (Hains 
and Truscott, 2010).  However, the possibility that deamidated asparagine residues were more 
readily detected than glutamine by the selected treatment and analysis procedure cannot be 
excluded. A slight preference was shown for deamidation of residues within the rod domain 
of the protein, with 5 of the 8 potential deamidation sites being found to be deamidated in this 
work compared to 2 of the 4 potential deamidation sites in the tail domain being observed. 
Interestingly, no deamidation was detected in the head domain of filensin, although this is 
likely to be due to the absence of asparagine residues in this region, in addition to N-terminal 
truncation (Figure 3.11A).  
The rod domain of filensin, together with phakinin form the beaded-chain filament, localising 
at fibre cell membranes in the outer cortex before becoming distributed in the cytoplasm in 





Prescott, Carter, et al., 1995; Oka et al., 2008). As deamidation is able to induce structural 
changes including partial protein unfolding (Kim et al., 2002; Flaugh et al., 2006; Hains and 
Truscott, 2010; Lampi et al., 2014; Soulby et al., 2015; Takata and Fujii, 2015), it is possible 
that the high degree of deamidation in these complexes, together with any previous unfolding 
that contributes to deamidation in this domain, enables filensin to recruit proteins, including 
αB, from the cytoplasm, forming HMWCs that localize at fibre cell membranes. 
Alternatively, high levels of deamidation of cytoplasmic filensin may induce further 
membrane association of the protein, which may account for the presence of the complexes in 
the barrier and nuclear regions of the 77 year-old lens (Figure 3.7).  
Although filensin from each complex had between 2-5 deamidated sites, no obvious pattern 
was observed between migration rate and extent of either deamidation or phosphorylation. 
Nor was there any observed pattern that was dependent on the protein composition, other 
than a decrease in pI induced by the presence of phakinin (Figure 3.9A). Two sites of 
phosphorylation of filensin previously reported by Wang et al. (2013) were also observed in 
this study (i.e. S488 and T460). This work also identified two oxidation sites (M649 and 
M207) in complexes 1-7 (Figure 3.9A). To our knowledge, this is the first report of oxidation 
of filensin in lens tissue. Two oxidised residues in filensin were identified in complex 1, 
which had a molecular mass of ~95 kDa, whereas only single oxidized residues were 
identified in complexes 2-7 which had masses of ~45 kDa (Figure 3.9A). This 2-fold increase 
in mass observed for complex 1 is probably explained by less truncation of the C-terminal 
residues (as evidenced by increased sequence coverage). However, as the spots were digested 
with trypsin, and there was no consistent pattern between sequence coverage and complex 
size for the other complexes, and it is not possible to establish this definitively. Moreover, as 
the increase in sequence coverage was not sufficient to account for a 2-fold increase in mass, 
it is possible that increased oxidation contributes to a greater degree of crosslinking and 
hence higher molecular weight complexes. However, it should be noted that oxidation of 
methionine can take place artifactually. 
A single oxidation site was observed for αB (M68) but did this not appear to correlate with 
migration patterns of the proteins i.e. did not correlate with increased mass or pI of the 
complexes (Figure 3.9A). Oxidation of lenticular proteins has repeatedly been found to be 
increased in cataractous lenses and in insoluble lens fractions (Garner and Spector, 1980; 
Lund et al., 1996; Boscia et al., 2000; Hanson et al., 2000). As oxidation can induce protein 





increased levels of protein crosslinks between filensin and other proteins in the complex, or 
an increased rate of protein recruitment from the cytoplasm. Despite the common assertion 
that oxidation and oxidative damage is the direct factor leading to cataract formation 
(Truscott, 2005), relatively little is known about the factors that contribute to the oxidative 
environment of the lens. To more fully comprehend the exact mechanism behind cataract 





It is apparent that phosphorylation may be necessary to maintain chaperone activity of αB. 
However, increased levels of multiply phosphorylation αB in high density lens fractions and 
in the nuclear region of aged lenses offers an insight into a potentially pathogenic role for the 
phosphorylated protein. Although αB participates in complexes that localise at fibre cell 
membranes, how this may be regulated by phosphorylation and how this may be involved in 
cataract formation remains to be elucidated. However, as deamidation of several sites of 
filensin was a consistent feature of the HMWCs analysed in this chapter, this suggests that 
deamidation and potential partial unfolding of intermediate filaments, particularly filensin, is 
an important factor in recruiting αB and phosphorylated αB to fibre cell membranes. This 
would then result in an overall loss of non-complexed αB, reducing the ability of αB to 
maintain the solubility of protein complexes in the lens, ultimately contributing to cataract 
formation. In this chapter, we propose that the barrier region of the lens acts a transition zone 
between the cortex and the barrier, characterised by an increase in αB phosphorylation, 






















Investigation of αB association with  















It is generally accepted that the accumulation of oxidative damage of lenticular proteins is the 
direct cause of nuclear cataract formation, resulting in protein crosslinking and aggregation 
(Truscott, 2005). Early stage cataractous lenses have been shown to have higher levels of 
oxidative stress compared to healthy lenses (Li et al., 2009). Higher rates of oxidation were 
also observed in membrane fractions from cataractous (Garner and Spector, 1980) and 
diabetic lenses (Boscia et al., 2000) compared to healthy lenses, and higher rates of αA 
oxidation and protein crosslinking has been observed in insoluble protein fractions compared 
to soluble fractions (Lund et al., 1996).  
The burden of oxidative damage in the lens is generally minimised by high concentrations of 
reduced GSH. However, the GSH concentration decreases in the nucleus of lenses prior to 
cataract formation (Reddy and Giblin, 1984; Giblin, 2000; Truscott, 2005). Some contention 
surrounds the mechanism of GSH loss. It has been proposed that the breakdown of the redox 
cycle responsible for keeping GSH in its reduced form (Giblin, 2000), or the loss of activity 
of enzymes involved in GSH production i.e. glutathione synthetase and γ-glutamylcysteine 
synthetase (Rathbun et al., 1993), may be involved. As GSH is synthesised in the cortex and 
is dependent on pore proteins for transport into the nucleus, an alternative hypothesis 
stipulates that the presence of an impediment to GSH transport may be responsible (Sweeney 
and Truscott, 1998).  
This phenomenon was first observed by Sweeney and Truscott (1998), following the 
incubation of human lenses in [35S] cysteine to mimic GSH transport. Although [35S] cysteine 
diffused uniformly throughout the nucleus of the young lenses, diffusion was restricted to the  
cortex of aged lenses (Sweeney and Truscott, 1998). Notably, this point of obstruction was 
consistent between lenses, and coincided with the sclerotic zones as well as the point where 
GSH levels decrease dramatically in cataractous lenses (Sweeney and Truscott, 1998). This 
suggests that a physical barrier at the interface of the cortical and nuclear regions, known as 
the nucleocortical barrier, is responsible for the loss of GSH in the nuclear region of aged 
lenses (Sweeney and Truscott, 1998). This was later supported by Moffat and Pope (2002), 
who reported a similar deficit in the transport of water into the nucleus of aged lenses. It is 
not currently clear how or why this barrier forms, although explanations such as changes in 
sphingolipid distribution have been proposed (Deeley et al., 2010). Alternatively, is has been 





responsible for this impediment, obstructing pore proteins to prevent the transport of GSH as 
well as water (Cobb and Petrash, 2002b; Friedrich and Truscott, 2009; Friedrich and Truscott, 
2010). However, the mode of α-crystallin association with fibre cell membranes has not been 
elucidated; it is unclear as to whether membrane association is mediated by αB interaction 
with membrane phospholipids, or with membrane pore proteins (e.g. Cx46 and AQP0).  
Although αA and αB have been shown to protect AQP0 against thermal stress in vitro 
(Swamy-Mruthinti et al., 2013) and to interact with AQP0 following co-transfection into 
HeLa cells (Liu and Liang, 2008), direct interactions between αB and AQP0 in situ are yet to 
be reported. To our knowledge, αB has not been previously reported to interact with Cx46 in 
human lenses. However, if interactions between αB and AQP0 and/or Cx46 in situ can be 
confirmed, this would provide evidence that αB contributes to barrier formation by 
mechanically blocking the transport of GSH from middle age onwards. This chapter 
describes work aimed at mapping the membrane association of αB isoforms across aged 
human lens sections, and to determine what, if any, effect phosphorylation has on its 
membrane association. Additionally, interactions between αB isoforms and AQP0 and Cx46 
were mapped across aged human lens sections in order to determine how αB membrane 
association may contribute to barrier formation.  
 
 
4.2 Experimental Rationale 
 
Determination of the distribution and membrane association of αB in the lens has often 
involved techniques that necessitate tissue homogenisation such as electrophoresis and MS, 
inevitably leading to loss of spatial integrity of the tissue. To overcome this, immunoconfocal 
microscopy was utilised to detect αB isoforms, and to visualise (with fine detail) its 
subcellular distribution across intact human lens sections (sections 2.3.1 and 2.3.2). The 
putative location of the nucleocortical barrier i.e. the point at which membrane association 
would be expected to peak if involved in barrier formation, was determined based on the 
previous study by Sweeney and Trucsott (1998) that reported that diffusion becomes 





Potential interactions between two or more proteins have traditionally been identified through 
methods such as co-immunoprecipitation or co-localisation experiments. These technologies 
however have limitations. For example, co-immunoprecipitation involves tissue 
homogenisation that results in a loss of spatial detail and can introduce artefactual protein 
interactions. Additionally, conventional microscopy techniques used for co-localisation 
experiments can only localise proteins to an accuracy of 200 nm. Information relating to 
direct protein interactions is therefore limited. By utilising a commercially available 
proximity ligation assay kit (Duolink®, Sigma, USA), this study was able to detect likely 
direct interactions between αB isoforms (i.e. total, pSer19 and pSer59), and AQP0 or Cx46 
(section 2.3.1 and 2.3.3). Proximity ligation assays involve labelling two proteins of interest 
with antibodies with attached short oligonucleotides. These oligonucleotides anneal when in 
close proximity (i.e. ≤40 nm), and with the addition of polymerase, ligase and fluorescently-
labelled nucleotides, produce a fluorescent product able to be detected using confocal 
microscopy (Figure 4.1)  
 
Figure 4.1: Summary of proximity ligation assay protocol. 1. Two proteins of interest are 
labelled with primary antibodies derived from two different species. 2. PLA + and PLA – 
probes with attached oligonucleotides bind the primary antibodies. 3. The addition of ligase 
anneals oligonucleotides forming a circle. 3. The addition of polymerase causes rolling circle 
amplification of annealed oligonucleotides. 4. Amplification results in fluorescent produced 






As the reaction only proceeds when the proteins of interest are within 40 nm of each other, a 
signal is only produced when the proteins are in close enough proximity for direct interaction 
and therefore interaction is highly likely. Furthermore, as the fluorescent product is produced 
through an amplification reaction, the assay is highly sensitive (i.e. able to detect relatively 
low levels of interaction in situ), with each signal representing a single interaction. This 
method was selected as it maintains spatial integrity of the tissue while indicating possible 
interactions based on proximity of the proteins of interest with higher resolution than other 
co-localisation techniques. As pSer19 and pSer59 of αB were previously found to be 
associated with low and high levels of total phosphorylation respectively (section 3.3.2), they 
were selected for use in this study in order to compare the effect of phosphorylation on 
membrane association.  AQP0 and Cx46 were selected due to their reported roles in water 




4.3.1 Phosphorylated αB becomes predominantly membrane associated by 500 µm in from 
the outside of the lens. 
Human lens tissue sections were labelled for pSer19, pSer45 and pSer59 αB and imaged 
using confocal microscopy in order to map phosphorylated αB (pαB) membrane association 
throughout the lens. Each αB phosphoisoform was found to associate with fibre cell 
membranes, with the extent of association increasing towards the nucleus of the lens (Figure 
4.2Ai-iii, v-x, B). Zones of membrane interaction were identified based on degree of 
membrane association of αB. In the outer ~150 µm of the sections (zone 1), each of the αB 
phosphoisoforms were distributed in the cytoplasm (Figure 4.2B). In the region ~150-500 µm 
in from the periphery of the lens (zone 2), each αB phosphoisoform was partially membrane 
associated (Figure 4.2B). In the region starting from ~500 µm from the periphery and 
continuing towards the centre (i.e. ~5 mm from the periphery, zone 3), each αB 
phosphoisoform was completely membrane associated with minimal amounts being 
distributed in the cytoplasm (Figure 4.2B). Non-specific binding of secondary antibodies was 
tested for by labelling a tissue section with rabbit IgG. Minimal background staining was 







Figure 4.2: Localisation of pαB at fibre cell membranes in human lenses. Sections were 
obtained from a 63 year-old human lens using a cryostat and labelled with rabbit anti-pSer19, 
pSer45 or pSer59 αB antibodies. A separate section was labelled with rabbit IgG for use as a 
negative isotype control. Alexa-488 conjugated goat anti-rabbit antibody was used to 
visualize sections by confocal microscopy. (A) Images were obtained from the periphery 
(cortex), 1 mm inside the periphery (barrier) and the centre (nucleus) of each section. (B) 
Tiled images were obtained of the outer 1.1 mm of each section (pSer59 shown). Zones of 
cytosolic pαB distribution (zone 1), partial membrane association (zone 2), complete 
membrane association (zone 3), and putative location of the nucleocortical barrier were 





4.3.2 αB and phosphorylated αB associate directly with membrane pore proteins AQP0 and 
Cx46. 
It was previously shown that pαB becomes predominantly associated with cell membranes as 
the cells are located closer to the lens nucleus (section 4.3.1). This association could involve 
interactions with phospholipids or membrane pore proteins. To investigate this aspect further, 
proximity ligation assays were performed on human lens sections from a 62 year-old lens 
using a Duolink® labelling kit to visualise and map interactions between αB, pSer19 and 
pSer59 αB, and AQP0 across the lens. Direct interactions between each αB isoform and 
AQP0 were detected. The majority of interactions occurred in the outer 500 µm of the lens 
with the incidence of interaction decreasing towards the nucleus (Figure 4.3Ai-iii, C). 
Interactions between AQP0 and total αB (i.e. αB) were abundant in the outer cortex (Figure 
4.3A, C). At a discrete point, ~500 µm from the lens periphery, the number of interactions 
decreased dramatically compared to the outer cortex (Figure 4.3C). Interactions between 
AQP0 and total αB continued to gradually decrease from this point towards the nucleus, 
where interactions were sparse (Figure 4.3Ai-iii, C).  
Interactions between AQP0 and pSer19 αB were minimal throughout the lens section (Figure 
4.3iv-vi, C), with a slightly higher number of interactions occurring in the outer cortex (i.e. 
the outer 500 µm) (Figure 4.3Aiv).  
Interactions between AQP0 and pSer59 αB were abundant in the outer cortex (Figure 
4.3Avii, C). At a discrete point, ~500 µm from the lens periphery, the number of interactions 
decreased dramatically compared to the outer cortex, similar to that observed for total αB 
(Figure 4.3C). From this point, interactions between AQP0 and pSer59 αB were sparse and 











Figure 4.3: Direct association of αB with AQP0. Sections were obtained from a 62 year-old 
human lens using a cryostat and co-labelled with rabbit anti-αB, pSer19 or pSer59 αB and 
goat anti-AQP0 antibody. Separate sections were incubated with TBST (no antibodies) or 
goat anti-AQP0 and rabbit IgG for use as negative controls, or goat anti-AQP0 and rabbit 
anti-BFSP2 for use as a positive control. A Duolink® assay kit was used to detect 
interactions, and sections were visualised by confocal microscopy. (A) Images were obtained 
from the periphery (cortex), 1 mm inside the periphery (barrier) and the centre (nucleus) of 
each section. (B) Control images were obtained from the periphery (cortex). (C) Tiled images 
were obtained of the outer 4 mm of each section. The putative location of the nucleocortical 





Proximity assays were performed on human lens sections from a 62 year-old lens using a 
Duolink® labelling kit to visualise and map interactions between αB, pSer19 and pSer59 αB, 
and Cx46 across the lens. Direct interactions between each of the αB isoforms and Cx46 were 
detected. The majority of interactions occurred in the outer 250 µm of the lens with the 
incidence of interaction decreasing towards the nucleus (Figure 4.4B). Interactions between 
Cx46 and total αB (i.e. αB) or pSer19 αB were minimal throughout the lens section, with a 
slightly higher number of interactions occurring in the outer cortex (i.e. the outer 250 µm) 
(Figure 4.4A, B).  By contrast, interactions between Cx46 and pSer59 αB were abundant in 
the outer cortex (Figure 4.4A, B). At a discrete point, ~250 µm from the lens periphery, the 
number of interactions between Cx46 and pSer59 decreased dramatically compared to the 
outer cortex (Figure 4.4B). From this point, interactions between Cx46 and pSer59 αB 


















Figure 4.4: Direct association of αB with Cx46. Sections were obtained from a 62 year-old 
human lens using a cryostat and co-labelled with rabbit anti-αB, pSer19 or pSer59αB and 
goat anti-Cx46 antibody. Separate sections were incubated with TBST (no antibodies) or goat 
anti-AQP0 and rabbit IgG for use as negative controls, or goat anti-AQP0 and rabbit anti-
BFSP2 for use as a positive control. A Duolink® assay kit was used to detect interactions, 
and sections were visualised by confocal microscopy. (A) Images were obtained from the 
periphery (cortex), from 1 mm inside the periphery (barrier) and the centre (nucleus) of each 
section. (B) Tiled images were obtained of the outer 4 mm of each section. The putative 
location of the nucleocortical barrier is indicated with an arrow, and a dashed line is used to 







4.4.1 αB and phosphorylated αB membrane-binding coincides with location of barrier  
To determine whether the association of phosphorylated or non-phosphorylated isoforms of 
αB with fibre cell membranes may be involved in the formation of the nucleocortical barrier, 
aged human lens sections were labelled for the pSer19, pSer45 and pSer59 αB isoforms, and 
cellular distribution was visualised across lens sections. Each of the phosphorylated αB 
isoforms tested were found to associate with fibre cell membranes (Figure 4.2A), and all 
followed a similar pattern of distribution. The association patterns occurred in three zones 
(zones 1-3) throughout the coronal cross section of the lens, with the extent of membrane 
association increasing towards the nucleus (Figure 4.2). Complete membrane association of 
αB occurred from a point ~500 µm interior to the periphery of the lens and continued towards 
the centre (i.e. zone 3) (Figure 4.2B). Notably, Sweeney and Truscott (1998) observed that 
the diffusion of [35S] in aged human lenses was abruptly disrupted at a point ~500 µm in from 
the periphery of the lens. This point, which indicated the presence of a physical barrier to 
diffusion (Sweeney and Truscott, 1998), approximately coincides with the location of zone 3 
in this study (Figure 4.2B), suggesting that large-scale membrane association of 
phosphorylated αB may be implicated in barrier formation. This is consistent with previous 
results from 2D gels that indicated that α-crystallin was the predominant protein to associate 
with fibre cell membranes, the majority of which was phosphorylated (Friedrich and Truscott, 
2010). 
As only lenses of a narrow age range were analysed, it cannot be confirmed whether the 
location of these zones change with age. However, as it is likely that the distribution pattern 
is the result of an age-related process that begins at the newly deposited cells at the lens 
periphery, it is likely that the zones remain at a consistent distance from the periphery, similar 
to the barrier region described by Sweeney and Truscott (1998). 
 
4.4.2 αB and phosphorylated αB associates directly with membrane pore proteins AQP0 and 
Cx46 
To determine whether interactions with membrane proteins may be responsible for αB 
membrane association, proximity ligase assays were performed on aged human lens sections 
to visualize interactions between αB isoforms (total, pSer19 and pSer59 αB), and AQP0 and 





with interaction with AQP0 (Figure 4.3) and Cx46 (Figure 4.4) at fibre cell membranes. 
These interactions occurred preferentially in the cortex; interactions involving AQP0 were 
largely restricted to the outer 500 µm of the cortex (Figure 4.3C) and interactions with Cx46 
predominantly occurred in the outer 250 µm of the cortex (Figure 4.4B). This distinct pattern 
was more pronounced for interactions involving pSer59 αB than for pSer19 αB, for which 
interactions were minimal throughout the lens section. As it was previously shown that 
pSer59 is more common in multiply phosphorylated αB species compared to pSer19 (section 
3.3.2), this may suggest that the presence of multiple phosphorylated residues in αB may 
increase its interaction with AQP0 and Cx46. This may be due to structural changes induced 
by phosphorylation, that act to increase substrate affinity (Aquilina et al., 2004). 
Alternatively, as it was previously suggested that pSer19 may inhibit phosphorylation at other 
residues in αB (section 3.4.2), it is also conceivable that pSer19 decreases αB membrane 
binding capacity. Further membrane binding assays are required in the future to further 
elucidate the mechanism by which αB associates with membrane proteins. 
The lens regions where interactions were most abundant (i.e. outer 500 µm for AQP0 and 
outer 250 µm for Cx46), coincide with zones 2 and 3 (Figure 4.2B). These are the same 
regions in which the association of phosphorylated αB isoforms with membranes increases. 
Together, this suggests that the αB membrane association observed in this region is mediated 
by interactions with AQP0 and Cx46, or that αB co-localises with Cx46 and AQP0 due to 
association with the fibre cell membrane such that it is in very close proximity to the 
membrane proteins. As this region also coincides with the putative location of the 
nucleocortical barrier (Sweeney and Truscott, 1998), it is likely that interactions between αB 
isoforms and AQP0 and Cx46, whether direct or via fibre cell membranes, contribute to the 
inhibition of diffusion in the barrier region of aged lenses.  
As AQP0 and Cx46 are responsible for the transport of water (Gorin et al., 1984) and GSH 
(Slavi et al., 2014) into the nucleus of the lens respectively, any event that decreases the 
transport activity of these proteins would be detrimental to the lens. In fact, mutations of both 
AQP0 (Francis et al., 2000; Ganesan et al., 2012; Hu et al., 2012; Kumari et al., 2013) and 
Cx46 (Burdon et al., 2004; Wang and Zhu, 2012), which affect channel formation, have been 
implicated in autosomal congenital cataract. With regards to mutations that lead to a loss of 
Cx46 function, it has previously been proposed that the decrease in GSH transport into the 
nucleus is responsible for nuclear cataract formation (Cobb and Petrash, 2002b; Friedrich and 





conducive to protein cross-linking and proteolysis (Reddy and Giblin, 1984; Giblin, 2000; 
Truscott, 2005). In support of this, Cx46 knockout mice develop nuclear cataract 
characterised by proteolysis of crystallin proteins (Gong et al., 1997). Additionally, in this 
study, crosslinked complexes were previously identified in high density lens fractions 
(section 3.3.3). It is therefore likely that the obstruction of AQP0 and Cx46 channels by αB in 
the cortex of the lens is a contributing factor in barrier formation, which leads to subsequent 
damage and eventual cataract formation. 
The association of αB with fibre cell membranes was found throughout the nucleus of the 
lens (Figure 4.2), despite interactions between αB and AQP0 and Cx46 being localised in the 
cortex (Figure 4.3, Figure 4.4). This suggests that αB membrane association in the nucleus 
may be mediated via interactions with membrane lipids, cytoskeletal proteins or additional 
membrane proteins other than AQP0 and Cx46. It is, however, difficult to exclude the 
presence of interactions with AQP0 and Cx46 in the nucleus as a possibility. It is possible 
that the accumulation of HMWCs at fibre cell membranes prevents the proteins of interest 
from being accessed by antibodies and therefore being detected. However, as these lens 
sections were washed with PBS prior to labelling, this is less likely to be a significant factor.  
Alternatively, truncation of AQP0 and Cx46, which increases in the nucleus of the lens (Ball 
et al., 2004; Grey et al., 2009; Wang and Schey, 2009), could conceivably affect either αB 
interaction or antibody detection of AQP0 and Cx46. Truncation sites of AQP0 have been 
identified at Asn246  (Ball et al., 2004; Grey et al., 2009), Pro249, Asn259, Thr260, Gln261 
and Ala262 (Ball et al., 2004), resulting in the loss of the C-terminal residues. As the 
antibody used for this study was specific to a sequence within the region Gly100 to Asp150 
of AQP0 (Santa Cruz Biotechnology, Inc., personal correspondence), it is therefore more 
likely that the decrease in interactions in the nucleus is due to αB dissociation from AQP0, as 
opposed to a loss of antibody recognition sequences within AQP0. This may suggest that the 
αB binding site for AQP0 lies within the C-terminus. Although it is not possible to exclude 
C-terminal truncation of AQP0 itself as a factor in decreased function (Gonen et al., 2004; 
Korlimbinis et al., 2009), another study suggests that AQP0 function is not strongly affected 
by C-terminal truncation in vivo (Ball et al., 2003). This is likely due to the regulation of 
AQP0 water permeability, whereby increased Ca+ and decreased pH increases the 
permeability of AQP0 to compensate for the loss of non-truncated protein (Varadaraj et al., 
2005). Truncation sites for human Cx46 have been less extensively studied, although a 





Leu255 (Shearer et al., 2008; Wang and Schey, 2009), Gly121, His122, Asp124, Gly251, 
Asn259, Ile267, Phe269, Tyr273, Ala274, Ser278, Ser284, Ala285, Glu344, Gly347, Gln352 
and Gly2 (Wang and Schey, 2009)). These residues lie within the C-terminus, cytoplasmic 
loop and N-terminal regions of the protein, and within close proximity of the recognition site 
for the antibody used in this study, i.e. residues 375-425 of human Cx46 (Santa Cruz 
Biotechnology, Inc., personal correspondence). This makes it impossible to determine 
whether the decrease in interaction between αB isoforms and Cx46 in the nucleus compared 
to the cortex is due to truncation of the αB binding site or the antibody recognition site. The 
narrower region of interaction for Cx46 with αB compared to AQP0 (i.e. 250 µm versus 500 
µm) in the lens is consistent with a higher rate of truncation of Cx46, at an earlier age. As 
Cx46 truncation occurs so extensively in all regions of the protein (Shearer et al., 2008; 
Wang and Schey, 2009), the effect of truncation itself on Cx46 function in the lens is worthy 
of further investigation.  
Ultimately, as interactions between αB and Cx46 or AQP0 were not observed in the nucleus 
of the lens, it remains unclear how αB associates with the membrane in this region and how 
this may affect transport in the lens. However, as transport in the lens occurs from the cortex 
into the nucleus, interactions that occur in the cortex, such as those identified in this thesis, 





Isoforms, including phosphorylated isoforms, of αB interact with fibre cell membranes, in 
part, through interactions with the membrane pore proteins AQP0 and Cx46. This provides a 
mechanism for αB membrane association to be directly involved in the inhibition of small 
metabolite transport, notably that of GSH. This impediment to GSH transport into the lens 
nucleus and the loss of re-reduction of oxidized GSH in the cortex, is likely to result in the 
oxidation of nuclear proteins leading to the formation of protein crosslinking and ultimately 
cataract formation. Additionally, it appears that phosphorylation increases membrane binding 
capacity of αB, potentially resulting in increased interactions between αB and AQP0 and 
Cx46 in the cortex of the aged lens. Thus, this work provides some insight into the 





is also important to note that some limitations to this research exist. As only a single lens was 
investigated, further studies utilizing multiple lenses across a broader age range will need to 
be undertaken in order to confirm and extend these findings. As the control antibody was the 
same used for the AQP0 experiment for which very little non-specific binding was observed, 
an  IgG/Cx46 negative control was not performed, but should be incorporated into future 
experiments to exclude the possibility of non-specific interactions . In addition, although the 
results suggest it is highly likely that αB directly interacts with Cx46 and AQP0 in vivo in the 
cortical and barrier region, these findings would be strengthened if direct interaction could be 
confirmed through other methods such as immunoprecipitation assays, in order to exclude the 



































Deamidation involves the conversion of asparagine and glutamine residues to aspartate and 
glutamate residues respectively (Figure 1.5). In the lens, deamidation is believed to occur 
primarily via non-enzymatic reactions (Hains and Truscott, 2010). The susceptibility of 
residues to deamidation is affected primarily by the surrounding residues (Robinson et al., 
1970; Robinson et al., 1974; Robinson and Robinson, 1991; Wright, 1991; Robinson and 
Robinson, 2001) which have both a steric and catalytic effect (Robinson and Robinson, 
2004b), the secondary structure with deamidation being facilitated by more flexible α-helical 
structures as opposed to β-sheets (Paranandi et al., 1994; Kosky et al., 1999; Hooi et al., 
2012; Truscott and Friedrich, 2016), and tertiary (Kossiakoff, 1988) and quaternary structure, 
with surface exposed residues being more susceptible  (Lapko et al., 2002). Deamidation of 
αB at N146 reduces chaperone activity, decreases hydrophobic exposure and increases 
oligomeric size compared to WTαB (Gupta and Srivastava, 2004; Asomugha et al., 2011). 
Deamidation at either N146 or N78 has also been reported to increase association of αB with 
βA3-crystallin in vitro (Tiwary et al., 2015). Deamidation is known to destabilise β- and γ-
crystallins triggering aggregation (Kim et al., 2002; Lampi et al., 2002; Flaugh et al., 2006; 
Lampi et al., 2006; Takata et al., 2007; Takata et al., 2008; Michiel et al., 2010) as well as 
interrupting H-bond formation at oligomeric interfaces causing predominantly tertiary 
structural changes  (Lampi et al., 2006; Takata et al., 2007; Takata et al., 2008; Takata et al., 
2009) and interfering with hetero-oligomeric interactions with other β-crystallins (Takata et 
al., 2009). As such, it is speculated to be involved in cataract formation, also being elevated 
in insoluble human lens fractions compared to soluble fractions (Hanson et al., 2000; 
Srivastava and Srivastava, 2003). Isomerisation of αB at Asp96 resulting from deamidation, 
is believed to partially unfold the protein, making it more susceptible to cleavage (Takata and 
Fujii, 2015).  
Outside of the lens, deamidation can be induced by acidic or basic conditions. The 
mechanisms behind these reactions differ; acidic environments (pH<5.0) allow direct 
hydrolysis of the amide group of asparagine and glutamine residues (Catak et al., 2009) 
(Figure 1.5B). Under neutral to basic environments, cyclic intermediates are produced that 
are then hydrolysed to form aspartate and glutamate (Geiger and Clarke, 1987; Capasso et al., 
1991; Wright, 1991; Catak et al., 2009) (Figure 1.5A).  Deamidation at asparagine residues 





glutamine forms a glutaminide (6-member ring) intermediate (Capasso et al., 1991; Wright, 
1991). As the reaction is non-enzymatic, spontaneous deamidation of proteins can occur. For 
example, insulin has been reported to undergo non-enzymatic deamidation during storage at -
15°C (Berson and Yalow, 1966). However, the susceptibility of αB to non-enzymatic 
deamidation under storage conditions has not been previously studied. As deamidation can 
alter the structure and function of proteins (Gupta and Srivastava, 2004; Asomugha et al., 
2011; Tiwary et al., 2015), the presence of deamidated residues can be problematic for 
experimental interpretation (such as for functional studies of proteins). The susceptibility of 
proteins to deamidation and the impact it can have on function therefore needs to be 
considered when interpreting data. This chapter examines deamidation of αB when stored at -
20°C and 4°C, as well as following heat-treatment under different buffer conditions, in order 
to determine the susceptibility of αB to non-enzymatic deamidation in vitro. 
 
 
5.2 Experimental Rationale 
 
To determine which αB residues are susceptible to non-enzymatic deamidation under 
different buffer conditions, a protocol was developed to induce deamidation using heat 
treatment under different pH and unfolding buffer conditions. A protocol developed by Liao 
et al. (2009) used low concentrations of acetic acid (0.03-0.14M) coupled with high 
temperatures (121ºC), to induce deamidation in wheat gluten while avoiding other 
modifications (i.e. hydrolysis and isomerisation) that can be introduced with other acids (e.g. 
hydrochloric acid and phosphoric acid). An inherent obstacle in this procedure is the 
instability of Hsps at such high temperatures. In an attempt to overcome this, the protocol 
was modified to incorporate lower temperatures and increased incubation times. To 
determine the effect of pH on deamidation, ammonium acetate (~pH 7.0), ammonium 
bicarbonate (~pH 8.0) and acetic acid (~pH 3.0) were used as buffer systems in order to 
compare which residues were susceptible to deamidation via the succinimide intermediate 
(basic conditions) versus direct hydrolysis pathway (acidic conditions) (section 2.4.1).  
Proteins were also heat-treated with urea in order determine the effect of protein unfolding on 





used to prevent protein aggregation (section 2.4.2). Experimental conditions are described in 
Table 5.1. 
Table 5.1: Experimental conditions for each of the αB samples analysed in this section 
of work. 
Section Batch Storage Buffer Incubation Digestion Analysis 







5.3.2 1 5 years at -
20°C 
34 mM 




16 hours at 
50 °C ± 5 
minutes at 
100°C 
5 minutes or 
2 hours 
MS 
5.3.3 1 1 year at -
20°C 
6 M urea or 
 


















5.3.1 Modifications following incubation in acetic acid at 4°C 
Recombinant human αB (i.e. batch 1) that had been stored at -20°C in 200 mM ammonium 
acetate (for a minimum of 5 years) was incubated in 34 mM acetic acid (~pH 3.0) at 4°C for 
0-72 hours before being analysed by MS to determine if modifications occurred to the protein 
under these conditions. The dominant peak for each sample, peak A, had a mass of 20159.5 
Da, consistent with unmodified αB (Figure 5.1, Table 5.2). The mass of peak A remained 
consistent following incubation at 4°C (Figure 5.1, Table 5.2).  In the sample that was not 
incubated (i.e. control), another peak, peak B (20174.4 Da) showed a 15 Da increase in mass 
compared to peak A, consistent with the addition of a methyl group (Figure 5.1, Table 5.2). 
The mass of peak B increased by a further 3 Da after a 24 hour incubation at 4°C, and by 
another 2 Da after a 72 hour incubation at 4°C (Table 5.2). This 5 Da increase of peak B over 
72 hours of incubation is consistent with deamidation at 5 sites.  
In the control sample (i.e. not incubated), a peak at 20200.8 Da (peak C) showed a mass 
increase of 41.3 Da compared to peak A, consistent with acetylation of αB (Figure 5.1, Table 





consistent with deamidation at a single site. The control sample also contained a peak 
corresponding to a mass of 20257.4 Da (peak D) (Figure 5.1, Table 5.2). The increase in 
mass of peak D over peak A, 39.9 is consistent with pyro-carbamidomethylation of the 
protein (Figure 5.1, Table 5.2). The mass of peak D remained constant following incubation 
at 4°C, but was increased in relative amount compared to peak A following a 24 hour 
incubation before decreasing again following a 48 hour incubation, suggesting decomposition 
of the compound upon further incubation. It is important to note that as the samples were not 














Figure 5.1: Mass spectra of αB following incubation at 4°C for 0-72 hours. Recombinant 
human αB was incubated at 4°C for 0-72 hours in 34 mM acetic acid (~pH 3.0) at a 
concentration of 1 mg.mL-1. The protein was then analysed using MS. The position of 4 









Table 5.2: Masses of αB isoforms calculated from the peaks identified by MS following 
incubation at 4°C for 0-72 hours. Recombinant human αB was incubated at 4°C for 24-72 
hours in 34 mM acetic acid (~pH 3.0) at a concentration of 1 mg.mL-1. The protein was 
analysed using MS and masses of peaks were calculated using Masslynx software. Peak D 




A B C D 
0 hours 20159.5 20174.4 20200.8 20257.4 
24 hours 20159.5 20177.7 20201 20257.7 
48 hours 20159.1 20177.9 20201.2 20257.6 
72 hours 20159.4 20179.6 20201.5 NP 
 
 
5.3.2 Deamidation under acidic or basic conditions 
To determine which asparagine or glutamine residues in αB residues were susceptible to heat-
induced deamidation under acidic or basic conditions, recombinant human αB (batch 1) was 
incubated at 50°C for 2 hours in either 34 mM acetic acid (i.e. acidic sample; ~pH 3.0) or 200 
mM ammonium acetate (i.e. basic sample; ~pH 7.0). The protein was then digested with 
trypsin for 5 minutes and analysed by MS. Complete tryptic digestion of αB yielded 21 
peptides, five of which contain an asparagine or glutamine residue. For the control sample, 11 
αB tryptic peptides were identified (Table 5.3, Figure 5.2). A single deamidation site was 
identified at N146 on peptide 124-149 (Table 5.3, Figure 5.2). Following incubation under 
acidic conditions, 7 αB tryptic peptides were identified, 6 of which were the same peptides as 
identified in the control sample (Table 5.3, Figure 5.2). No extra deamidation sites were 
identified following incubation under acidic conditions (Table 5.3, Figure 5.2). Following 
incubation under basic conditions, 8 αB tryptic peptides were identified, 7 of which were the 
same peptide as identified in the control sample (Table 5.3, Figure 5.2). The same 
deamidation site (N146) was identified on peptide 124-149 as observed in the control sample, 
however, no additional deamidation sites were identified when the protein was incubated 







Table 5.3: αB tryptic peptides identified following incubation at 50°C for 2 hours + 
100°C for 5 minutes. Recombinant human αB was incubated at 50°C for 2 hours followed 
by 5 minutes at 100°C in either 34 mM acetic acid (acidic; ~pH 3.0) or 200 mM ammonium 
acetate (basic; ~pH 7.0) at a concentration of 1 mg.mL-1. Protein was digested with trypsin 
for 5 minutes and analysed using MS, and peptide masses were calculated using Masslynx 
software. Predicted masses were used to identify peptides and modification sites. Protein that 
was not incubated was analysed as a control. Modified residues are highlighted in red. 
m/z Expected 
Mass 
Residues Modification Sequence Observed 
Mass 
Control 
588.2 588.3 117-120  EFHR 588.2 
656.9 1313.7 124-149 N146 IPADVDPLTITSSLSSDGVL 
TVNGPR 
1313.6 
700.4 700.4 158-163  TIPITR 700.4 
772.3 772.4 151-157  QVSGPER 772.3 
900.5 900.5 150-157  KQVSGPER 900.5 
1088.5 1088.5 108-116  QDEHGFISR 1088.5 
1140.6 1140.6 164-174  EEKPAVTAAPK 1140.6 
1268.7 1268.7 164-175  EEKPAVTAAPKK 1268.7 
1374.6 1374.7 12-22  RPFFPFHSPSR 1374.6 
1388.7 1388.7 1-11  MDIAIHHPWIR 1388.7 
1496.6 1496.7 57-69  APSWFDTGLSEMR 1496.6 
Acidic  
700.4 700.4 158-163  TIPITR 700.4 
772.4 772.4 151-157  QVSGPER 772.4 
900.4 900.5 150-157  KQVSGPER 900.4 
986.5 986.5 83-90  HFSPEELK 986.5 
1088.5 1088.5 108-116  QDEHGFISR 1088.5 
1140.6 1140.6 164-174  EEKPAVTAAPK 1140.6 
1268.7 1268.7 164-175  EEKPAVTAAPKK 1268.7 
Basic  
588.3 588.3 117-120  EFHR 588.3 
700.4 700.4 158-163  TIPITR 700.4 
772.4 772.4 151-157  QVSGPER 772.4 
900.5 900.5 150-157  KQVSGPER 900.5 
1140.6 1140.6 164-174  EEKPAVTAAPK 1140.6 
1165.6 1165.7 93-103  VLGDVIEVHGK 1165.6 
1268.7 1268.7 164-175  EEKPAVTAAPKK 1268.7 









Figure 5.2: Sequence coverage of αB following heat treatment and 5 minute tryptic 
digestion. Regions of αB identified by tryptic digestion and subsequent MS analysis are 
underlined. Potential deamidation sites are highlighted in red. The deamidated residue (i.e. 
N146) is indicated by a green asterisk. 
 
To determine whether additional deamidated residues could be detected by increasing the 
incubation and digestion time, recombinant human αB was incubated for 16 hours at 50°C, 
digested with trypsin for 2 hours and analysed by MS. For the control sample, 6 αB tryptic 
peptides were identified (Table 5.4). No deamidation sites were identified (Table 5.4, Figure 
5.3D). Following incubation under acidic conditions, 3 αB tryptic peptides were identified, 2 
of which were the same peptide identified in the control sample (Table 5.4). A single 
deamidation site was identified at N146 on peptide 124-149 (Figure 5.3B, D, Table 5.4). 
Following incubation under basic conditions, 6 αB tryptic peptides were identified, 3 of 
which were the same peptide identified in the control sample (Table 5.4). The same 
deamidation site (N146) was identified on peptide 124-149 as observed following incubation 
under acidic conditions (Figure 5.3C, D, Table 5.4). However, an additional deamidation at 
N78 was identified on peptide 75-82 following incubation under basic conditions (Figure 
5.3C, D, Table 5.4). Deamidation at this site was not observed following the shorter 









Figure 5.3: Mass spectra of αB tryptic digests following incubation at 50°C for 16 hours. 
Recombinant human αB was incubated at 50°C for 16 hours in either 34 mM acetic acid 
(acidic; ~pH 3.0) or 200 mM ammonium acetate (basic; ~pH 7.0) at a concentration of 1 
mg.mL-1. (A) Protein was digested with trypsin for 2 hours and analysed using MS. Predicted 
masses were used to identify peptides (some of which are labelled in the spectra above, refer 
to 5.3) and modification sites detected following treatment with (B) acidic or (C) basic 
conditions. Peaks corresponding to a deamidated peptides are labelled with their m/z value 
(B, C). Protein that was not incubated was analysed as a control. (D) Regions of αB identified 
following heat treatment and 2 hour tryptic digestion and subsequent MS analysis were 
mapped onto the protein sequence. Potential deamidation sites are highlighted in red. 





Table 5.4: αB tryptic peptides identified following incubation at 50°C for 16 hours. 
Recombinant human αB was incubated at 50°C for 16 hours in either 34 mM acetic acid 
(~pH 3.0) or 200 mM ammonium acetate (~pH 7.0) at a concentration of 1 mg.mL-1. Protein 
was digested with trypsin for 2 hours and analysed using MS, and peptide masses were 
calculated using Masslynx software. Predicted masses were used to identify peptides and 
modification sites. Protein that was not incubated was analysed as a control. Modified 
residues are highlighted in red. 
m/z Expected 
Mass 
Residues Modification Sequence Observed 
mass 
Control  
588.3 588.3 117-120  EFHR 588.3 
700.5 700.4 158-163  TIPITR 700.5 
772.4 772.4 151-157  QVSGPER 772.4 
900.5 900.5 150-157  KQVSGPER 900.5 
1088.5 1088.5 108-116  QDEHGFISR 1088.5 
1140.6 1140.6 164-174  EEKPAVTAAPK 1140.6 
ACIDIC  
656.9 1313.7 124-149 N146 IPADVDPLTITSSLSSDGVL 
TVNGPR 
1313.8 
700.5 700.4 158-163  TIPITR 700.5 
772.4 772.4 151-157  QVSGPER 772.4 
BASIC  
656.9 1313.7 124-149 N146 IPADVDPLTITSSLSSDGVL 
TVNGPR 
1313.8 
700.5 700.4 158-163  TIPITR 700.5 
772.4 772.4 151-157  QVSGPER 772.4 
900.6 900.5 150-157  KQVSGPER 900.6 
1268.8 1268.7 164-175  EEKPAVTAAPKK 1268.8 












5.3.3 Deamidation under folding and unfolding conditions 
To determine which αB residues were susceptible to deamidation under folding and 
unfolding conditions, recombinant human αB (i.e. batch 2) that had been stored at -20°C for 
<1 year was incubated in 1 M ammonium bicarbonate (~pH 8.0) for 18 hours at 50°C or in 6 
M urea (~pH 8.0) for 4 hours at 37°C, digested with trypsin overnight and analysed using 
MS. The sample treated with 6 M urea was incubated at a lower temperature for a shorter 
time period to prevent insolubilisation of the unfolded protein. Protein in PBS (~pH 7.4) with 
and without heating for 18 hours at 50°C were used as controls. From each of the samples, 8 
deamidated αB tryptic peptides (denoted peptide 1-8) were identified (site of modification 
given in parentheses); peptide 1 - 75-82 (N78); peptide 2 - 75-90 (N78); peptide 3 - 124-149 
(N146); peptide 4 - 150-157 (Q151); peptide 5 -  23-46 (Q26); peptide 6 - 108-116 (Q108); 
peptide 7 - 151-157 (Q151); peptide 8 - 122-149 (N146) (Figure 5.3). There was no 
significant difference in amount of deamidation between each treatment for peptides 1-6 
(Figure 5.4, Table 5.5).  
One-way ANOVA analysis indicated that there was a significant effect of treatment on the 
amount of deamidation of peptide 7 that contains Q151 [F (3, 8) = 11.8, p = 0.003]. The 
amount of deamidation of peptide 7 was significantly increased in the heat-treated PBS 
sample (i.e. PBS + heat, 26.8±4.6%) compared to the other samples (P≤0.05, Figure 5.4, 
Table 5.5). All other samples had similar levels of deamidation for Q151 (Figure 5.4, Table 
5.5).  
One-way ANOVA analysis indicated that there was a significant effect of treatment on the 
amount of deamidation of peptide 8 that contains N146 [F (3, 44) = 8.99, p = 0.0001]. The 
amount of deamidation of peptide 8 was significantly increased in the PBS-treated sample 
(64.5±6.2%) compared to the samples in ABC that were heat-treated (i.e. ABC ± heat, 
49.7±6%) or urea-treated (i.e. urea + heat, 55.6±6.8, P≤0.05; Figure 5.4, Table 5.5). The 
amount of deamidation of peptide 8 was also significantly increased in the heat-treated PBS 
sample (i.e. PBS + heat, 59±9.2%) compared to the sample in ABC that was heat-treated (i.e. 
ABC + heat, P≤0.05), but not the heat-treated urea sample (Figure 5.4, Table 5.5). There was 
no significant difference in the amount of deamidation of peptide 8 between the PBS and 
heat-treated PBS samples, or the heat-treated ABC (i.e. ABC + heat) and urea (i.e. urea + 





Table 5.5: Percentage of αB deamidation following heat treatment in urea or 
ammonium bicarbonate buffer. Recombinant human αB was incubated at 37°C for 4 hours 
in 6 M urea (~pH 8.0) or at 50°C for 18 hours in 1 M ammonium bicarbonate (ABC; ~pH 
8.0), at a concentration of 2 mg.mL-1. Protein was digested with trypsin and analysed using 
MS/MS. Peptides and modified residues were identified using a MASCOT database search, 
and percentage deamidation for each peptide (1-8) was calculated using a computer 
simulation method. Differences between treatments were tested using a one-way ANOVA 
(P≤0.05 shaded grey) and post-hoc Tukey’s tests (P≤0.05 marked with asterisk). Values are 
presented as means±1SD. Samples were anlaysed in triplicate, n = number of observations of 
that peptide. 
Peptide Residues Deamidation 
site 
ABC + heat PBS PBS + heat Urea + heat 
1 
(n=3) 
75-82 N78 19.4±5.8 16.2±5.4 21±5.1 24.4±5.1 
2 
(n=12) 
75-90 N78 55.7±19.1 59.8±19.5 54.5±21.4 59.8±22.2 
3 
(n=12) 
124-149 N146 44.9±9.7 58.2±8.9 52.4±9.8 50±13.6 
4 
(n=3) 
150-157 Q151 14.7±10 15.2±8.4 15.5±1.4 5±2 
5 
(n=9) 
23-46 Q26 50.7±7.3 52.9±9.1 51.2±13.3 55.9±4.1 
6 
(n=6) 
108-116 Q108 23.9±6.6 25.1+12.2 18.5±3.3 17.4±7.8 
7 
(n=3) 
151-157 Q151 11.4±2.7 17.3±2.4 26.8±4.6* 18.2±2.6 
8 
 (n=12) 











Figure 5.4: Sequence coverage of αB following heat treatment in folding or unfolding 
conditions and overnight tryptic digestion. Regions of αB identified by tryptic digestion 
and subsequent MS/MS analysis are underlined. Deamidated residues are highlighted in red. 
Deamidated residues that show statistical significance between treatments (P≤0.05) as 





Recombinant proteins are a convenient way to study protein structure and function in vitro. 
However, recombinant proteins are prone to the accumulation of non-enzymatic 
modifications, even under frozen storage conditions (Berson and Yalow, 1966). Modified 
forms of αB (including methylated, deamidated and pyro-carbamidomethylation) were 
present in protein that had been stored at -20°C in 200 mM ammonium acetate (~pH 7.0) for 
5 years (Figure 5.1, Table 5.2). Unfortunately, the protein used as a control for these 
experiments (i.e. not heat treated) had been stored under frozen conditions for a minimum of 
one year. As such, it is impossible to determine whether the modifications present were 
introduced during protein expression or during storage. The use of a recently expressed 
protein batch as a control would help elucidate this in future experiments. It was possible 
however, to determine whether further incubation in non-frozen conditions could contribute 
to the introduction of further modifications. 
When αB was incubated at 4°C, the majority of the additional modifications (the dominant 
being deamidation) were introduced within the first 24 hours (Figure 5.1, Table 5.2). This 
suggests that deamidation of αB occurs readily and spontaneously under common 





An additional site of deamidation (i.e. N78) was identified when αB was heat-treated in a 
basic buffer (200 mM ammonium acetate, ~pH 8.0) compared to an acidic buffer (34 mM 
acetic acid, ~pH 3.0) (Table 5.3, Table 5.4). These treatments induce deamidation via two 
different pathways i.e. via a succinimide ring intermediate (basic conditions), and via direct 
hydrolysis (acidic conditions) (Geiger and Clarke, 1987; Catak et al., 2009). The sample 
heat-treated in ammonium acetate (~pH 8.0) showed the highest number of deamidated 
residues (N78 and N146) (Figure 5.3, Table 5.4), with the peak corresponding to deamidation 
at N146 (m/z 656.9) being more prominent in this sample compared to the sample heat-
treated in acetic acid (~pH 3.0) (Figure 5.3 compare panels B, C). This is consistent with αB 
being preferentially deamidated via the succinimide intermediate pathway rather than direct 
hydrolysis in vitro. This is most likely due to higher thermodynamic favourability of the 
succinimide forming pathway (Catak et al., 2009). Takemoto et al. (2001) reported that γ-
crystallin in human cataractous lenses undergoes deamidation via this same pathway, as 
indicated by the formation of iso-aspartate, demonstrating that this pathway to deamidation 
occurs in vivo.  
It is important to note that deamidation at N78 was only detected when the samples were 
subjected to the longer digestion time (i.e. 2 hours versus 5 minutes). Although overall 
peptide coverage was higher for the samples subjected to the 5 minute digestion, the peptide 
containing N78 was not detected (Figure 5.3). Therefore, repeat experiments incorporating 
overnight digestion of samples may lead to the identification of deamidation at more residues. 
Furthermore, a limitation for identifying PTMs of whole proteins is the accuracy and 
sensitivity of the mass spectrometer used. Although the samples were run on the same day 
and using the same setting to help ensure accuracy, only a single replicate was performed. 
This is particularly pertinent regarding the identification of deamidation, as the modification 
only introduces a mass change of 1 Da, a change too small for many mass spectrometres to 
detect. The mass of peak B increased by 3 Da in the first 24 hours of incubation and by a 
further 2 Da by 72 hours (Table 5.2). Although this is consistent with deamidation at five 
sites, a possibility given that deamidation occurs relatively rapidly in acidic buffers, the 
finding is tentative and would need to be confirmed with higher resolution mass 
spectrometry. 
Hydrolysis of the succinimide intermediate has been reported to be the rate-limiting step in 
deamidation via this mechanism (Catak et al., 2009). A significant decrease in the amount of 





(~pH 8.0) compared to samples in PBS (pH 7.4) (Figure 5.4, Table 5.5). This suggests that 
hydrolysis of the succinimide intermediate occurs faster at slightly acidic pH, and that even 
slight increases in pH may therefore act to reduce heat-induced deamidation. The lens has a 
pH gradient that decreases from ~pH 7.2 in the cortex (Bassnett et al., 1987; Eckert, 2002) to 
~pH 6.7 in the nucleus (Bassnett et al., 1987). If this slight decrease in intracellular pH is 
sufficient to affect αB deamidation, this may provide another explanation (in addition to 
protein longevity) for the high levels of deamidation in the nucleus of aged lenses (Siebinga 
et al., 1992; Hains and Truscott, 2007). As deamidation, particularly at N146, reduces the 
chaperone activity of αB (Gupta and Srivastava, 2004; Asomugha et al., 2011), the higher 
incidence of αB deamidation, associated with the decrease in pH in the nucleus, may 
facilitate the formation of nuclear cataract in the lens. 
Isomerisation resulting from deamidation following the succinimide intermediate pathway is 
reported to increase the susceptibility of proteins to tryptic cleavage by inducing partial 
unfolding (Takata and Fujii, 2015). However, following longer heat-treatment and digestion 
times, the number of αB tryptic peptides identified decreased as the number of deamidated 
residues increased (Table 5.3, Table 5.4). Additionally, when N78 was identified on two 
separate peptides (i.e. peptide1 and peptide 2; Table 5.5), the presence of an additional 8 
residues on peptide 2 led to an increase in the average amount of deamidation detected on 
that peptide by 37% (Figure 5.4, Table 5.5). This was not observed for other residues. If 
deamidation at N78 occurred during heat-treatment, this finding suggests that deamidation at 
N78 protects surrounding residues from cleavage. Several studies have reported that peptides 
derived from crystallin proteins form HMWCs during the onset of age-related cataract 
formation (Ramalho et al., 1996; Santhoshkumar et al., 2008; Su et al., 2015). These peptides 
are believed to form via autolytic cleavage at serine residues in the lens nucleus with age (Su  
et al., 2012). Notably, there is a serine residue one residue away from N78 (Figure 5.3), and 
thus this region may be susceptible to autolytic cleavage in the lens. However, if deamidation 
of N78 inhibits cleavage of αB in vivo, this may act as a protective mechanism to prevent 
protein cleavage that could lead to cataract. The possibility that N78 deamidation may not be 
involved in cataract formation is supported by previous findings that deamidation at N78 
does not affect the chaperone activity or oligomeric size of αB (Gupta and Srivastava, 2004). 
Hains and Truscott (2010) previously reported that αB was deamidated at asparagine residues 
at a ~3-fold higher rate than glutamine residues in the human lens. This can likely be 





asparagine residues (Wright, 1991; Robinson and Robinson, 2004a; Li et al., 2010). With the 
exception of N78 in peptide 1 and Q26 in peptide 5, the current results support this finding of 
a higher rate of deamidation at asparagine residues compared to glutamines (Figure 5.4, 
Table 5.5). Deamidation of N78 (peptide 2) and N146 (peptide 3 and peptide 8) was, on 
average, 3.3-fold higher than the amount of deamidation measured at Q151 (peptide 4 and 
peptide 7) and Q108 (peptide 6). However, the average amount of deamidation for asparagine 
and glutamine residues reported here (46.5% and 26.2%, respectively) were higher than the 
amount reported by Hains and Truscott (2010) in vivo (22.6% and 6.6%, respectively). This 
difference can be attributed to different experimental conditions (i.e. in vivo versus in vitro 
conditions) as well high levels of deamidated Q26 (peptide 5) in this work. When Q26 is 
excluded from the analysis, asparagine and glutamine were deamidated to the same extent as 
reported by Hains and Truscott (i.e. 3:1) (2010), thus suggesting a similar preference for 
asparagine residue deamidation in vitro. As Q26 is located within an α-helical region it may 
be expected to be deamidated to a lesser extent than Q151 which lies within an unstructured 
coil region (Figure 5.5A). Additionally, as all three glutamine residues (i.e. Q26, Q108 and 
Q151) are surface exposed (Figure 5.5B), the mechanism of the higher amount of 
deamidation at Q26 (peptide 5) compared to Q151 (peptide 4 and peptide 7) and Q108 




Figure 5.5: Model of αB indicating location of Q26, Q108 and Q151. Model of the (A) 
monomer depicted as a ribbon representation (β-sheets – orange, α-helices – blue, coil – grey) 
and the (B) 24mer depicted as a surface representation of human αB (pdb entry 3J07; Jehle et 
al. (2011)). The deamidated residues Q26 (red), Q108 (magenta) and Q151 (green) are 





The only residues for which the amount of deamidation was significantly affected by 
treatment were N146 (peptide 8) and Q151 (peptide 7), whereby changes in buffer pH, but 
not protein unfolding, increased the amount of deamidation of these sites (Figure 5.4, Table 
5.5). These residues lie within five residues of each other (Figure 5.4); N146 lies within the 
β9-strand of the ACD and Q151 lies within the hinge loop region (Laganowsky et al., 2010). 
As deamidation of these sites was not affected by unfolding (Table 5.5), this suggests that 
surface exposure was not a limiting factor. This was confirmed by mapping the location of 
N146 and Q151 in a structural model of oligomeric αB (Figure 5.4). Both residues are highly 
solvent exposed in the αB oligomer (Figure 5.5A), making them susceptible to non-
enzymatic deamidation. Deamidation is also facilitated by the conformational flexibility of 
the surrounding region (Truscott and Friedrich, 2016), as well as the presence of 
neighbouring glycine and basic residues (Hains and Truscott, 2010). As such, the flexibility 
of the surrounding hinge loop region may facilitate deamidation of N146 and Q151. 
Deamidation of N146 and Q151 may also be further facilitated by the presence of 
neighbouring glycine (G147) and arginine residues (R149) respectively, accounting for the 
high amount of deamidation at these residues in this study. As the amount of deamidation of 
N146 and Q151 was affected by pH, this suggests that the surrounding region may also 
undergo conformational changes at lower pHs that make these residues more susceptible to 
deamidation, such as a further increase in conformational flexibility. Moreover, since the 
amount of deamidation was significantly increased in the heat-treated PBS sample compared 
to the untreated PBS sample for N146 but not Q151 (Figure 5.4, Table 5.5), this suggests that 
Q151 is more susceptible to deamidation under conditions that promote changes in 
conformation than N146.  
In addition to being highly solvent exposed, N146 is positioned in close proximity to the 
subunit interaction site of αB (Figure 5.6). As deamidation induces a structural change in the 
protein, it is likely that deamidation of N146 may interfere with subunit interactions, causing 
the dissociation of dimers from the αB oligomer. It has previously been shown that αB 
deamidation mutants (N146D and N78D αB) have increased binding affinity for βA3-
crystallin compared to WTαB (Tiwary et al., 2015). It is therefore plausible that dimer 
dissociation induced by deamidation at N146 may result in the exposure of substrate binding 
sites, thereby increasing the substrate affinity of αB. This can be tested experimentally by 
measuring structural changes in N146D and N78D mutants using techniques such as circular 





fluorescence, and resulting changes in oligomeric size can then be observed using methods 
such as size exclusion chromatography or native mass spectrometry.  If this results in 
irreversible substrate binding, this may account for the high levels of deamidation observed in 
insoluble protein fractions from human lenses (Hanson et al., 2000; Srivastava and 












Figure 5.6: A model of the structure of oligomeric αB highlighting the position of 
deamidation sites N146 and Q151 identified in this work. Model of the  24-mer (i) and  
dimer forms (ii) of αB (pdb entry 3J07; Jehle et al. (2011)) depicted as a (A) ribbon 
representation and as a (B) surface representation highlighting the secondary structure 
elements (β-sheets – orange, α-helices – blue). The deamidated residues N146 (green) and 
Q151 (magenta) are highly solvent exposed at the surface of the oligomer, and are located in 





5.5  Conclusion 
 
Non-enzymatic deamidation of αB has been implicated in protein insolubilisation in the lens 
and cataract formation. To study this, in vitro studies often use recombinant protein as an 
experimental model. However, non-enzymatic deamidation of αB resulting from expression, 
storage or treatment conditions can affect the structure and therefore function of the protein. 
The results in this chapter indicate that deamidation of αB at Q151 and N146 can be induced 
by common buffer and treatment conditions i.e. neutral pH and high temperatures. It is 
therefore important to consider the presence of deamidated residues in recombinant proteins, 
and how this may affect protein function and chaperone assays. Such modifications need to 
be taken into account to interpret experimental results appropriately. As similar conditions to 
those that were shown to induce deamidation in vitro exist in the nucleus of the aging lens, 
these results also provide an insight into the susceptibility and potential consequences of non-




































Despite its pivotal role in maintaining the health and transparency of the lens, αB has also 
been implicated in various pathological states (Shinohara et al., 1993; Chin et al., 2005; 
Kamradt et al., 2005; Moyano et al., 2006; Liu et al., 2015; Yilmaz et al., 2015). This thesis 
investigated the possible role that phosphorylated αB plays in age-related cataract formation 
by addressing four separate aims. The first aim was to determine how the addition of a 
negative charge, similar to that added by phosphorylation, modulates the chaperone activity 
of αB. To achieve this, the ability of αB isoforms with mutations that mimic phosphorylation 
to inhibit the heat-induced aggregation of CPK was assessed using aggregation assays. The 
second aim was to compare αB phosphorylation profiles across different regions, sucrose 
density gradient fractions and ages of human lenses in order to determine whether αB 
phosphorylation could be involved in protein insolubilisation. This was achieved by isolating 
fractions from lenses using sucrose density gradient centrifugation, and assessing the 
phosphorylated status of αB in the fractions by 2D SDS-PAGE. The constituents of HMWCs 
were determined, and modification sites identified, by MS/MS analysis of 2D spots with 
masses of 40-100 kDa. The third aim was to identify interactions between αB and abundant 
membrane proteins (AQP0 and Cx46) at fibre cell membranes to determine how association 
of αB with membranes may contribute to barrier formation. This was achieved by co-
labelling lens sections for αB and membrane proteins using a Duolink® proximity assay kit, 
and visualising interactions across the section using confocal microscopy. The final aim was 
to determine which αB residues are susceptible to non-enzymatic deamidation. To do this, 
recombinant human αB was heat-treated under acidic (~pH 3.0), alkaline (~pH 8.0) and 
unfolding buffer conditions, and deamidation sites were identified using MS. Taken together, 
the results of the current thesis suggest that αB participates in multiple pathways that 
ultimately can facilitate cataract formation in the lens.  
 
 
6.2 A potential role of phosphorylation and deamidation 
 
Previous studies have provided conflicting results into how the addition of a negative charge, 





Kamei et al., 2001; Augusteyn et al., 2002; Aquilina et al., 2004; Ecroyd et al., 2007). The 
results of this study indicate that WTαB, at concentrations equal to the substrate, induces 
protein aggregation following heat treatment (section 3.3.1). Although it is likely that this 
occurs via co-deposition of αB with the substrate protein (Aquilina et al., 2004; Ecroyd et al., 
2007), this was not confirmed in the present study. The ability of αB to inhibit the 
aggregation of substrate (i.e. CPK) was, however, significantly increased with the addition of 
multiple negative charges, such that the introduction of 3 negative charges (via aspartate 
substitution at Ser19, Ser45 and Ser59) inhibited CPK aggregation by 83.9±1.3% (section 
3.3.1). These results are consistent with previous findings that mutations that mimic 
phosphorylation of αB act to increase its capacity to inhibit stress-induced protein 
aggregation compared to the WT chaperone (Ghosh et al., 2006; Ecroyd et al., 2007; Ahmad 
et al., 2008). It has been proposed that this increase in chaperone activity is a result of the 
dissociation of αB oligomers into higher activity monomers (Ecroyd et al., 2007; Peschek et 
al., 2013) which have higher substrate affinity (Koteiche and Mchaourab, 2003; Ecroyd et al., 
2007). If a similar mechanism occurs in the lens acts to maintain sufficient αB activity to 
maintain protein solubility. It is possible, however, that if substrate affinity is increased to the 
point of irreversible substrate binding, co-deposition of αB with the substrate protein may 
occur (Aquilina et al., 2004; Ecroyd et al., 2007). 
Although mutations of cytoskeletal proteins in the lens have been implicated in cataract 
formation (Conley et al., 2000; Jakobs et al., 2000; Alizadeh et al., 2002; Alizadeh et al., 
2003; Ramachandran et al., 2007; Muller et al., 2009), modification of these proteins have 
been largely overlooked. This study reported evidence of the formation of crosslinked protein 
complexes involving αA, αB and filensin, suggesting that the association of αB with fibre cell 
membranes may be mediated by interactions with cytoskeletal components. Such complexes 
have been reported previously, but have not been well characterised in lenses over the age of 
45 (Srivastava et al., 2004). The predominance of αA, particularly C-terminally truncated αA, 
in these complexes led to the suggestion that they were first formed via crosslinking between 
crystallin proteins (Srivastava et al., 2004). Furthermore, it was suggested that these 
crosslinks were mediated by αA oxidation and serine to DHA conversion, with the age-
related addition of intermediate filaments, including filensin, in older lenses (Srivastava et al., 
2004). This study characterised HMWCs isolated from a 77 year-old lens; filensin was found 
to be the predominant protein in these complexes, followed by αA (Figure 3.9). Without 





whether the predominance of filensin in the complexes isolated from this older lens is a result 
of the age-related incorporation of intermediate filaments into crosslinked crystallin 
complexes, or the result of age-related binding of crystallins to the intermediate network.  
While filensin, αA and αB in the HMWCs were all N- and C-terminally truncated, αA was 
more extensively truncated than previously reported (Srivastava et al., 2004), suggesting that 
proteolytic cleavage, particularly of αA, may contribute to complex formation. Additionally, 
a high degree of deamidation of filensin was also detected, particularly at N303 (29.2-66.8% 
for each complex), which resides in the rod domain of the protein (Table 3.3). High levels of 
deamidation were also detected at N383 and N478 in the tail domain (Table 3.3). However, 
as peptides containing N383 and N478 were not detected for most complexes (likely due to 
C-terminal truncation), this suggests that N303 plays a larger role in complex formation. It 
remains to be determined how deamidation at N383 contributes to complex formation. 
However, as deamidation-induced isomerisation can cause partial unfolding of proteins 
(Takata and Fujii, 2015), it is conceivable that structural changes in filensin caused by 
deamidation at N303, in conjunction with increased substrate affinity of phosphorylated αB, 
may trigger αB to associate with the intermediate network at fibre cell membranes.  
Together these results suggest that, whether through direct interaction or by accumulation of 
proteins at fibre cell membranes, the association of αB at fibre cell membranes may obstruct 
membrane pores, contributing to the formation of the nucleocortical barrier at middle age. 
Based on the results of the work presented here, a new model of how αB contributes to age-











Figure 6.1: Possible roles of αB in age-related nuclear cataractogenesis. In aged lenses, 
(1) phosphorylation (red circles) of multiple serine residues in cortical αB (green oval) results 
in an increase in the chaperone activity of αB. (2) Deamidation (orange circles) of 
cytoskeletal proteins, including filensin (red lines), induces protein unfolding, increasing 
substrate affinity of cytoskeletal proteins and, together with the increase in the chaperone 
activity of αB, induces association of αB at fibre cell membranes. Association of αB with 
fibre cell membranes occludes (3A) Cx46 pores (purple ovals) inhibiting GSH transport, and 
(3B) AQP0 pores (pink ovals) inhibiting water transport from the cortex (dark blue) into the 
nucleus (light blue), leading to the formation of the nucleocortical barrier (dashed line) at 
middle age. (4) An increased level of oxidation in the nucleus, as a result of decreased GSH 
transport from the cortex, results in the formation of crosslinked HMW protein complexes 
involving filensin, αA (blue oval) and αB. (5A) Age-related, non-enzymatic deamidation of 
αB (e.g. at N146 and Q151) decreases the chaperone activity of the remaining non-
complexed αBand (5B) deamidation of nuclear proteins, such as filensin, increases the 
recruitment of proteins into HMWCs. (6) Reduced activity of non-complexed αB, and the 
loss of soluble, chaperone-active αB into HMWCs in the nucleus results in these protein 






6.2.1 Barrier to GSH transport 
To investigate how the association of αB at fibre cell membranes may be involved in barrier 
formation, 2D profiles of membrane proteins fractions were compared (section 3.3.2), and the 
distribution of interactions between αB and abundant membrane pore proteins (i.e. Cx46 and 
AQP0) was mapped across human lens sections (section 4.3.2).  
Two dimensional electrophoretic profiles of high density protein fractions of aged human 
lenses showed increased amounts of highly phosphorylated αB isotypes compared to low 
density fractions (section 3.3.2). As these high density fractions have previously been shown 
to represent membrane associated protein (Friedrich and Truscott, 2009; Friedrich and 
Truscott, 2010), this suggests that increased αB phosphorylation leads to increased membrane 
association.  
The association of αB with Cx46 and AQP0 was restricted to the cortical region of the lens 
(outer 500 µm for AQP0 and outer 250 µm for Cx46) (section 4.3, section 4.4.2) (section 
3.4.2). This region coincides with the onset of the association of αB with fibre cell 
membranes (i.e. zone 3) (section 4.3.1) and the putative location of the nucleocortical barrier 
(section 4.4.2). It has been previously postulated that the presence of this barrier may cause 
the decrease in nuclear GSH that is believed to be a precursor to cataract formation (Cobb 
and Petrash, 2002b; Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). The 
association of αB with membrane proteins, particularly Cx46, reported in this study supports 
this hypothesis. If, as a result of this association between αB and Cx46, these gap junctions 
become obstructed, GSH transport into the nucleus may be hindered leading to a decrease in 
nuclear GSH concentrations and the accumulation of oxidative protein damage (Figure 6.1).  
This would potentially result in the formation of HMWCs, such as those observed during this 
study (section 3.4.3). Furthermore, the presence of an additional oxidation site at M649 on 
filensin corresponded with a ~2-fold increase in the size of the complexes reported in this 
study (section 3.4.3). It has been proposed that the insolubility of such complexes is the 
dominant pathway leading to insoluble protein associated with cataract formation (Smulders 
et al., 1998). Additionally, the increased susceptibility of proteins to non-enzymatic 
deamidation in the nucleus could also contribute to the recruitment of proteins into HMWCs, 
while reducing the chaperone activity of αB (Gupta and Srivastava, 2004; Asomugha et al., 
2011). The loss of soluble and chaperone-active αB, due to its incorporation into crosslinked 





6.3 Future directions 
 
This study utilised αB phosphomimics to determine how phosphorylation may affect the 
chaperone activity of αB (section 3.3.1). Phosphomimics are often used as they impart a 
negative charge to proteins similar to phosphorylation, while allowing the targeting of 
specific residues to give a homogeneous product. However, as phosphomimics are non-
physiological and impart a single charge compared to the double negative charge introduced 
by phosphorylation, their relevance as models of the effect of phosphorylation is limited. 
Although some residue specificity is lost, protein kinases are commercially available, and can 
be used to induce phosphorylation of recombinant protein in vitro. For example, 
commercially available MAPKAP2, the kinase responsible for phosphorylation of Ser59 
(Kato et al., 1998), could be used to phosphorylate Ser59 of αB in vitro. This would provide a 
more physiologically relevant model of phosphorylated αB, and may provide further insight 
into how the chaperone activity of αB is regulated by phosphorylation.  
Although interactions between αB and membrane proteins (i.e. Cx46 and AQP0) were 
observed in this work (section 4.3.2), it is possible that membrane association could also be 
mediated by association of αB with cytoskeletal components or membrane phospholipids. 
Previous reports regarding this have been conflicting. For example, Mulders et al. (1985) 
reported that α-crystallin associated only with fibre cell membrane extracts that retained some 
native proteins, while association with artificial phospholipid vesicles only occurred when the 
vesicles had been reconstituted with MP26 (Mulders et al., 1985). However, Cobb and 
Petrash (2002a) later reported that α-crystallin was able to bind artificial phospholipid 
bilayers in the absence of all proteins. Performing further substrate binding and membrane 
affinity assays may elucidate the precise nature by which αB associates with membranes cells 
from the lens. Furthermore, the use of αB phosphomimics for such assays would provide 
further insight into how phosphorylation affects this process.  
Deamidation of αB at both N146 and Q151 was increased by heat-treatment under neutral 
conditions (Table 5.5, section 5.4). While deamidation at N146 is well characterised and 
known to reduce chaperone activity of αB (Gupta and Srivastava, 2004; Asomugha et al., 
2011), deamidation at Q151 has not been investigated due to its relatively low abundance in 
vivo. Mutants that mimic deamidation at asparagine residues of αB (i.e. N→D substitutions) 
have been extensively used to study the functional impact of deamidation of proteins (Gupta 





Q180E mutants have been used previously for structural studies of βA3-crystallin (Takata et 
al., 2008). However, to our knowledge, studies utilising Q→E mutants to mimic deamidation 
at glutamine residues of αB have not been previously attempted. Performing aggregation 
assays utilising αB Q→E deamidation mimics may help elucidate whether deamidation at 





The results of this work provide evidence of a role for αB in multiple pathways that 
culminate in the formation of age-related nuclear cataract. The model described in this thesis 
proposes that phosphorylation of αB increases its molecular chaperone activity, thereby 
inducing association with highly deamidated intermediate filament proteins (i.e. filensin) at 
fibre cell membranes. This results in the occlusion of membrane pore proteins, including 
Cx46 and AQP0, leading to the formation of a physical barrier to diffusion into the nucleus 
i.e. the nucleocortical barrier. The presence of this barrier inhibits the transport of GSH into 
the nucleus of the lens, leading to low levels of nuclear GSH and the accumulation of 
oxidative damage, resulting in the formation of crosslinked HMW complexes involving αB. 
The accumulation of non-enzymatic deamidation of αB, together with the loss of soluble, 
chaperone-active αB, is then suggested to lead to the insolubilisation of HMW complexes, 
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Phosphorylation sites identified in human lens αA-crystallin.  
Site Reference 
S20  Wang et al., 2013; Wang et al., 2014 
S45 Wang et al., 2013; MacCoss et al., 2002 
S51 Wang et al., 2013 
S59 Wang et al., 2013; Wang et al., 2014 
S62 Wang et al., 2013; Wang et al., 2014 
S66 Huang et al., 2011; Wang et al., 2013 
S81 Huang et al., 2011 ; Wang et al., 2013 
S122 Wilmarth et al., 2013; Wang et al., 2013; Searle et al., 2004; MacCoss et al., 2002; 
Miesbauer et al., 1994 
S127 Wang et al., 2013 
S130 Wang et al., 2013 
S134* Previously unreported 
S162 Wang et al., 2013; Wang et al., 2014 
S172 Wang et al., 2013 
S173 Wang et al., 2013 
T13 MacCoss et al., 2002; Wang et al., 2013; Wang et al., 2014 
T43 Wang et al., 2013 
T55 Wang et al., 2013 
T86 Wang et al., 2013 
T140 MacCoss et al., 2002 
T148 Huang et al., 2011; Wang et al., 2013; Wang et al., 201 
T168/S169 Wang et al., 2013 
T153 Huang et al., 2011; Wang et al., 2013 
Y47 Wang et al., 2013 











Phosphorylation sites identified in human lens αB-crystallin. 
S19 Wang et al., 2013; Wilmarth et al., 2006; Huang et al., 2011; MacCoss et al., 2002; 
Miesbauer et al., 1994 
S21 Huang et al., 2011; Wang et al., 2013; MacCoss et al., 2002 
S43 Wang et al., 2013; MacCoss et al., 2002 
S45 MacCoss et al., 2002; Miesbauer et al., 1994; Wang et al., 2013 
S53 Wang et al., 2013; Wang et al., 2014; MacCoss et al., 2002 
S59 Wilmarth et al., 2006; Huang et al., 2011; Wang et al., 2013; Wang et al., 2014; 
Searle et al., 2004; MacCoss et al., 2002; Kamei et al., 2000; Miesbauer et al., 
1994 
S66 Wang et al., 2013 
S76 Wilmarth et al., 2006; Huang et al., 2011; Wang et al., 2013; MacCoss et al., 2002 
S85 Wang et al., 2013 
S136 Wang et al., 2013 
S138 Wang et al., 2013; Wang et al., 2014 
S139 Huang et al., 2011; Wang et al., 2013; Wang et al., 2014 
S153 Wang et al., 2013 
T63 Wang et al., 2013 
T170 Wang et al., 2014 
T132 Wang et al., 2013 
T134 Wang et al., 2013 















Deamidation sites identified in human lens αA and αB-crystallin. 
Subunit Site Reference 
αA Q6 Lund et al., 1996; Hanson et al.,  
2000; Searle et al., 2005; Wilmarth 
et al., 2006  
 Q50 Lund et al., 1996; Wilmarth et al., 
2006 
 Q90 Lund et al., 1996; Hanson et al.,  
2000; Searle et al., 2005; Hains 
and Truscott, 2010 
 Q104 Hanson et al.,  2000; Hains and 
Truscott, 2010 
 Q126 Wilmarth et al., 2006 ; Hains and 
Truscott, 2010 
 Q147 Lund et al., 1996; Hanson et al.,  
2000; Searle et al., 2005; Hains 
and Truscott, 2010 
 N101 Lund et al., 1996; Wilmarth et al., 
2006 
 N123 Searle et al., 2005; Wilmarth et al., 
2006; Hains and Truscott, 2010 
αB Q26 Wilmarth et al., 2006; Hains and 
Truscott, 2010 
 Q108 Lund et al., 1996; Hanson et al.,  
2000; Srivastava and Srivastava, 
2003; Hains and Truscott, 2010 
 N78 Hanson et al.,  2000; Hains and 
Truscott, 2010 
 N146 Searle et al., 2005; Wilmarth et al., 
2006; Asomugha et al., 2010; 













PBS: 137 mM NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 1 mM KH2PO4, pH 7.4 
Sucrose buffer: 10 mM Tris-base, 2 mM EDTA, 2 mM BME, adjusted to pH 8.0 with 10 M 
HCl 
SSS buffer: 8 M Urea, 100 mM DTT, 4% w/v CHAPS, 0.8% v/v 100x BioLyte® 3/10 
Carrier Ampholyte, 100 mM Tris-base 
2 times loading buffer: 125 mM Tris-HCl, 0.03% w/v bromophenol blue, 33% glycerol, 3.3% 
w/v SDS. Prior to use, 1 M DTT in 10 mM sodium acetate (pH 5.2) was added at the ratio 
1:4, for a final DTT concentration of 200 mM. 
Coomassie stain: 40% v/v methanol, 10% v/v acetic acid, 0.2% w/v coomassie blue R in 
milli-Q water 
Coomassie destain: 40% v/v methanol, 10% v/v acetic acid in milli-Q water 
HBSS buffer: 137 mM NaCl, 5.4 mM KCl, 250 mM Na2HPO4, 0.01% w/v glucose, 440 µM 
KH2PO4, 1.3 mM CaCl2, 1 mM MgSO4, 4.2 mM NaHCO3, pH 7.3 
TBST: 20 mM Tris-base, 150 mM NaCl, 0.17% Tween-20, adjusted to pH 7.5 with 10 M 
HCl 
TBS: 20 mM Tris-base, 150 mM NaCl, adjusted to pH 7.5 with 10 M HCl 
DAB working solution: one DAB tablet was solubilised in TBS, with 12 µL of 30% 
hydrogen peroxide added prior to use.  
Equilibration buffer: 6 M Urea, 0.1% w/v SDS, 300 mM Tris-HCl, 20% v/v Glycerol, 0.1% 
w/v DTT, 2.5% v/v acrylamide, pH 8.8 
Colloidal coomassie stain: 1.3 M ammonium sulphate, 3% v/v phosphoric acid, 0.1% w/v 
coomassie G, 34% v/v methanol in milli-Q water. N.B. Coomassie G was solubilised in 
ammonium sulphate solution before adding phosphoric acid and methanol to reach final 
concentrations. 
Colloidal destain: 1% v/v acetic acid in milli-Q water 
PFA: PFA was added to PBS to a final concentration of 0.75% w/v. A few drops of 10 M 
NaOH were added and the solution was heated at 80°C until fully solubilised, before the pH 
was adjusted to 7.4. 
Wash buffer A: 0.01 M Tris-base, 0.15 M NaCl, 0.05% v/v Tween-20, adjusted to pH 7.4 





Wash buffer B: 0.2 M Tris-base, 0.1M NaCl, adjusted to pH 7.5 with 10 M HCl 

































Heat induced aggregation of WTαB and αB containing single, double or triple 
mutations that mimic phosphorylation. WT, 1P, 2P or 3P αB was incubated in PBS (pH 
7.4) at 40°C at a concentration of either (A) 0.5 µM or (B) 0.25 µM, and the change in light 





Heat induced aggregation of WTαB and αB containing mutations that mimic 
phosphorylation at Ser19, Ser45 or Ser59. WT, S19D, S45D or S59D αB was incubated in 
PBS (pH 7.4) at 40°C at a concentration of either (A) 0.5 µM or (B) 0.125 µM, and the 









Results of ANOVA of CPK aggregation assays. Test performed on experimental end-point 
values from data presented in Figures 3.3.1 and 3.3.2 for relative amount of CPK aggregation 
following incubation with αB (at molar ratios of 1cpk:1αB, 1cpk:2αB or 1cpk:1αB) with multiple 
or single aspartate substitutions. N=3 
  P F Fcrit 
Multiple 1cpk:1αB 
(data in Figure 3.3.1A) 
6.26-11 52.8 2.5 
Multiple 1cpk:2αB 
(data in Figure 3.3.1B) 
1.36-11 63.1 2.5 
Single 1cpk:1αB 
(data in Figure 3.3.2A) 
3.67-7 18.3 2.5 
Single 1cpk:4αB 
(data in Figure 3.3.2B) 




Tukey’s test of aggregation assay performed on data presented in Figure 3.1A: Test 
performed on experimental end-point values for relative amount of CPK aggregation 
following incubation with αB (at molar ratios of 1cpk:1αB) with single (1P), double (2P) or 
triple (3P) aspartate substitutions. Statistical significance at P<0.05 shaded in dark green, 
P<0.01 shaded in light green. N=3. 
 CPK WT/CPK 1P/CPK 2P/CPK 3P/CPK WT 1P 2P 3P 
CPK   0.001 0.9 0.195 0.009 0.003 0.003 0.005 0.007 
WT/CPK 0.001   0.001 0.001 0.001 0.001 0.001 0.001 0.001 
1P/CPK 0.9 0.001   0.049 0.002 0.001 0.001 0.001 0.001 
2P/CPK 0.195 0.001 0.049   0.769 0.497 0.515 0.631 0.693 
3P/CPK 0.009 0.001 0.002 0.769   0.9 0.9 0.9 0.9 
WT 0.003 0.001 0.001 0.497 0.9   0.9 0.9 0.9 
1P 0.003 0.001 0.001 0.515 0.9 0.9   0.9 0.9 
2P 0.005 0.001 0.001 0.631 0.9 0.9 0.9   0.9 
3P 0.007 0.001 0.001 0.693 0.9 0.9 0.9 0.9    
 
 
Tukey’s test of aggregation assay performed on data presented in Figure 3.1B: Test 





following incubation with αB (at molar ratios of 1cpk:2αB) with single (1P), double (2P) or 
triple (3P) aspartate substitutions. Statistical significance at P<0.05 shaded in dark green, 
P<0.01 shaded in light green. N=3. 
  CPK WT/CPK 1P/CPK 2P/CPK 3P/CPK WT 1P 2P 3P 
CPK   0.9 0.134 0.001 0.001 0.001 0.001 0.001 0.001 
WT/CPK 0.9   0.392 0.001 0.001 0.001 0.001 0.001 0.001 
1P/CPK 0.134 0.392   0.049 0.001 0.001 0.001 0.001 0.001 
2P/CPK 0.001 0.001 0.049   0.001 0.001 0.001 0.001 0.008 
3P/CPK 0.001 0.001 0.001 0.001   0.9 0.9 0.9 0.513 
WT 0.001 0.001 0.001 0.001 0.9   0.9 0.9 0.43 
1P 0.001 0.001 0.001 0.001 0.9 0.9   0.9 0.579 
2P 0.001 0.001 0.001 0.001 0.9 0.9 0.9   0.62 
3P 0.001 0.001 0.001 0.008 0.513 0.43 0.579 0.62    
 
 
Tukey’s test of aggregation assay performed on data presented in Figure 3.2A: Test 
performed on experimental end-point values for relative amount of CPK aggregation 
following incubation with αB (at molar ratios of 1cpk:1αB) with single aspartate substitutions 
at Ser19 (S19D), Ser45 (S45D) or Ser59 (S59D). Statistical significance at P<0.05 shaded in 
dark green, P<0.01 shaded in light green. N=3. 
  CPK WTαB/CPK S19D/CPK S45D/CPK S59D/CPK WTαB S19D S45D S59D 
CPK   0.001 0.9 0.9 0.9 0.031 0.025 0.022 0.02 
WTαB/CPK 0.001   0.001 0.001 0.001 0.001 0.001 0.001 0.001 
S19D/CPK 0.9 0.001   0.9 0.9 0.044 0.035 0.031 0.028 
S45D/CPK 0.9 0.001 0.9   0.9 0.049 0.04 0.035 0.031 
S59D/CPK 0.9 0.001 0.9 0.9   0.177 0.148 0.131 0.12 
WTαB 0.031 0.001 0.044 0.049 0.177   0.9 0.9 0.9 
S19D 0.025 0.001 0.035 0.04 0.148 0.9   0.9 0.9 
S45D 0.022 0.001 0.031 0.035 0.131 0.9 0.9   0.9 









Tukey’s test of aggregation assay performed on data presented in Figure 3.2B: Test 
performed on experimental end-point values for relative amount of CPK aggregation 
following incubation with αB (at molar ratios of 1cpk:4αB) with single aspartate substitutions 
at Ser19 (S19D), Ser45 (S45D) or Ser59 (S59D). Statistical significance at P<0.05 shaded in 
dark green, P<0.01 shaded in light green. N=3. 
  CPK WTαB/CPK S19D/CPK S45D/CPK S59D/CPK WTαB S19D S45D S59D 
CPK   0.1 0.9 0.9 0.9 0.116 0.166 0.138 0.307 
WTαB/CPK 0.1   0.017 0.024 0.008 0.001 0.001 0.001 0.001 
S19D/CPK 0.9 0.017   0.9 0.9 0.476 0.585 0.529 0.79 
S45D/CPK 0.9 0.024 0.9   0.9 0.39 0.5 0.443 0.705 
S59D/CPK 0.9 0.008 0.9 0.9   0.684 0.792 0.736 0.9 
WTαB 0.116 0.001 0.476 0.39 0.684   0.9 0.9 0.9 
S19D 0.166 0.001 0.585 0.5 0.792 0.9   0.9 0.9 
S45D 0.138 0.001 0.529 0.443 0.736 0.9 0.9   0.9 



















Peptides detected from HMW1-10: peptides were detected using MS/MS (APAF) and 
identified by comparison with a peptide database. Modified residues in peptide sequences are 
highlighted red. 
Protein Mass Peptide 
Mass 
(Da) 
Residues Sequence Modification Mod. 
Site 
Complex 1 
Filensin 74499 797.54 399-405 K.LVQVVLK.E   
  1014.54 484-492 R.FYVSSITAK.G   
  1098.64 294-303 R.QLAVAQQTLK.N   
  1131.6 621-630 K.TVEVVESIEK.I   
  1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.66 147-157 K.EADEALLHNLR.L   
  1306.63 457-467 K.EPETPTELYTK.E   
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1371.69 380-392 K.DKTDGALEDAPLK.G Deamidation N383 
  1486.83 399-411 K.LVQVVLKEESESK.F   
  1554.78 470-483 R.HVLVTGDANYVDPR.F   
  1555.76 470-483 R.HVLVTGDADYVDPR.F Deamidation N478 
  1618.81 454-467 R.SPKEPETPTELYTK.E   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1979 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2252.1 418-439 K.EVSPLTQEGAPEDVPDGGQISK.G   
  2457.22 631-652 K.ISTESIQTYEETAVIVETMIGK.T Oxidation M649 
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3338.79 179-208 K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E 
Oxidation M207 
  3724.97 179-211 K.NLLEVQTYISILQQIIHTTPPASIVTSGMRE
EK.L 
Oxidation M207 
Phakinin 45851 1265.62 201-211 K.AAEEEINSLYK.V   
  1359.79 77-89 R.ALGISSVFLQGLR.S   
  1878.98 122-137 K.VHALEQVSQELETQLR.M   
  2081 174-191 R.LMLQTETIQAGADDFKER.Y Oxidation M175 
  2179.1 221-239 K.MDLESQIESLKEELGSLSR.N Oxidation M221 
αA-Crystrallin 19897 979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  3363.64 22-49 R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q   
γS-Crystallin 20993 1728.89 159-174 R.KPIDWGAASPAVQSFR.R   
  1896.98 132-146 K.VLEGVWIFYELPNYR.G   
Serum Albumin 69321 1622.78 233-245 K.DVFLGMFLYEYAR.R   
  1638.77 233-245 K.DVFLGMFLYEYAR.R Oxidation M238 
Vimentin 53619 1168.71 130-139 K.ILLAELEQLK.G   
  1532.84 223-235 R.KVESLQEEIAFLK.K   
  1538.9 130-143 K.ILLAELEQLKGQGK.S   
Complex 2 
Filensin 74499 942.51 312-319 R.IIEIEGNR.L   
  1098.64 294-303 R.QLAVAQQTLK.N   
  1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1371.69 380-392 K.DKTDGALEDAPLK.G Deamidation N383 
  1486.82 399-411 K.LVQVVLKEESESK.F   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   





  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1771.88 382-398 K.TDGALEDAPLKGLEDTK.L Deamidation N383 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1840.87 125-138 R.SKYENECECQLLLK.E 2 Propionamide C131, 
C133 
  1979.02 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2639.18 255-275 K.SAHECYDDEIQLYNEQIETLR.K Propionamide C259 
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2767.28 255-276 K.SAHECYDDEIQLYNEQIETLRK.E Propionamide C259 




  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3338.79 179-208 K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E 
Oxidation M207 
Phakinin 45851 1265.61 201-211 K.AAEEEINSLYK.V   
  1353.72 90-103 R.SSGLATVPAPGLER.D   
  1359.79 77-89 R.ALGISSVFLQGLR.S   
  1801.92 6-22 R.VVVDLPTSASSSMPLQR.R Oxidation M18 
  1878.98 122-137 K.VHALEQVSQELETQLR.M   
  2081.01 174-191 R.LMLQTETIQAGADDFKER.Y Oxidation M175 
  2442.18 319-339 R.VELHNTSCQVQSLQAETESLR.A Propionamide C326 
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
  1449.76 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
  1718.82 188-202 K.VSSGTWVGYQYPGYR.G   
  2007.04 93-110 R.SIIVSAGPWVAFEQSNFR.G   
Retinal 
Dehydrogenase 1 
54827 1188.6 69-78 R.QAFQIGSPWR.T   






  1543.77 144-156 R.TIPIDGNFFTYTR.H   
  1589.77 421-435 R.ANDTFYGLSAGVFTK.D Deamidation N423 
  1644.8 309-321 R.IFVEESIYDEFVR.R   
  1745.94 396-410 R.IAKEEIFGPVQQIMK.F Oxidation M409 
αB-Crystallin 20146 1164.65 93-103 K.VLGDVIEVHGK.H   
  1191.62 73-82 K.DRFSVNLDVK.H   
  1373.67 12-22 R.RPFFPFHSPSR.L   
  1511.67 57-69 R.APSWFDTGLSEMR.L Oxidation M68 
  2623.37 124-149 R.IPADVDPLTITSSLSSDGVLTVNGPR.K   
αA-Crystallin 19897 979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1192.63 12-21 K.RTLGPFYPSR.L   
  1285.63 89-99 K.VQDDFVEIHGK.H   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
  1725.8 173-188 K.DSSDFGAPHPQVQSVR.R   
  2189.01 169-188 K.GDYKDSSDFGAPHPQVQSVR.R   
γS-Crystallin 20993 1516.73 8-19 K.ITFYEDKNFQGR.R   
  1728.89 159-174 R.KPIDWGAASPAVQSFR.R   
  1896.98 132-146 K.VLEGVWIFYELPNYR.G   
Serum Albumin 69321 1638.93 438-452 K.KVPQVSTPTLVEVSR.N   
Glutathione 
Synthetase 
52352 940.57 26-34 R.ALAEGVLLR.T   
βA3-Crystallin 25134 1454.7 33-44 K.ITIYDQENFQGK.R   
Tubulin α-1A 50104 1084.61 78-86 K.EIIDLVLDR.I   
γD-Crystallin 20725 1270.6 143-152 R.QYLLMPGDYR.R Oxidation M147 
γC-Crystallin 20865 1364.72 143-152 R.QYLLRPQEYR.R   
Tubulin β-4A 49554 1038.59 310-318 R.YLTVAAVFR.G   
Complex 3 
Brain Acid 
Soluble Protein 1 
22680 1774.85 103-121 K.APEQEQAAPGPAAGGEAPK.A   
  2297.13 98-121 K.AEPPKAPEQEQAAPGPAAGGEAPK.A   
  2635.23 122-149 K.AAEAAAAPAESAAPAAGEEPSKEEGEPK.
K 
  
  2763.36 199-226 K.AQGPAASAEEPKPVEAPAADSDQTVTVK.
E 
Deamidation N218 
Filensin 74499 1014.54 484-492 R.FYVSSITAK.G   
  1131.6 621-630 K.TVEVVESIEK.I   





  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  2457.22 631-652 K.ISTESIQTYEETAVIVETMIGK.T Oxidation M649 
Phakinin 45851 1265.61 201-211 K.AAEEEINSLYK.V   
  1359.79 77-89 R.ALGISSVFLQGLR.S   
  2081.01 174-191 R.LMLQTETIQAGADDFKER.Y Oxidation M175 
  2179.07 221-239 K.MDLESQIESLKEELGSLSR.N Oxidation M221 
Serum Albumin 69321 1622.78 233-245 K.DVFLGMFLYEYAR.R   
  1638.77 233-245 K.DVFLGMFLYEYAR.R Oxidation M238 
αA-Crystallin 19897 1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
βB1-Crystallin 28006 1449.76 61-72 R.LVVFELENFQGR.R   
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  1164.65 93-103 K.VLGDVIEVHGK.H   
Complex 4 
Filensin 74499 942.51 312-319 R.IIEIEGNR.L   
  1098.64 294-303 R.QLAVAQQTLK.N   
  1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1373.7 277-287 K.EIEETERVLEK.S   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1979.03 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2639.18 255-275 K.SAHECYDDEIQLYNEQIETLR.K Propionamide C259 
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2767.28 255-276 K.SAHECYDDEIQLYNEQIETLRK.E Propionamide C259 




  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3051.55 147-173 K.EADEALLHDLRLQLEAQFLQDDISAAK.D Deamidation N155 
  3316.73 320-351 R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A 
  
  3338.79 179-208 K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E 
Oxidation M207 
  3466.89 178-208 K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E 
Oxidation M207 
  3724.97 179-211 K.NLLEVQTYISILQQIIHTTPPASIVTSGMRE
EK.L 
Oxidation M207 
  3755.97 312-347 R.IIEIEGNRLTSAFIETPIPLFTQSHGVSLSTG
SGGK.D 
  
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
  1449.77 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
  2007.02 93-110 R.SIIVSAGPWVAFEQSNFR.G   
  2439.13 161-182 K.GNTIEIQGDDAPSLWVYGFSDR.V   
αB-Crystallin 20146 1164.65 93-103 K.VLGDVIEVHGK.H   
  1373.7 12-22 R.RPFFPFHSPSR.L   
  2623.37 124-149 R.IPADVDPLTITSSLSSDGVLTVNGPR.K   
  2624.35 124-149 R.IPADVDPLTITSSLSSDGVLTVDGPR.K Deamidation N146 
αA-Crystallin  979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1285.63 88-98 K.VQDDFVEIHGK.H   
  3363.64 22-49 R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
  1759.83 146-160 R.VQSGTWVGYQYPGYR.G   
  2189.01 169-188 K.GDYKDSSDFGAPHPQVQSVR.R   
γS-Crystallin 20993 1516.73 8-19 K.ITFYEDKNFQGR.R   
  1896.98 132-146 K.VLEGVWIFYELPNYR.G   
Phakinin 45851 1359.79 77-89 R.ALGISSVFLQGLR.S   
Niban-like 
Protein 2 









Filensin 74499 942.51 312-319 R.IIEIEGNR.L   
  1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1840.87 125-138 R.SKYENECECQLLLK.E 2 Propionamide C131 
C133 
  1979.02 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2639.18 255-275 K.SAHECYDDEIQLYNEQIETLR.K Propionamide C259 
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2767.28 255-276 K.SAHECYDDEIQLYNEQIETLRK.E Propionamide C259 
  2831.47 320-247 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3316.73 320-351 R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A 
  
  3338.79 179-208 K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E 
Oxidation M207 
  3466.89 178-208 K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E 
Oxidation M207 
  3724.97 179-211 K.NLLEVQTYISILQQIIHTTPPASIVTSGMRE
EK.L 
Oxidation M207 
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
  1449.76 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
  2007.02 93-110 R.SIIVSAGPWVAFEQSNFR.G   
αA-Crystallin 19897 979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1285.63 89-99 K.VQDDFVEIHGK.H   
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  1164.65 93-103 K.VLGDVIEVHGK.H   
  1373.7 12-22 R.RPFFPFHSPSR.L   
  4003.02 23-56 R.LFDQFFGEHLLESDLFPTSTSLSPFYLRPPS
FLR.A 
  
Serum Albumin 69321 1622.78 233-245 K.DVFLGMFLYEYAR.R   
  1638.77 233-245 K.DVFLGMFLYEYAR.R Oxidation M238 
γS-Crystallin 20993 1516.73 8-19 K.ITFYEDKNFQGR.R   
  1896.98 132-146 K.VLEGVWIFYELPNYR.G   
Phakinin 45851 1359.79 77-89 R.ALGISSVFLQGLR.S   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
Niban-like 
Protein 2 





Filensin 74499 1182.67 353-362 R.LQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1979.02 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-176 R.LQLEAQFLQDDISAAKDR.H   
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3316.73 320-351 R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A 
  







  3466.89 178-208 K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E 
Oxidation M207 
  3756.96 312-347 R.IIEIEGNRLTSAFIETPIPLFTQSHGVSLSTG
SGGK.D 
Deamidation N318 
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  1164.65 93-103 K.VLGDVIEVHGK.H   
  1191.62 73-82 K.DRFSVNLDVK.H   
  1373.7 12-22 R.RPFFPFHSPSR.L   
  2623.37 124-149 R.IPADVDPLTITSSLSSDGVLTVNGPR.K   
  2624.35 124-149 R.IPADVDPLTITSSLSSDGVLTVDGPR.K Deamidation N146 
  2943.52 122-149 K.YRIPADVDPLTITSSLSSDGVLTVDGPR.K Deamidation N146 
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
  1449.76 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
  2007.02 93-110 R.SIIVSAGPWVAFEQSNFR.G   
Serum Albumin 69321 1622.78 233-245 K.DVFLGMFLYEYAR.R   
  1638.77 233-245 K.DVFLGMFLYEYAR.R Oxidation M238 
αA-Crystallin 19897 979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1285.63 89-99 K.VQDDFVEIHGK.H   
γS-Crystallin 20993 1896.98 132-146 K.VLEGVWIFYELPNYR.G   
Phakinin 45851 1359.79 77-89 R.ALGISSVFLQGLR.S   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
LIM Domain and 
Actin-binding 
Protein 1 
 1174.58 165-175 K.ISADEDSLAVR.S 2 Deamidation N168 
N170 
Complex 7 
Filensin 74499 1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1840.87 125-138 R.SKYENECECQLLLK.E 2 Propionamide C131 
C133 
  1979.02 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2639.18 255-275 K.SAHECYDDEIQLYNEQIETLR.K Propionamide C259 
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2767.28 255-276 K.SAHECYDDEIQLYNEQIETLRK.E Propionamide C259 
  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3316.73 320-351 R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A 
  
  3338.79 179-208 K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E 
Oxidation M207 
  3466.89 178-208 K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E 
Oxidation M207 
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  1164.65 93-103 K.VLGDVIEVHGK.H   
  1373.7 12-22 R.RPFFPFHSPSR.L   
  2623.37 124-149 R.IPADVDPLTITSSLSSDGVLTVNGPR.K   
  2624.35 124-149 R.IPADVDPLTITSSLSSDGVLTVNGPR.K Deamidation N146 
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
  1449.76 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
Serum Albumin 69321 1622.78 233-245 K.DVFLGMFLYEYAR.R   
  1638.77 233-245 K.DVFLGMFLYEYAR.R Oxidation M238 
αA-Crystallin 19897 1036.53 13-21 R.TLGPFYPSR.L   
  1171.59 79-88 K.HFSPEDLTVK.V   
  1174.62 55-65 R.TVLDSGISEVR.S   
Phakinin 45851 1359.79 77-89 R.ALGISSVFLQGLR.S   
  1878.98 122-137 K.VHALEQVSQELETQLR.M   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   






Filensin 74499 1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1979.02 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2767.28 255-276 K.SAHECYDDEIQLYNEQIETLRK.E Propionamide C259 
  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3316.73 320-351 R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A 
  
  3338.79 179-208 K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E 
Oxidation M207 
  3466.89 178-208 K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E 
Oxidation M207 
  3756.96 312-347 R.IIEIEGDRLTSAFIETPIPLFTQSHGVSLSTG
SGGK.D 
Deamidation N318 
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  1164.65 93-103 K.VLGDVIEVHGK.H   
  1191.62 73-82 K.DRFSVNLDVK.H   
  1373.7 12-22 R.RPFFPFHSPSR.L   
  2623.37 124-149 R.IPADVDPLTITSSLSSDGVLTVNGPR.K   
  2624.35 124-149 R.IPADVDPLTITSSLSSDGVLTVDGPR.K Deamidation N146 
  2943.52 122-149 K.YRIPADVDPLTITSSLSSDGVLTVNGPR.K   
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
  1449.76 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
  2007.02 93-110 R.SIIVSAGPWVAFEQSNFR.G   
αA-Crystallin 19897 979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1285.63 89-99 K.VQDDFVEIHGK.H   
  3363.64 22-49 R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q   
Phakinin 45851 1359.79 77-89 R.ALGISSVFLQGLR.S   
γS-Crystallin 20993 1896.98 132-146 K.VLEGVWIFYELPNYR.G   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
Complex 9 
Filensin 74499 1182.67 352-362 R.ALQDITAAKPR.Q   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1555.76 470-483 R.HVLVTGDADYVDPR.F Deamidation N478 
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1635.86 144-157 R.LNKEADEALLHDLR.L Deamidation N155 
  1635.86 144-157 R.LDKEADEALLHNLR.L Deamidation N145 
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1725.94 294-308 R.QLAVAQQTLKNELDR.Y   
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1788.93 158-173 R.LQLEAQFLQDDISAAK.D   
  1840.87 125-138 R.SKYENECECQLLLK.E 2 Propionamide C131 
C133 
  1979.02 223-239 R.SQLEEGREVLSHLQAQR.V   
  2060.05 158-175 R.LQLEAQFLQDDISAAKDR.H   
  2639.18 255-275 K.SAHECYDDEIQLYNEQIETLR.K Propionamide C259 
  2722.33 24-50 R.AAEPERPADEGWAGATSLAALQGLGER.
V 
  
  2767.28 255-276 K.SAHECYDDEIQLYNEQIETLRK.E Propionamide C259 




  2831.47 320-347 R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D   
  3316.73 320-351 R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A 
  
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   





  1449.76 61-72 R.LVVFELENFQGR.R   
  1456.7 203-214 R.GYQYLLEPGDFR.H   
  1718.8 188-202 K.VSSGTWVGYQYPGYR.G   
  1934.99 236-252 K.QWHLEGSFPVLATEPPK.-   
  2007.02 93-110 R.SIIVSAGPWVAFEQSNFR.G   
  2439.13 161-182 K.GNTIEIQGDDAPSLWVYGFSDR.V   
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  921.48 75-82 R.FSVDLDVK.H Deamidation N78 
  1164.65 93-103 K.VLGDVIEVHGK.H   
  1191.62 73-82 K.DRFSVNLDVK.H   
  1373.7 12-22 R.RPFFPFHSPSR.L   
  1511.67 57-69 R.APSWFDTGLSEMR.L Oxidation M68 
  1715.9 93-107 K.VLGDVIEVHGKHEER.Q   
  1881.9 57-72 R.APSWFDTGLSEMRLEK.D Oxidation M68 
  2624.35 124-149 R.IPADVDPLTITSSLSSDGVLTVDGPR.K Deamidation N146 
αA-Crystallin 19897 979.57 71-78 K.FVIFLDVK.H   
  1036.53 13-21 R.TLGPFYPSR.L   
  1171.59 79-88 K.HFSPEDLTVK.V   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1192.63 12-21 K.RTLGPFYPSR.L   
  1285.63 89-99 K.VQDDFVEIHGK.H   
  3363.64 22-49 R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q   
Phakinin 45851 1353.72 90-103 R.SSGLATVPAPGLER.D   
  1359.79 77-89 R.ALGISSVFLQGLR.S   
  1878.98 122-137 K.VHALEQVSQELETQLR.M   
  2081.01 174-191 R.LMLQTETIQAGADDFKER.Y Oxidation M175 
γS-Crystallin 20993 1516.73 8-19 K.ITFYEDKNFQGR.R   
  1728.89 159-174 R.KPIDWGAASPAVQSFR.R   
  1896.98 132-146 K.VLEGVWIFYELPNYR.G   
βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
  1725.81 173-188 K.DSSDFGAPHPQVQSVR.R   
  1759.83 146-160 R.VQSGTWVGYQYPGYR.G   
  2189.01 169-188 K.GDYKDSSDFGAPHPQVQSVR.R   
βA3-Crystallin 25134 1454.70 33-44 K.ITIYDQENFQGK.R   
  1499.74 126-137 K.MTIFEKENFIGURER.Q Oxidation M126 
  1690.75 96-109 R.WDAWSGSNAYHIER.L   
γD-Crystallin 20715 1270.6 143-152 R.QYLLMPGDYR.R Oxidation M147 
Phosphoglycerate 
Kinase 1 
44586 2022.03 280-297 K.ITLPVDFVTADKFDENAK.T   
βA4-Crystallin 22360 1741.85  R.EWGSHAPTFQVQSIR.R   
Complex 10 
Filensin 74499 1014.54 484-492 R.FYVSSITAK.G   
  1094.5 484-492 R.FYVSSITAK.G Phosphorylation S488 
  1131.6 621-630 K.TVEVVESIEK.I   
  1279.65 147-157 K.EADEALLHNLR.L   
  1280.64 147-157 K.EADEALLHDLR.L Deamidation N155 
  1306.63 457-467 K.EPETPTELYTK.E   
  1310.68 78-90 R.LGELAGPEDALAR.Q   
  1386.6 457-467 K.EPETPTELYTK.E Phosphorylation T460 
  1554.78 470-483 R.HVLVTGDANYVDPR.F   
  1555.76 470-483 R.HVLVTGDADYVDPR.F Deamidation N478 
  1618.81 454-467 R.SPKEPETPTELYTK.E   
  1634.87 144-157 R.LNKEADEALLHNLR.L   
  1671.9 240-254 R.VELQAQTTTLEQAIK.S   
  1698.77 454-467 R.SPKEPETPTELYTK.E Phosphorylation T460 
  1726.92 294-308 R.QLAVAQQTLKDELDR.Y Deamidation N304 
  1725.9 294-308 R.QLAVAQQTLKNELDR.Y   
  1796.84 545-560 K.EIEPDGAELEGPEEKR.E   
  1840.91 468-483 K.ERHVLVTGDADYVDPR.F Deamidation N478 
Phakinin 45851 1265.61 201-211 K.AAEEEINSLYK.V   
  1266.6 201-211 K.AAEEEIDSLYK.V Deamidation N207 
  1268.72 286-297 K.NRVEAGALLQAK.Q   
  1269.7 286-297 K.DRVEAGALLQAK.Q Deamidation N286 
  1307.63 221-231 K.MDLESQIESLK.E Oxidation M221 
  1353.72 90-103 R.SSGLATVPAPGLER.D   
  1359.79 77-89 R.ALGISSVFLQGLR.S   
  1393.71 200-211 R.KAAEEEINSLYK.V   
  1394.69 200-211 R.KAAEEEIDSLYK.V Deamidation N207 
  1660.77 401-415 K.DVASYHALLDREESG.-   
  1795.87 174-189 R.LMLQTETIQAGADDFK.E Oxidation M175 





  2075.97 155-173 R.ASWASSCQQVGEAVLENAR.L Propionamide C161 
  2081.01 174-191 R.LMLQTETIQAGADDFKER.Y Oxidation M175 
Actin, 
cytoplasmic 1 
41719 1176.61 316-326 K.EITALAPSTMK.I Oxidation M325 
  1197.7 29-39 R.AVFPSIVGRPR.H   
  1515.69 360-372 K.QEYDESGPSIVHR.K   
  1789.88 239-254 K.SYELPDGQVITIGNER.F   
  1953.06 96-113 R.VAPEEHPVLLTEAPLNPK.A   
  2230.06 292-312 K.DLYANTVLSGGTTMYPGIADR.M Oxidation M305 
αA-Crystallin 19897 1036.53 13-21 R.TLGPFYPSR.L   
  1174.62 55-65 R.TVLDSGISEVR.S   
  1192.63 12-21 K.RTLGPFYPSR.L   
  1285.63 89-99 K.VQDDFVEIHGK.H   
Vimentin 53619 1168.71 130-139 K.ILLAELEQLK.G   
  1322.61 197-207 R.EEAENTLQSFR.Q   
Glutathione 
Synthetase 
52352 940.57 26-34 R.ALAEGVLLR.T   
  1027.57 222-230 R.AIENELLAR.N   
Paralemmin-1 42050 1085.64 42-51 R.VLSSTTLLPR.Q   
Spectrin α chain 28436
4 
989.53 251-259 K.LFGAAEVQR.F   
  1084.62 286-295 R.DLASVQALLR.K   
Retinal 
Dehydrogenase 1 





βB2-Crystallin 23365 1407.74 109-120 K.IILYENPNFTGK.K   
βB1-Crystallin 28006 1124.59 151-160 K.ISLFEGANFK.G   
αB-Crystallin 20146 920.5 75-82 R.FSVNLDVK.H   
  1164.65 93-103 K.VLGDVIEVHGK.H   
BASP 1 22680 2297.13 98-121 K.AEPPKAPEQEQAAPGPAAGGEAPK.A   





65047 1097.64 93-101 K.VQEDIILLR.E   
NCAM 14380
0 
1244.62 706-715 K.LSPYVNYSFR.V   
βA3-Crystallin 25134 1454.7 33-44 K.ITIYDQENFQGK.R   




















Tukey’s test of percentage of deamidation for P7: Test performed using data presented in 
Table 5.5. Statistical significance at P≤0.01 shaded in light green, P≤0.05 shaded in dark 
green. 
P7 (Q151) ABC + heat PBS PBS + heat Urea + heat 
ABC + heat  0.19 0.002 0.12 
PBS   0.03 0.98 
PBS + heat    0.04 
Urea + heat     
 
 
Tukey’s test of percentage of deamidation for P8: Test performed using data presented in 
Table 5.5. Statistical significance at P≤0.01 shaded in light green, P≤0.05 shaded in dark 
green. 
P8 (N146) ABC + heat PBS PBS + heat Urea + heat 
ABC + heat  0 0.01 0.2 
PBS   0.25 0.02 
PBS + heat    0.65 
Urea + heat     
 
 
 
 
 
 
 
 
 
 
 
 
